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ABSTRACT OF DISSERTATION 
 
 
 
INVESTIGATIONS OF OXIDATIVE STRESS EFFECTS AND THEIR 
MECHANISMS IN RAT BRAIN AFTER SYSTEMIC ADMINISTRATION OF CERIA 
ENGINEERED NANOMATERIALS 
 
 
Advancing applications of engineered nanomaterials (ENM) in various fields 
create the opportunity for intended (e.g. drug and gene delivery) or unintended (e.g. 
occupational and environmental) exposure to ENM. However, the knowledge of ENM-
toxicity is lagging behind their application development. Understanding the ENM hazard 
can help us to avoid potential human health problems associated with ENM applications 
as well as to increase their public acceptance. Ceria (cerium [Ce] oxide) ENM have many 
current and potential commercial applications. Beyond the traditional use of ceria as an 
abrasive, the scope of ceria ENM applications now extends into fuel cell manufacturing, 
diesel fuel additives and for therapeutic intervention as a putative antioxidant. However, 
the biological effects of ceria ENM exposure have yet to be fully defined. Both pro-and 
anti-oxidative effects of ceria ENM exposure are repeatedly reported in literature. EPA, 
NIEHS and OECD organizations have nominated ceria for its toxicological evaluation. 
All these together gave us the impetus to examine the oxidative stress effects of ceria 
ENM after systemic administration.  
 
Induction of oxidative stress is one of the primary mechanisms of ENM toxicity. 
Oxidative stress plays an important role in maintaining the redox homeostasis in the 
biological system. Increased oxidative stress, due to depletion of antioxidant enzymes or 
molecules and / or due to increased production of reactive oxygen (ROS) or nitrogen 
(RNS) species may lead to protein oxidation, lipid peroxidation and/or DNA damage.  
Increased protein oxidation or lipid peroxidation together with antioxidant protein levels 
and activity can serve as markers of oxidative stress.  
 
To investigate the oxidative stress effects and the mechanisms of ceria-ENM 
toxicity, fully characterized ceria ENM of different sizes (~ 5nm, 15nm, 30nm, 55nm and 
nanorods) were systematically injected into rats intravenously in separate experiments. 
Three brain regions (hippocampus, cortex and cerebellum) were harvested from control 
and ceria treated rats after various exposure periods for oxidative stress assessment. The 
levels of oxidative stress markers viz. protein carbonyl (PC), 3-nitrotyrosine (3NT), and 
protein bound 4-hydroxy-2-trans-nonenal (HNE) were evaluated for each treatment in 
each control and treated rat organ. Further, the levels and activities of antioxidant 
proteins, such as catalase, glutathione peroxidase (GPx), glutathione reductase (GR), 
super oxide dismutase (SOD), were measured together with levels of heat shock proteins 
heme oxygenase -1 and 70 (HO-1 and Hsp-70). In addition, the levels of pro-
inflammatory cytokines IL-1β, TNF-α, pro-caspase-3, and autophagy marker LC-3A/B 
were measured by Western blot technique. In agreement with the literature-proposed 
model of oxidative stress hierarchy mechanism of ENM-toxicity, the statistical analysis 
of all the results revealed that the ceria ENM-induced oxidative stress mediated 
biological response strongly depends on the exposure period and to some extent on the 
size of ceria ENM. More specifically, a single intravenous injection of ceria ENM 
induced tier-1 (phase-II antioxidant) response after shorter exposure periods (1 h and 20 
h) in rat brain. Upon failure of tier-1 response after longer exposure periods (1 d to 30 d), 
escalated oxidative stress consequently induced tier-2 and tier-3 oxidative stress 
responses. Based on our observations made at chronic exposure period (90 d) after the 
single i.v. injection of ceria ENM, we could extend the model of oxidative stress 
hierarchy mechanisms for ceria-ENM-induced toxicity. Considering the evaluation of all 
the oxidative stress indices measured in 3-brain regions, oxidative stress effects were 
more prominent in hippocampus and the least in cerebellum, but no specific pattern or 
any significant difference was deduced. 
 
Keyword: Ceria, cerium oxide, nanomaterial, nanoparticles, nanotoxicity, oxidative 
stress, phase-II enzymes. 
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CHAPTER 1 
 
INTRODUCTION 
 
The rapid growth of nanotechnology has given rise to vast array of engineered 
nanomaterials (ENM) that vary in size, shape, charge, chemistry, coating, and solubility. 
The present generation ENMs are designed to accomplish one type of task, but next 
generation ENM are envisioned to accomplish multiple tasks such as smart drug delivery 
devices, sensors, actuators. Due to the unique physical, chemical, electrical, optical, and 
magnetic properties, ENMs could accomplish variety of applications in various field 
including electronics, electrical, medicinal, chemical industry etc. The significantly 
different properties of ENM compared to constituent bulk material are attributed to the 
size- surface area, chemical composition, crystallinity, and surface functionalization of 
ENM. These very properties also dictate chemical and biological behavior of ENM and 
hence their toxicity (Nel et al. 2006; Buzea et al. 2007).  
According to U.S. National Nanotechnology Initiative (NNI), an intentionally 
manufactured material with one or more dimensions in the range of 1 to 100 nm is 
referred to as engineered nanomaterial (ENM) (NSET). ENM are compatible in size to 
viruses, and due to their small sizes ENM can enter, and translocate within with 
circulatory system, penetrate biological barriers, and gain access to different biological 
compartments, as well as organelles. Therefore, although impressive from useful 
application point of view, the novel properties of ENM raise concern about detrimental 
effects on biological systems. There are about 40,000 publications discussing the 
usefulness of nanomaterials, however, only 500 discuss the potential toxic effects of the 
same (Buzea et al. 2007). As much as it is important to give attention to the health effects 
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related to ENM, at the same time it is important to remember that although by virtue of 
their unique physico-chemical properties all the ENM have potential to have toxic 
biological effects, not all the ENM are actually toxic to biological system (Oberdorster et 
al. 2009). Therefore, the major challenge before toxicologists is not to test every variation 
of new nanoparticles generated but to identify key factor andor tests that can be used to 
predict toxicity of ENM (Stone et al. 2006). Nel and co-worker and some other 
researchers are proposing that the biological hazards associated with ENM are best 
predicated by examining the oxidative stress effects within cells (Nel et al. 2006; Stone et 
al. 2006; Xia et al. 2006; Buzea et al. 2007; Meng et al. 2009).  
One such metal oxide ENM is ceria (a.k.a. Cerium oxide, CeO2, CAS# 1306-38-3), it has 
wide range of commercial applications including, abrasive for chemical-mechanical 
planarization, of advanced integrated circuits, as a diesel fuel catalyst ceria it  is used to 
improve combustion, reduce fuel consumption, and decrease exhaust emission, solid 
oxide fuel cells solar cells (Murray et al. 1999; Esposito et al. 2008), (Corma et al. 2004) 
gas sensors (Izu et al. 2003), and UV screens (Gilliss et al. 2005). The popularity of ceria 
has drawn attention of NIEHS and OECD. Both these organization have nominated nano-
scale ceria for toxicological consideration (NIEHS 2006; Oberdorster et al. 2009).  
The primary anticipated routes of human exposure to ENMs intended for industrial or 
environmental applications include inhalation exposure, dermal uptake, and oral 
ingestion with possible subsequent absorption of ENMs into systemic circulation. 
Translocation from the lung to systemic organs, particularly the liver, has been observed 
before (Yokel et al. 2009). There is considerable interest in ENMs to enhance drug 
delivery to the brain (Koziara et al. 2006; Nazem et al. 2011). Although some data exist 
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on the absorption properties and associated toxicities of ENMs after exposure via the 
pulmonary, oral, and topical routes, little is known about their distribution into the brain 
once they reach systemic circulation. 
We selected ceria for the present dissertation work because; ceria has been reported to 
have both anti- and pro-oxidant effects. Ceria ENMs have toxic effects associated with 
increased oxidative stress (Brunner et al. 2006; Thill et al. 2006) . However, numerous 
studies reported ceria ENM to be neuroprotective, suggesting that it has utility in medical 
disorders caused by reactive oxygen species (ROS) (Chen et al. 2006; Schubert et al. 
2006; Das et al. 2007; Xia et al. 2008). Many of these results were attributed to 
antioxidant effects caused by defects (vacancies) in the ENM lattice structure and/or 
cerium (Ce) ion redox cycling. All these studies of the oxidative stress of ENMs were 
conducted in cell culture.  
In addition to this, ceria is a very good candidate to characterize ENM biodistribution 
from blood and its effect on oxidative stress points because 1) It is an insoluble metal 
oxide that can be readily observed in situ by electron microscopy (EM), making it a 
useful in vivo tracer, 2) it is redox active (Zhang et al. 2004), 3) it can be functionalized 
[e.g. (Qi et al. 2008)], 4) it is available in sizes relevant to for up take across the blood 
brain barrier, one of the most limiting mammalian membranes, and  it can be produced in 
a  variety of different shapes by many different methods (Yokel et al. 2009).  
The interest in ceria as a potential therapeutic agent with anti-oxidant properties is also 
increasing and there is possibility of future research for medical applications probability 
that it will be further studied for medical applications (Celardo et al. 2011). Therefore, 
understanding of its distribution from the central compartment (blood) and resultant 
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effects is important. The current study is the first report of the distribution and effects of 
ceria from the central compartment, after introduction into blood. As stated in a review of 
the risks of industrial nanomaterials, ‘The effect of nanomaterials on organs ‘‘inside’’ the 
body (e.g., liver and brain) and the blood have been studied from the few publications on 
the permeation of nanomaterials through the lung, skin, or intestinal barrier . . . ’ 
(Wolfgang 2004). 2004). However, the form of ceria employed in the present study 
would not be effective as a vehicle for drug delivery to the brain. 
The objective of this work is; 
1) To determine oxidative stress end-points in rat brain after its biodistribution from 
blood; 
a. Measure marker of cellular redox status GSH:GSSG ratio 
b. Measure levels and activities of phase II enzymes GPx, GR, catalase, 
SOD, GST etc. 
c. Measure levels of protein oxidation, protein nitration and lipid 
peroxidation markers, as well as heat shock proteins. 
d. Measure levels of cytokines, pro-apoptotic proteins, marker of autophagy. 
2) Influence of size, shape and exposure period on the oxidative stress effects of 
ceria ENM 
a. Sizes: ~5nm, 15 nm, 30 nm, 55 nm 
b. Aspect ratio / Shapes: cubic (aspect ratio-1), nanorod (aspect ratio- 5-60) 
c. Exposure periods: 1 h, 20 h, 1 d, 7 d, 30 d, and 90 d 
3) To understand the mechanism of oxidative stress effects induced by ceria ENM  
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Obtain different oxidative stress end-points from different exposure period after 30 nm 
ceria ENM administration. 
 
 
 
 
 
 
 
 
 
 
 
. 
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CHAPTER 2 
 
BACKGROUND 
The various new  technologies are continuously exploring new avenues for applications 
of different nanoscale products and materials in optoelectronics, electronics, magnetic, 
medicine imaging, drug delivery, catalysis, dental bonding, corrosion-resistance, coating 
applications, consumer goods, motor vehicles, personal care products, and cosmetics 
(O'Brien et al. 2008). These applications capitalize on the physico-chemical properties of 
engineered nanomaterials (ENMs) such as strength, stiffness, weight reduction, stability, 
anti-fogging, scratch resistance, as well as optical, electromagnetic, catalytic, and 
pharmacokinetic. ENMs such as carbon based single walled (SWCNTs) and multiwall 
(MWCNTs) nanotubes, metal and metal oxide based nanoparticles, and nanofilaments, 
and quantum dots are building block for various current technological application. There 
are ~2500 commercial nanomaterials have been identified by Nanowrek, which includes 
~27% metal oxides, 24% CNTs, 18% elements, 7% quantum dots and 5% fullerenes 
(Yokel et al. 2011).  
2.1. What are engineered nanomaterials (ENMs)?  
According to U.S. National Nanotechnology Initiative (NNI), nanoscale materials that are 
intentionally manufactured with at least one dimension in the range of 1 to 100 
nanometers (nm) and have properties that are often unique owing to their dimensions 
(Yokel et al. 2011) (Figure 2.1a) can be termed as engineered nanomaterials (ENMs).  
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Figure 2.1a: The size of nanomaterials plays key role in determining their physico-
chemical and biological behavior. Typical nanoparticles size can vary from 1-100 nm and 
could be as small as glucose molecules or DNA or as big as a virus and can get access to 
the cellular compartments. Due to the smaller size of a nanomaterial the quantum effects 
becomes dominant, so similar to atoms and molecules nanomaterials may behave 
according to lows of quantum mechanics instead of  laws of classical mechanics. 
[Adapted from (Yokel et al. 2011) with the copyright permission from BioMed Central 
publishing groups] 
ENMs exhibit properties which differ in fundamental and valuable ways from those of 
individual atoms, molecules and bulk matters. There are two main size-dependent factors 
that govern the properties of nanomaterials: surface effects (related to the fraction of 
atoms or molecules present on the surface), and quantum effects (related to the materials 
with delocalized electrons) (Roduner 2006). Compare to micromaterials or bulk 
materials, for a given mass or volume nanomaterials have very large surface areas and a 
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high particle number per unit mass.. The specific surface area (surface area/ mass) and 
fraction of atoms or molecules on the surface of nanomaterial are inversely proportional 
to the size of nanomaterials (Figure 2.1b). Due to availability of larger specific surface 
area, chemical reactivity of nanomaterials may enhance by multiple -folds (Buzea et al. 
2007). Thus the surface effects are a key to define the chemical and biological properties 
of nanomaterials.  
 
Figure 2.1b: Specific surface area (surface area/ mass) (left) and the percent molecules 
present on the surface of ENMs (Bhabra et al.) are inversely proportional to the size of 
ENM. At 100 nm of size ~2% of molecules are present on the surface, but when size 
decreases to 10 nm or 2 nm, number of surface molecules increases up to 20% and 60%. 
As molecules present on surface are involved in the chemical interaction with 
surroundings, % surface molecules determines the chemical and biological reactivity of 
nanomaterials. [Courtesy (Roduner 2006)and (Oberdörster et al. 2005)] 
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2.2. Physico-chemical properties of ENMs 
The differential chemical as well as biological reactivity of ENMs than their bulk 
materials is by virtue of physico-chemical properties such as size, shape or aspect ratio, 
aggregation, composition, and surface functionalization etc.  
2.2.1. Size and surface area: Due to their small size, ENMs can be translocated from 
their point of entry to circulatory or lymphatic systems and gain access to various remote 
cellular compartments like the cardiovascular system or even brain, which are usually 
inaccessible to larger particles. Studies have demonstrated that small ENMs (<100 nm) 
cause adverse respiratory health effects compare to larger ENM of same material 
(Oberdörster et al. 1994; Donaldson et al. 2003; Oberdörster et al. 2005; Buzea et al. 
2007). As the size of ENMs decreases, their specific surface area and fraction of atoms or 
molecules present on the ENM-surface increases exponentially (Figure 2.1b). With 
decreasing size, surface effects and quantum effects also become dominant, which are 
primary factors that render the physico-chemical properties of ENM significantly 
different than bulk materials. Especially ENM with one or more dimensions in the range 
of ~15 nm to 30 nm, exhibits differential chemical behavior  and potential for more 
profound biological effects than either smaller or larger ENM with similar composition 
(Jiang et al. 2008; Auffan et al. 2009; Yokel et al. 2011). Therefore, size and specific 
surface area, are important factors to determine the toxicity of ENMs. 
2.2.2. Aspect ratio: The morphology of ENMs can be sub- categorized as high aspect 
ratio and low aspect ratio ENMs. The classification of aspect ratio (length to diameter) is 
a relative terminology, typically ENMs with length ≤ 1 µm is considered as low aspect 
ratio materials, length >1 µm is considered as high aspect ratio materials (Yokel et al. 
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2011). Low aspect ratio morphology includes spheres, ovals, cubes, prisms, helices, 
pillar, wires or rods (Buzea et al. 2007). High aspect ratio morphology includes 
nanotubes and nanowires, with various shapes like helices, zigzags,belts, with varing 
diameters and lengths (Buzea et al. 2007). Depending up on the aspect ratio (L-length / 
D-diameter) of nanofilament, the toxicity of ENM varies, generally higher the aspect 
ratio, the more toxic the particle is (Lippmann 1990). Due to low clearance of long length 
fibers or high aspect ratio ENM (> 20 µm) by alveolar microphages, their  accumulated 
lead to various degrees of pulmonary toxicity ranging from asbestosis, mesothelioma to 
lung cancer (Lippmann 1990; Buzea et al. 2007). High aspect ratio material with length > 
5µm and diameter ≥ 100 nm is considered highly toxic, regardless of its chemical 
composition (Buzea et al. 2007; Lewinski et al. 2008). However, studies with long 
SWCNT’s and MWCNT’s with diameter < 100 nm are reported to produce significant 
pulmonary toxicity compared to short length or spherical nanomaterials (Lam et al. 2004; 
Warheit et al. 2004; Muller et al. 2005; Bottini et al. 2006; Kostarelos 2008; Kim et al. 
2010). Similarly, even low aspect ratio material (D < 100 nm, L < 1 µm) which can 
escape phagocyte clearance entering into vascular system, might end up in various organs 
including brain, liver, kidney etc., causing adverse health effects (Buzea et al. 2007; 
Oberdorster et al. 2009; Yokel et al. 2011).  
2.2.3. Agglomeration: Depending upon chemical and electromagnetic properties on 
ENMs, they can exist as dispersed aerosols, suspension or colloidal solution or in the 
form of aggregates. ENMs composed of single constituent material like metal, metal 
oxide, or carbon have a tendency to agglomerate; similarly, ENMs with magnetic 
properties tend to form clusters. In an agglomerated state, ENM lose its high-surface area 
 11 
property and may behave as large particle depending upon the size of agglomerate. To 
prevent agglomeration, ENM are either coated with suitable materials or mixed with 
some other nanoscale material. For example magnetic ENM are coated with nonmagnetic 
materials (Buzea et al. 2007), metal oxide ENMs are coated with citrates (Hardas et al. 
2010), whereas mixing nanopowders of silica (SiO2) or titania (TiO2) with CNTs can 
reduce agglomeration of CNTs (Davé et al. 2006). 
2.2.4. Chemical composition: As stated  on physico-chemical properties of ENM and 
their toxicity relation, “….Therefore, the toxic potential (of ENM) may change by 
reducing the size of particles, but the threshold value depends upon the chemical nature 
of (nano) particles…..” (Fubini et al. 2010). ENM can be composed of single constituent 
materials like metal, metal oxides, inorganic material or carbon or composites of several 
materials as a mixture or doping of one material with other. The chemical properties of 
constituent materials play important roles in chemical reactivity of ENM as well as in the 
interaction of ENM with biological matter. For example, transition or redox active metal/ 
metal-oxide based ENMs also exhibit high catalytic behavior and often facilitate 
biological reactions or generate free radicals (Nel et al. 2006). This point is exemplified 
by the finding that zero valent iron ENM induced ROS levels in human bronchial 
epithelial cells owing to the redox properties of iron (Keenan et al. 2009). On other hand, 
TiO2 responding to UV radiation can generate electron-hole pairs which can further 
induce reactive oxygen species (ROS) levels in biological system (Xia et al. 2008), 
whereas zinc metal is important for mammalian cells and therefore exposure to ZnO 
ENM can interfere with various metabolic reactions; in addition, the zinc ions that leach 
out from the ENM can induce ROS levels in cells (Xia et al. 2008).  
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2.2.5. Surface coating or functionalization: The surface of ENM is a key in 
determining the toxicity of ENM, as the surface makes direct contact with biological 
matter. Surface modification employed in drug development research, usually prolong 
ENM circulation in the blood, enhance its uptake at target site, affect its translocation, 
and alter the excretion of ENM. Surface coating can dramatically change the magnetic, 
electric, optical properties and chemical reactivity ultimately manipulating the biological 
toxicity. Researchers have shown that the presence of oxygen, ozone (Risom et al. 2005), 
oxygen radicals (Lioy et al. 2002), and transition metals on surface of ENM (Fubini et al. 
2003), lead to generation of ROS and induction of inflammation. Studies on hamsters 
showed that formation of blood clots was increased when the surface of polystyrene 
ENM was functionalized by amine groups (Nemmar et al. 2002). Nickel ferrite ENM 
showed differential cytotoxic effects with and without surface coating of oleic acid (Yin 
et al. 2005). The cytotoxicity of fullerenes was systematically correlated with the 
chemical functionalization on the surface of ENM, and with decreased cell viability in 
human (skin and liver) carcinoma cells caused by increased lipid peroxidation mediated 
by ROS production (Sayes et al. 2004). Gold ENMs with CTAB coating were rendered 
nontoxic when the coating was replaced by benign polyethylene glycol moieties 
(Goodman et al. 2004; Connor et al. 2005). Cytotoxicity of quantum dots of CdS was 
dramatically reduced after application of proper surface coating material (Derfus et al. 
2003).  
2.3. Interactions at nano-bio interface  
Currently our understanding of bio-physicochemical interactions at the nano-bio interface 
is far from clear; however, some pockets of knowledge available can guide us to develop 
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an understanding of this matter. As explained in detailed in Section 2.2., chemical 
activity as well as biological reactivity of ENMs depend on factors like size, surface area, 
chemical composition, crystallinity and surface coating, etc. Due to the size, which is 
1000 to 10,000 smaller than a white blood cell, ENMs can travel with blood flow, 
potentially pass through cell membranes and can gain access to the various cellular 
compartments. However, once suspended in biological medium, it is the surface of the 
ENMs that directly interacts with biological environment. For a given size or specific 
surface area, the surface properties of ENMs are shaped by the material’s inherent 
properties like, chemical composition, surface functionalization, shape and angle of 
curvature, porosity, charge, crystallinity, heterogeneity, roughness, and hydrophobicity or 
hydrophilicity (Vertegel et al. 2004; Oberdörster et al. 2005; Nel et al. 2006). On the 
other hand, by virtue of characteristic like the ionic strength, pH, temperature, presence 
of large organic molecules of the surrounding media, ENMs may acquire some properties 
such as effective surface charge, particle aggregation, and state of dispersion, stability / 
biodegradability, dissolution characteristics, hydration and valence of the surface layer. 
With the combined contribution of the inherent and acquired properties, ENMs can 
interact with bio-medium through (i) promoting the adsorption of ions, biomolecules, and 
natural organic materials, (ii) double layer formation, (Owens Iii et al.) dissolution, or 
(Owens Iii et al.) minimizing free surface energy by surface reconstructuring.  
In biological fluid, blood or plasma, by virtue of original or pre-existing surface 
properties (hydrophobicity, size, radius of curvature, charge, coating that exert steric or 
electrostatic effects, etc.) of ENMs, proteins interact and form a corona around the ENM 
constituting a primary nano-bio interface. The dynamic nature of protein corona comprise 
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of characteristic protein adsorption and desorption, competitive binding interactions, 
steric hindrance offered by pre-adsorbed polymer or presence of detergent (from ENM 
suspension), and the protein profile of the biological fluid. The nature of corona also 
changes as ENM moves from one biological compartment to another.  
 
Figure 2.3a: Formation of protein corona is dictated by pre-existing properties of ENMs. 
The colored symbols represent various types of proteins and biomolecules with different 
physico-chemical properties. [Adapted from (Nel et al. 2009) with copyright permission 
from Nature Publishing Groups] 
The primary nano-bio interface will shape the fate of ENMs as well as they have 
influence on the structural conformation of proteins forming the corona. For instance, 
binding of proteins like complement and immunoglobulin to ENM, promotes receptor-
mediated phagocytosis clearance of ENMs; polyethylene glycol (Moreira et al.)-coating 
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hinders ENM interaction with plasma proteins which increases the circulation of 
PEGylated ENMs and decrease the clearance from body (Owens Iii et al. 2006). The 
presence of proteins and organic substances facilitates the leaching and solubalization of 
metal ions from ZnO, CdSe, iron oxide, and aluminum oxide based ENMs (Xia et al. 
2008). On the other hand ENM and nano-bio interface may also alter conformations of 
proteins that form a corona on ENM leading to exposure of new epitopes, alterations in 
protein function or enzymatic activities (Nel et al. 2009) (Figure 2.3a). An abiotic 
experiment has shown that ceria, copolymer ENM and CNTs act as a catalyst, exposing 
protein interaction domains that induce human β-microglobulin fibrillation (Baca et al. 
2006).  There is no biological evidence available yet; however repetition of same process 
in the brain could contribute to the neurodegenerative process in Alzheimer disease (Nel 
et al. 2009). Similarly, possible formation of electron-hole pair or electron confinement 
on ENM’s surface could oxidatively damage covalent bonding and cross-linking of 
protein-SH domains, e.g. SiO2 ENMs induces unfolding of α-helix, and cause loss of 
enzyme activity in chicken egg lysosomes (Vertegel et al. 2004). On a similar note, if 
cryptic epitopes of proteins are exposed on ENM surface, then newly exposed antigen 
sites may induce auto-immune response (Figure 2.3b) (Nel et al. 2009).  
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Figure 2.3b: Impact of nano-bio interactions on protein structure and function. The 
colored symbol represents various types of proteins with different physico-chemical 
properties. [Adapted from (Nel et al. 2009) with copyright permission from Nature 
Publishing Groups] 
2.4. Physico-chemical properties and toxicity of ENM 
With burgeoning technological growth, intentional or unintentional exposure to any 
material used in industrial, consumer, medical or research application has always been a 
major topic of concern. Similarly, from the past decade, researchers are putting efforts in 
investigation of potential health risk associated with nanomaterial usage. However, 
compared to the exponential growth of nanotechnology, the efforts in the field of toxicity 
of nanomaterials are negligible. For example, compare to the number of publications on 
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nanotechnology from year 1990 to 2005, the research publications on nanotoxicity during 
that period is less than 0.002% (Buzea et al. 2007; Yokel et al. 2009).  
Nanometer sized particles generated from natural activities such as dust storms, forest 
fires, volcanic eruptions, ocean and water evaporation, organisms-viruses, or as by-
products of human activities, like diesel and engine exhaust nanoparticles, cigarette 
smoke, burning coal or wood, building construction, and cosmetic or other consumer 
products etc., are known as ambient ultrafine particles (Buzea et al. 2007).  A short- or 
long-term exposure to any of these nano-sized materials is shown to have adverse health 
effects. This knowledge about toxicity of ambient nanomaterials has helped to form a 
basis to understand the potential adverse health effects of ENMs (Oberdörster et al. 2005; 
Buzea et al. 2007). The critical point to consider with ENMs is that they can be 
manufactured in almost any size and shape with variety of combinations of chemical 
compositions and surface coatings. These very properties of ENMs that are exploited for 
diverse applications of ENMs can have detrimental side-effects on health and 
environment. Therefore, while evaluating the nanotoxicity, it is important to consider the 
role of physico-chemical properties of ENMs in their toxicity (Oberdörster et al. 1994; 
Nel et al. 2006; Buzea et al. 2007; Fubini et al. 2010). In this dissertation research we 
have explored influence of size- and shape or aspect ratio as well as exposure period on 
the toxicity of ceria ENMs.    
The possible conformational and structural changes in protein corona leading to their 
functional disability can cause potential molecular mechanism of injury that could 
contribute to disease pathogenesis. The primary nano-bio interactions at lysosome are a 
key to use ENM in the drug delivery as well as for nanomaterial toxicity, however only 
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toxicity related points are discussed here. Amino-labeled polystyrene, cationic 
dendrimers and polymers bind with high affinity to the surface lipid-groups on lysosome, 
which then is endocytosed in the crowded vesicle. Once entered, amino groups from 
ENM keep the proton pumps on the lysosome surface in continuously active state, 
flooding the vesicle with chloride ions and water molecules. Eventually the lysosome 
swells beyond its capacity and bursts open expelling internal content, triggering 
intracellular Ca2+ release, ultimately causing cytotoxicity (Xia et al. 2007). In another 
experiment, uptake of ZnO ENM in lysosome accelerates its dissolution due to acidic 
environment and release of excess zinc ions into the cell can induce cytokine production 
and cytotoxicity (Xia et al. 2008). 
Another review article has summarized possible mechanisms by which ENMs can induce 
oxidative stress mediated cytotoxicity (Nel et al. 2006) (Figure 2.4). Fullerene or TiO2 
based or any other metal oxides based ENMs with discontinuous crystal planes and 
defects or with semiconductor type compositions or with electron donor groups can 
reduce biomolecules on their surface. Ambient ultrafine particles, carbon nanotubes or 
metal based ENMs (Fe) or organic materials (quinone) can facilitate Fenton type 
chemical reactions or enzymatic reaction. TiO2 based ENMs can act as photo-catalyst and 
generate electron and hole pair in presence of UV light, so they have applications in 
cosmetic industries, solar cells, etc. However, when ENM came in contact with 
biomaterial in UV or natural light, they may cause reduction of biological molecules (Xia 
et al. 2008). Zinc, cadmium and selenium ions leaching out from ZnO or CdSe or CdTe 
based ENMs can disrupt cellular metabolism (Kirchner et al. 2004; Zhang et al. 2007; 
Xia et al. 2008). 
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Figure 2.4: Oxidative stress mechanism of ENM cytotoxicity and involvement of surface 
chemistry. 
2.5. Free radicals, antioxidants and oxidative stress 
Oxidative stress is one of the important mechanisms of nanoparticles toxicity. 
Nanoparticles with metal atoms or ions, or electron donor or acceptor groups, any other 
redox active groups present on their surface can generate free radicals on their surface in 
presence of oxygen or ozone (Nel et al. 2006).  Further the free radicals can impart toxic 
effects by reacting with biological molecules and damage them.  
2.5.1. Free radicals: Free radicals are atoms, molecules or ions with one or more 
unpaired electrons that render them very labile. To counteract this labile condition, free 
radicals are strongly impelled to reacts with electron donor or acceptor groups. At the end 
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of the reaction, free radicals gain or lose an electron and become stable, while the other 
group or species become labile. This newly form secondary radical then react with some 
other group to regain the stability and thus a free radical chain reaction propagates. When 
a radical chain reaction occurs in biological system, it leaves biological molecules 
proteins, lipids and DNA oxidatively damaged. In aerobic organisms free radicals are 
generated in and through normal physiological processes. The major source of free 
radicals is electron transport chain in mitochondria, and some other sources are NADPH 
oxidase, xanthine oxidase, cytochrome P450 and Haber-Weiss reactions with transition 
metals (Shigenaga et al. 1994). Although free radicals are highly reactive and potentially 
damaging, they are also integral part of some cellular processes. Extracellular secretion of 
free radicals by leucocytes and microphages evoke immune response against bacteria, 
viruses, degenerated cells and other foreign substances (Simko 2007; Simkó et al. 2011). 
Intracellular secretion of free radicals stimulates different cell signaling pathways, trigger 
oxidative stress defense response, as well as apoptosis (Simko 2007; Simkó et al. 2011). 
Apoptosis or programmed cell death mediated by free radicals is thought to be one of the 
tumor suppression mechanisms (Simko 2007; Simkó et al. 2011). Because of perilous 
nature of free radicals, cells have a counter mechanism know as antioxidant defense, to 
keep the free radical levels under check. Unfortunately, when certain conditions promote 
the excess production of free radicals or deplete the antioxidant defense that leads the cell 
to oxidative damage, oxidative stress is said to exist. This can be one consequence of 
exposure to nanoparticles.  
Some of the examples of free radicals are given in the Table 2.5.1. Free radicals much 
often are reactive oxygen species (ROS), or reactive nitrogen species (RNS) but all ROS 
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or RNS are not free radicals. Some of the well known ROS and RNS that are particularly 
discussed in the present dissertation work are superoxide (O2
•-), hydrogen peroxide 
(H2O2), hydroxyl radical (OH
•), nitric oxide radical (NO•), and peroxynitrite anion 
(ONOO-). 
 
Table 2.5.1: Examples of reactive oxygen (ROS) and reactive nitrogen species (RNS) 
2.5.1.1. ROS: Superoxide radical is formed by one electron reduction of oxygen.             
Although electron-transport chain at mitochondrial membrane is a highly efficient 
electron transporter, some electrons can leak and reduce oxygen molecule to form O2
•- , 
and mitochondria serves as a major source of O2
•-. Another location of electron-transfer is 
endoplasmic reticulum, where O2
•- can generate by leakage of electrons from NADPH 
cytochrome P450 reductase. Some additional sources of O2
•- are xanthine oxidase, 
phagocytic NADPH oxidase, as well as UV-γ radiation etc. 
 22 
Superoxide radical is further converted into H2O2 and oxygen by enzyme superoxide 
dismutase (SOD). Although both O2
•- and H2O2 can damage biomolecules, they are only 
moderately reactive with biomolecules (Kamata et al. 1999). However, both superoxide 
and hydrogen peroxide can further generate highly potent and notoriously reactive 
hydroxyl radical. Hydrogen peroxide alone undergoes Fenton type reaction to generate 
OH• radical in presence of transition metals Fe2+ or Cu1+ (Kehrer 2000). Whereas, O2
•- 
and H2O2 react together in presence of transition metals Fe
2+ or Cu1+, to produce OH• 
radical, and reaction is known as Haber-Weiss process (Kehrer 2000). 
 
 
 
All the above mentioned ROS can oxidize biomolecules proteins, lipid and DNA’s and 
functionally damage them.  
2.5.1.2. RNS: Nitric oxide (NO• or simply NO) and peroxynitrite (ONOO-) are reactive 
nitrogen species (RNS). NO is produced from amine acid L-arginine by enzymatic action 
of nitric oxide synthase (NOS) enzymes, as shown below.  
 
 ………NO synthesis 
 
     H2O2 + Fe
2+ or Cu1+                         OH• + OH- + Fe3+ or Cu2+ …..Fenton reaction 
     O2
•- + H2O2                    
Fe/ Cu
                 OH
• + OH- + O2            …..Haber-Weiss process 
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NO exhibits neuroprotective as well neurotoxic effects, depending on cellular redox 
status (Halliwell et al. 1999; Calabrese et al. 2006; Calabrese 2007). In the presence of 
O2
•-, nitric oxide form peroxynitrite anion, which get rapidly protonated under 
physiological condition to peroxynitrous acid, a very reactive RNS. Peroxynitrous acid 
itself can oxidize and nitrate proteins, lipids and DNA’s (Radi et al. 1991; Alvarez et al. 
2003), as well as it can undergo homolytic fission to form even more reactive OH• 
(Halliwell 2006).  
 
 
 
 
Peroxynitrite anion can react with carbon dioxide to form nitrogen dioxide radical, which 
can attack tyrosine amino acid residue of proteins to form protein nitration product 
known as 3-nitrotyrosine (3NT).  
 
2.5.2. Antioxidants: To protect biomolecules from detrimental effects of free radicals, 
the cell produces different antioxidant molecules and enzymes, which together they are 
known as the antioxidant defense system. According to Halliwell (Halliwell 2007), 
“antioxidant is any substance that delay, prevents, or remove oxidative damage to a target 
molecule”.  
Four very important antioxidant enzymes are superoxide dismutase (SOD), glutathione 
peroxidase (GPx), glutathione reductase (GR), and catalase and various other low 
molecular weight antioxidant molecules such as glutathione, ascorbic acid, vitamin-E, 
 NO• + O2
•-                            ONOO-                     …..Formation of peroxynitrite anion 
ONOO- + CO2              ONOOCOO
-               NO2
• + CO3
•-  ….Nitrogen dioxide formation       
    
   ONOOH                              NO2
• + OH•               …..Fission of peroxynitrous acid 
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vitamin-C, etc. constitute the cellular defense system. Considering the scope of this 
dissertation work, this discussion is limited to GPx, GR, SOD, catalase and glutathione 
antioxidants.  
 
Figure 2.5.2: Locations of antioxidant enzymes (blue) and anioxidant molecules (red). 
SOD stands for superoxide dismutase and GPx for glutathione peroxidase.  
2.5.2.1. Superoxide dismutase (SOD) converts superoxide radical into hydrogen 
peroxide and oxygen. Eukaryotic cells have two major isoforms of SOD, copper-zinc 
(CuZn SOD) localized in cytosol and manganese (MnSOD) localized in mitochondria. 
The importance of SOD has been exemplified by experiments with MnSOD-knockout 
mice (Murakami et al. 1998). As well as removing the O2
•- radicals, SOD also generates 
another ROS- H2O2. SOD usually works in conjunction with H2O2- removing enzymes 
such as GPx or catalase (Evans et al. 1999).  
               O2
•-        SOD          H2O2 + O2                                …..SOD reaction 
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2.5.2.2. Glutathione peroxidase (GPx) reduces various intracellular peroxides such as 
H2O2 and lipid peroxides, using glutathione (GSH) as electron donor. GPx has eight 
isoforms, identified in humans and GPx1 is the most abundant isoform, localized in 
cytosol (Muller et al. 2007). GPx has selenium at its active site. A mini review 
summarizes various oxidative stress effects caused by inactivation of GPx and cellular 
adaptive response to GPx inactivation (Miyamoto et al. 2003). 
 
 
2.5.2.3. Glutathione reductase (GR) is another GSH related enzyme, which reduces 
oxidized glutathione GSSG to its reduced form GSH. GR uses NADPH as reducing 
equivalent to carryout reduction of GSSG. GR is highly conserved in all the kingdoms, 
including animal, bacteria, yeast, and plants. Age-related decrease in GR activity has seen 
in mouse erythrocytes, kidney, heart and liver (Hazelton et al. 1980) as well as rat liver, 
lung, heart, spleen and brain (Blakytny et al. 1992). 
 
2.5.2.4. Catalase (Cat) is a very efficient enzyme that scavenges potent ROS hydrogen 
peroxide. Majority of catalase in localized in peroxisomes. Inhibition of catalase activates 
compensatory cellular response in goldfish liver in kidney and induces GPx and GST 
activities (Bagnyukova et al. 2005). Overexpression of catalase HepG2 cells, rescued the 
cells from cytochrome P450 induced oxidative stress injury (Bai et al. 2001). As well as 
reduced catalase expression and activity make the cells more susceptible to become 
carcinogenic (Khan et al. 2010). 
 
H2O2 + 2GSH      
GPx            2H2O + GSSG             …..GPx reaction 
GSSG + NADPH + H+         GR           2GSH + NADP+           …..GR reaction 
   H2O2            
Catalase                2H2O + O2                   …..Catalase reaction 
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2.5.2.5. Glutathione (GSH) an endogenous abundant antioxidant tri-peptide (Figure 
2.5.3.5a) that acts as an antioxidant due to virtue of its amino acid cysteine residue. GSH 
contains the amino acids glutamate, cysteine, and glycine, with glutamate and cysteine 
connected via a γ-linkage (Figure 2.6), therefore making the bond less susceptible to 
protease degradation.  
 
Figure 2.5.2.5a: Structure of Glutathione (GSH). 
GSH is a versatile antioxidant and its primary role is to provide electrons or H for 
detoxification of peroxides carried out by GPx. During this reaction GSH forms 
disulphide bond with another GSH molecule, oxidized glutathione GSSG is recycled 
back by another enzyme GR, using NADPH as a reducing equivalent (Figure 2.5.2.5b). 
The ratio of GSH: GSSG is indicative of oxidative stress; ~10:1 is what healthy cells 
usually have. A decrease in this ratio or depletion in GSH levels triggers various cellular 
defense responses, known as phase II antioxidant response (Lee et al. 2008; Speciale et 
al. 2011). In addition to the redox activity GSH can scavenge alpha-beta unsaturated 
aldehyde or ketone though Michael addition and can form nitroso-thiol to protect against 
nitrosative stress. As well as GSH can chelate heavy metal ions such as mercury, 
probably to prevent the metal toxicity mediated by ROS generation (Patrick 2002).  
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Figure 2.5.2.5b: Oxidation and reduction cycle of glutathione. GSH is the reduced form 
of glutathione which oxidized into GSSG, while scavenging peroxides by glutathione 
peroxidase (GPx) and then reduced back to original GSH by enzymatic action of 
glutathione reductase (GR). 
2.5.3. Heat shock proteins: Heat shock protein (HSPs) is the family of proteins that are 
of different molecular weight and structure but all functionally related. HSPs are named 
according to their molecular weight except ubiquitine, whose molecular weight is 8 kDa. 
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The important function of HSPs is to chaperon other proteins. HSPs play important roles 
in protein-protein interactions such as protein folding, assisting other proteins in 
attending proper conformation, and preventing unwanted protein aggregation. HSPs also 
help to stabilize partially unfolded proteins and escort them across membranes or through 
organelles within a cell for proteasome degradation. Some house-keeping HSPs are 
expressed under normal physiological conditions, but as their name suggests, HSPs are 
induced by temperature, exposure to heavy metals, cytotoxic drugs and other stress 
including oxidative stress (Calabrese et al. 2000; Calabrese et al. 2000). The HSPs 
studied in this dissertation work, Hsp70 and Hsp32 (a.k.a. Heme oxygenase-1 or HO-1) 
can be induced by oxidative stress (Calabrese et al. 2000; Calabrese et al. 2000).  
2.5.4. Oxidative stress: Is defined as “A disturbance in the pro-oxidant-anti-oxidant 
balance in favor of the former, leading to potential damage” (Halliwell 2007). Under 
normal physiological conditions although ROS and RNS are generated, their levels are 
efficiently regulated by antioxidant-enzymes and -molecules to maintain the cellular 
redox balance Figure 2.5.4. The imbalance in pro- and anti-oxidant can be caused by 
increased levels of free radical generation and/ or could be result of antioxidant depletion, 
failure of repair or replacement system (Halliwell et al. 2004; Halliwell et al. 2007). In 
any case, either both circumstances occurring together or separately, eventually will lead 
to deleterious modifications of biomolecules, and multitude of downstream 
consequences. Oxidative stress has been implicated in vast array of conditions including 
cancer, arthritis, cardiovascular diseases, diabetes, aging, and neurodegenerative 
disorders.    
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Figure 2.5.4: Different endogenous sources for ROS/ RNS, antioxidant defense and 
clearance of HNE. Where, GST stands for glutathione s-transferase, MRP1 stands for 
multidrug resistance protein 1 and HNE is one of the end-product of lipid peroxidation. 
Antioxidant enzymes are shown in blue and antioxidant molecules glutathione in green 
color. ROS and RNS are in red color. 
2.5.4.1. Oxidation of biomolecules- Protein carbonyls (PC): The functions of proteins 
are highly dependent on their tertiary structures and any disruption of this spatial 
arrangement can have serious consequences on the activities of enzymes and proteins. 
Increased oxidative stress induces oxidative modification of biological molecules such as 
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proteins, lipids and nucleic acids. Oxidative modifications such as carbonylation, 
nitration, s-nitrosylation, glycosylation etc. can severely disrupt spatial arrangement of 
proteins damaging their functions partially or completely. 
Protein carbonylation is one of the most common post-translational oxidative 
modifications, resulting from and direct cleavage of protein backbone (Figure 2.5.4.1a) 
and β-scission of the amino-acid side chains (Figure 2.5.4.1b) by ROS or RNS 
(Butterfield 1997; Stadtman 2006). Protein carbonyls (PC) can also arise from adduction 
of alkenals like HNE and acrolein to Cys, His, and Lys residues by Michael addition 
(Figure 2.5.4.1c) and glycoxidation reactions (Butterfield 1997; Stadtman 2006). Studies 
have shown that protein carbonylation does not depend on amount of proteins but some 
proteins are more susceptible to carbonylation than the other (Cabiscol et al. 2000; Jana 
et al. 2002; Choi et al. 2005; Dalle-Donne et al. 2006). Such selective susceptibly is 
likely due to protein structure and presence of transition metal binding-site (Stadtman 
1990; Stadtman 2006). Since protein carbonylation is an irreversible form of oxidative 
modification, immunochemical detection of protein carbonyl (PC) levels (described in 
Chapter 3) is a widely recognized way to index global oxidative stress and damaged to 
proteins in a given biological sample.  
Initial studies discovered that primary site of hydroxyl radical attack is alpha carbon of 
amino acids (Swallow 1960; Garrison et al. 1962; Schuessler et al. 1984; Garrison 1987) 
as well as aliphatic amino acid side chain (Stadtman et al. 2003). As shown in Figure 
2.5.4.1a, abreaction of H• from alpha carbon by hydroxyl radical produces a C-C cross 
linking in absence of oxygen and peroxyl radical (-COO•) in aerobic conditions. This 
peroxyl radical can be neutralized by abstraction H• from alpha carbon of adjacent 
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protein, thus propagating the radical chain reaction. In the presence of transition metal 
ions like Fe2+ or HO2• radical, the alkyl peroxide (ROO•) radical is converted into 
alkoxyl radical, which will be then lead to protein carbonylation either by α-amidation 
pathway or by diamide pathway (Figure 2.5.4.1a). In the α-amidation pathway, the 
alkoxyl radical is reduced to a hydroxyl, which will be eventually forming an N-terminal 
amide derivative and C-terminal alkyl carbonyl derivative. Alternatively alkoxyl radical 
can undergo diamide pathway and can form diamide derivative of N-terminal cleavage 
product and isocyanides derivative of C-terminal of protein after undergoing β-scission. 
As shown in Figure 2.5.4.1b [adapted from (Bader Lange 2010)], peptide bond of an 
amino acid residue say valine can directly undergo β-scission after attack of •OH 
(Stadtman 2006).  
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Figure 2.5.4.1a: Oxidative cleavage of peptide backbone.  
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Figure 2.5.4.1b: Oxidative cleavage of amino acid side chain- β-scission of valine. 
2.5.4.2. 3-Nitrotyrosine (3NT) and S-nitrosylation: Nitric oxide (NO•) is an extremely 
important biological radical, particularly because of its  role as a second messenger in 
vasodilatation (Calabrese 2007).However, in conditions of oxidative stress where 
excessive production of NO is induced and significant amounts of O2
-• are present, RNS 
resulting from their interaction can damage proteins. Proteins with tyrosine residue are 
especially susceptible to RNS attack. The interaction NO and O2
-• forms highly reactive 
peroxynitrite anion, which in presence of CO2 produces nitrite radical (NO2•) [described 
in section 2.5.1.2a, taken from (Bader Lange 2010)]. As shown in Figure 2.5.4.2, NO2• 
attacks the meta- or ‘3’-position of the tyrosine residue, because of the ortho- and para- 
directing electron-donating resonance effect of –OH group. The addition of nitrite group 
on tyrosine can disrupt protein structure as well as bulky nitrite group imposes steric 
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hindrance to the substitution of –OH group, interfering with the protein function and 
metabolic processes (Halliwell et al. 1999; Greenacre et al. 2001; Alvarez et al. 2003). 
Similar to PC, immunochemical detection of 3-nitrotyrosine (3NT) (described in Chapter 
3) is another index of protein oxidation and global oxidative stress in a given biological 
sample. 
Nitric oxide can also react with sulfur atom of cysteine and methionine amino acid 
residues in aerobic conditions (Broillet 1999; Fernhoff et al. 2009), to form S-
nitrosylation derivatives of corresponding proteins as shown in the Figure 2.5.4.2b. 
 
 
Figure 2.5.4.2a: Formation 3-nitrotyrosine (3NT) 
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Figure 2.5.4.2b: Formation S-nitrosylate derivatives of cysteine in aerobic conditions. 
2.5.4.3 Lipid peroxidation and 4-hydroxy-2-trans nonenal: Lipids with poly-
unsaturated fatty acid chains (PUFA’s) are more susceptible to ROS/RNS attack compare 
to the saturated ones. The brain contains extremely high levels of PUFA, in addition to it 
brain also consumes high amounts of O2, combining this together makes nervous system 
extremely vulnerable to oxidative stress. The majority of lipid peroxidation event that 
occurs within the cell are result of free radical chain reaction. In which allylic 
hydrocarbons undergo arrack of free radical, forming alkoxyl radical (ROO•) in aerobic 
conditions, alkoxyl radical can then further propagate the chain reaction unless quenched 
(Spiteller 2001) as shown below. 
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R1H + X•   R1• + XH 
R1• + O2   R1OO•  
R1OO• + R2H            R1OOH + R2•             …………..Free radical chain 
reaction propagates. 
R1OO• + R2OO•  non-radical form + O2    ……Quenching of radical chain 
reaction. 
Oxidative damage to lipids generally results in formation cytotoxic aldehyde and ketone 
derivatives. Typically free radicals have very short half life; therefore damage caused by 
them is localized. Unlike free radicals, lipid peroxidation products have longer half life 
and so they can diffuse into bilayer and can cause oxidative damage away from their site 
of production. For a given fatty acid, multiple aldehydic or ketonic products can arise as 
result of lipid peroxidation, depending upon which allylic carbon gets attacked to initiate 
the chain reaction. 4-Hydroxy-2-trans nonenal (HNE) is such very reactive product of 
lipid peroxidation. HNE is a product of oxidation of arachiodonic acid an important fatty 
acid abundantly present in brain. Abstraction of labile H• from 13th allylic carbon or 
oxidation of 11th carbon, followed by peroxyl and alkoxyl formation in presence of O2 
and transition metal ion Fe2+; then cyclization and β-scission results into formation of 
HNE (Figure 2.5.4.3a). It is also interesting to note that abstraction of same H• from 
arachidonic caid my yield multiple end products. 
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Figure 2.5.4.3a: HNE formation from Arachidonic acid. 
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Although formation of HNE itself is indicative of lipid peroxidation, the downstream 
products of interaction of HNE with other biomolecules can have serious consequences. 
HNE and other lipid peroxidation products, although less reactive than free radicals, are 
capable of migrating long distance from point of origin to attack biomolecules. HNE can 
covalently modify amino acid residues, such as histidine, cysteine, and lysine, by 
undergoing Michael addition (Esterbauer et al. 1991; Subramaniam et al. 1997; Schaur 
2003; Siems et al. 2003) (Figure 2.4.4.3b). Similar to PC, and 3NT, immunochemical 
detection of HNE (described in Chapter 3) is an index of lipid peroxidation and overall 
oxidative stress in a given biological sample (Waeg et al. 1996). 
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Figure 2.5.4.3b: Michael addition of HNE to protein residue. 
2.6. Oxidative stress paradigm for evaluation of ENM-toxicity 
When ENM of different size, shape, aspect ratio, aggregation, crystallinity, surface 
functionalization and so on come in contact with biological fluids, proteins, lipids, DNA, 
cell membrane, mitochondria, and lysosomes, can generate vast numbers of biochemical 
interactions. Such interactions could be biologically inert, beneficial for improvement of 
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biological function or process or detrimental to biological system and may or may not 
pose long term adverse health effects. Although many researchers have studied ENM-
toxicity, their research is very much case specific and there is a need to have a standard 
and reliable model or algorithm or template that can be followed to evaluate the toxicity 
of any ENM or ENM based consumer product (Meng et al. 2009).  
The knowledge about induction of oxidative stress and related biological responses such 
as phase II response, inflammation, apoptosis, necrosis etc. has been around for decades 
and well studied in case of various disease conditions and disorders. As various in-vitro 
and in-vivo studies reported that free radical generation can be triggered by ENMs, 
researcher are now accepting the induction of oxidative stress as a prominent mechanism 
of ENM-toxicity [as described in section 2.4.].  Based on the basic understanding of 
oxidative stress mediated biological responses Nel’s research group has proposed a 
hierarchy oxidative stress model for evaluation of ENM-toxicity in cell culture model. 
Some studies have successfully evaluated ENM-and UFP-toxicity in cell culture media, 
employing this oxidative stress paradigm.  
According to Nel’s research (Nel et al. 2006; Nel et al. 2009), as shown in Figure 2.6., at 
lower levels of oxidative stress (Tier-1), phase-II antioxidant enzymes are induced by 
nuclear factor (Nrf-2)-signaling pathways to restore cellular redox homeostasis. At 
intermediate levels of oxidative stress (Tier-2) or up on failure of Tier-1 response, yield 
to pro-inflammatory response by activation of redox-sensitive mitogen-activated protein 
kinase (MAPK) and nuclear factor-kappa B (NF-ĸB) cascade. At the highest levels (Tier-
3) of oxidative stress perturbation of mitochondrial inner membrane electron transfer and 
opening of permeability transition pore can trigger cellular apoptosis and cytotoxicity.      
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Figure 2.6: Hierarchy oxidative stress model proposed by Andre Nel’s research group 
2.7. Susceptibility of brain to oxidative stress and blood brain barrier 
 Although all aerobic cells are susceptible to oxidative damage, mammalian brain is 
especially vulnerable (Halliwell 1992). As well reviewed by Halliwell (Halliwell 2006), 
adult human brain consumes ~20% of basal levels of oxygen due to high turnover of ATP 
molecules, neuronal membranes are constitutes lipids with highly poly-unsaturated fatty 
acids side-chains as well as ~60 mg of non-heme iron present within various iron 
containing proteins, any damage to brain can release iron (as well as copper) ions which 
may initiate radical formation being the main reasons of vulnerability. Due to the high 
susceptibility and functional importance, brain and entire central nervous system is 
somewhat-isolated and protected from harmful xenobiotics and endogenous molecules by 
blood brain barrier (Bhaskar et al. 2010).  
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2.7.1. Blood Brain Barrier (BBB): Circulating blood is separated from the brain 
extracellular fluid in central nervous system by the presence of intracellular tight junction 
endothelial cellular lining inside blood vessels (Reese et al. 1967), Figure 2.7.1. The tight 
junction endothelial cell lining is present only in brain parenchyma and not the normal 
circulatory system. The BBB strictly regulates influx or efflux of biomolecules, protects 
brain from invasion of foreign substances- including viruses, bacteria, drug molecules, 
and thus help to maintain brain homeostasis (Ghersi-Egea et al. 1996; Shibata et al. 2000; 
Tanzi et al. 2004; Zlokovic 2005). The cells of adult brain parenchyma are non-
degenerative; any damage to these cells including oxidative damage can lead to 
nonreversible consequences such as neurodegenerative disorders. The BBB provides the 
brain with privileged immune environment shielding against any inappropriate immune 
response (Niederkorn 2006; Arck et al. 2008). 
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Figure 2.7.1: Over simplified presentation of cross-section of brain capillary and blood-
brain barrier.  
2.8. Exposure to ENM and neurological toxicity concerns 
With increasing applications of ENMs and ENM-based products in various sectors, 
eventually these ENMs will come in contact with biological world. The primary 
anticipated routes of human exposure to ENMs intended for industrial or environmental 
applications include inhalation exposure, dermal uptake, and oral ingestion with possible 
subsequent absorption of ENMs into systemic circulation. Although some data exist on 
the absorption properties and associated toxicities of ENMs after exposure via the 
pulmonary, oral, and topical routes, little is known about their distribution into the brain 
once they reach systemic circulation (Luther 2004). Apart from unintentional exposure to 
ENMs and thereafter the translocation to brain, there is also considerable interest in 
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ENMs to enhance drug delivery to the brain, as reviewed by Koziara et al. (Koziara et al. 
2006). Overcoming the BBB is often a major challenge in designing a suitable drug, 
therapeutic agents or imaging molecule targeted towards brain for medicinal or medicine 
related technological applications. ENMs have the potential to revolutionize filed of 
medicine with their ability to gain access to otherwise inaccessible biological 
compartments such as cardiovascular, mitochondrion, as well as brain. However, while 
major medical and pharmacological research is focused on beneficial applications of 
ENMs, the secondary negative effects are often neglected (Oberdörster et al. 2005; 
Thomas et al. 2005). It has been shown that ENMs from blood circulation may influence 
endothelial cell membrane integrity and / or BBB and may gain access to CNS (Chen et 
al. 2008; Simko et al. 2010). Metal- and metal oxide-based ENMs reviewed in Simko et 
al. (Simko et al. 2010) did translocate from the point of applications (respiratory tract, 
skin, and circulatory system) to the brains of the animals. It is well accepted that ENM-
induced oxidative stress leading to generations of ROS can disrupt BBB. Some in-vitro 
studies reviewed in the same report supported the concept that under specific in-vitro 
conditions, several types of ENMs can influence neuronal redox homeostasis.  
Formation of extra-and intra-cellular protein aggregates is one of the hallmarks for 
several neurodegenerative diseases and some ENMs may enhance this process. TiO2 
ENM is shown to trigger and promote formation of beta-amyloid aggregates in solution, 
which are associated with progression of Alzheimer disease (Wu et al. 2008). As well as 
some other ENMs [ceria, quantum dots, and carbon nanotubes] are able to stimulate 
faster formation of fibrils of β2-microglobulin protein in solution (Linse et al. 2007).  
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In-vivo animal studies suggest that although very low but definitely possible 
translocation of ENMs to brain can occur even after substantial instillation or inhalation 
(Sharma et al. 2007; Oberdorster et al. 2009; Simko et al. 2010). Therefore, it is feasible 
that in humans also some such degree of translocation of ENM can occur as a 
consequence of environmental and / or occupational exposure. Over the time, non-
biodegradable and non-excreted ENMs may accumulate in remote biological 
compartments and can exert hazardous health effects including oxidative stress effects; 
chronic exposure may also aggravate the ongoing pathological processes (Simko et al. 
2010). However, at this point these are only speculations as there is no long term data is 
available which could stimulate chronic exposure effects.   
2.9. Why ceria (cerium oxide) ENM? 
Cerium (atomic number 58) a member of lanthanide series has electronic configuration 
[Xe] 4f 5d 6s2, is a radox active metal with 4+ and 3+ are most stable oxidative states. 
Ceria (a.k.a.: CeO2, ceric oxide, Ce dioxide, Ce oxide, CAS # 1306-38-3) is a cerium 
metal oxide based ENM. Many ENMs are comprised primarily of metals and oxides of 
Al, Ce, Cu, Au, Fe, Pd, Si, Ag, Ti and Zn. Ceria was selected for this dissertation work to 
characterize ENM bio-distribution from blood and its effects on oxidative stress 
endpoints because: (1) It is an insoluble metal oxide that can be readily observed in situ 
by electron microscopy (EM), making it a useful as an in vivo tracer, (2) it is redox 
reactive (Zhang et al. 2004), (3) it can be functionalized [e.g. (Qi et al. 2008)], (4) it is 
available in sizes relevant for uptake across the BBB, one of the most limiting 
mammalian membranes, (5) it can be produced in a variety of shapes by many different 
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methods, including nanodisks, nanoplates, nanotubes, nanocubes, nanorods, 
nanopolyhydra, and 
tadpole, comet, and prism shapes (Bai et al. 2001; Mai et al. 2005; Si et al. 2005; Yu et 
al. 2005; Gao et al. 2006; Han W-Q et al. 2006; Yang et al. 2006), and (6) it has current 
commercial applications. A major commercial application of ceria is its use as an 
abrasive for chemical-mechanical planarization of advanced integrated circuits. This 
application of ENMs accounted for 60% of the $1 billion market for nanomaterials in 
2005 (Feng et al. 2006). Another significant application is its use as a catalyst in ENMs 
that have very small size, large surface area, and thermal stability to 6508C and are stable 
in humid air (Trovarelli 1996). For example, ceria (10 nm primary particles coated with a 
dispersant to facilitate its dispersion in fuel liquids) is marketed by Oxonica Ltd. as 
Envirox®, a diesel fuel catalyst to improve combustion, reduce fuel consumption and 
decrease exhaust emissions (UK MNT Network). Ceria was also considered to be a good 
candidate for these studies because it has been reported to have both pro-oxidant and anti-
oxidant properties. These properties represent the conundrum enveloping the 
development of ENMs: There is evidence for both beneficial and toxic effects to the same 
organ, the brain. Both the ILSIRF/RSI expert working group and the National Cancer 
Institute Nanotechnology Characterization Laboratory highlighted three key elements for 
a toxicity screening strategy of ENMs: (1) Physico-chemical characteristics, (2) cellular 
and non-cellular in vitro assays, and (3) in vivo assays. ‘Tier 1 evaluations’ of these 
groups included markers of inflammation and oxidant stress in selected remote organs 
and tissues such as the nervous system (Oberdörster et al. 2005). Nanoscale ceria has 
been nominated by the NIEHS for toxicological consideration, including toxicokinetic 
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studies, due to its widespread and expanding industrial uses, limited toxicity data, and a 
lack of toxicological studies for nanoscale ceria (Inc. 2006).  
The interest in ceria as a potential therapeutic agent with SOD- and catalase-enzyme-
mimetic properties increases the probability that it will be further studied for medical 
applications (Celardo et al. 2011). The regenerative redox cycling ability of ceria has 
shown promising future as radical scavengers and antioxidant therapeutics (Karakoti et 
al. 2008; Karakoti et al. 2009; Karakoti et al. 2009)as well as its ability to generate ROS 
can be employed in fight against cancer (Lin et al. 2006; Babu et al. 2010). Ceria has 
shown to improve the culture of mesenchymal stem cells and growth of cardiac 
progenitors in biodegradable polymer matrix (Mandoli et al. 2010) and additionally 
proved to be effective drug carriers for treatment against-tumor (Vincent et al. 2009). 
Thus the understanding of distribution of ceria ENM from the central compartment 
(blood) and resultant effects is important. This dissertation research  is the first report of 
the distribution and effects of ceria from the central compartment, after introduction into 
blood. However, the form of ceria employed in the present study would not be effective 
as a vehicle for drug delivery to the brain.  
Nonetheless we had focused our research on understanding the relationship between 
physico-chemical properties of ENM and ENM induced oxidative stress mediated 
biochemical response in rat brain after one-time intravenous injection of ceria ENMs, for 
both short term as well as chronic exposure with Nel’s oxidative stress model as a central 
guideline. 
 
Copyright © Sarita S. Hardas 2012 
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CHAPTER 3 
METHODS 
3.1. Nanomaterial 
Ceria ENM: Citrate coated ceria nanomaterials of different sizes and shapes were 
synthesized and obtained from our collaborators Dr. Eric Grulke (Department of 
Chemical Engineering, University of Kentucky) and Dr. Uschi Graham (Center for 
Applied Energy Research, University of Kentucky). A hydrothermal approach was used 
to synthesize ceria ENM (Schäf et al. 2004) using analytical grade inorganic salts of 
cerium, viz. cerium chloride or cerium nitrate as starting material. The reaction 
conditions such as temperature, pH, and time duration for heating cycle were varied to 
obtain the desired size and shape of the nanomaterial. The ceria ENM was citrate coated 
(capped) to prevent agglomeration seen with uncoated ceria that occurs in high ionic 
strength solutions, such as in blood (Xia et al. 2008). 
Silver NP: The different sized silver metal nanoparticles (NP) were purchased 
commercially and provided by our collaborator Dr. Jason Unrine (Department of Plant 
and Soil Sciences, University of Kentucky). 
3.2. Nanomaterial characterization 
Ceria ENM: The morphology, crystallinity, and particle size distribution of highly diluted 
samples of the citrate-coated ceria ENM were determined by our collaborators Dr. Eric 
Grulke (Department of Chemical Engineering, University of Kentucky), Dr. Uschi 
Graham (Center for Applied Energy Research, University of Kentucky) and Dr. Jason 
Unrine (Department of Plant and Soil Sciences, University of Kentucky). The ceria 
nanoparticles were crystalline and highly pure as determined by X–ray diffraction and 
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scanning transmission electron microscopy (Inc.). The potential presence of 
contaminating elements/metals was determined by inductively coupled plasma mass 
spectrometry (ICP-MS). Particle size distribution in aqueous dispersion was determined 
using dynamic light scattering (DLS). To indicate the stability of the ceria dispersion 
when infused into the rat, the zeta potential was measured. Analysis with electron energy 
loss spectroscopy (EELS) was concurrently conducted on the freshly synthesized ceria 
particles in vitro and after its iv infusion in in vivo, to determine its M4/M5 or Ce (Owens 
Iii et al.) vs. Ce(IV) ratio as a measure of its original oxidative signature.  
Silver NP: All the characterization was carried out by Dr. Jason Unrine’s laboratory 
members (Department of Plant and Soil Sciences, University of Kentucky). 
3.3. Ceria administration and BBB integrity assessment 
The ceria ENM and saline administration and blood brain barrier (BBB) integrity 
assessment was performed in our collaborator, Dr. Robert Yokel’s research laboratory 
(College of Pharmacy, University of Kentucky). Ceria dispersion was administered to the 
male Sprague-Dawley rats prepared with two cannulae, surgically inserted into femoral 
veins, which terminated in the vena cava. Five minutes before termination, the rats were 
given BBB integrity markers, anesthetized with ketamine, and decapitated to enable rapid 
harvest of the brain. The tissue samples were collected rapidly and weighed before 
freezing them in liquid nitrogen.  
The research was conducted in accordance with the Guiding Principles in the Use of 
Animals in Toxicology. 
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3.4. Light and electron microscopic assessment 
Ceria ENM: Light and electron microscopic assessment was carried on thin sections of 
brain tissue by Dr. Michael Tseng (Department of Anatomical Sciences and 
Neurobiology, University of Louisville) using TEM and high-resolution transmission 
electron microscopy (HRTEM).   
Silver NP: All the light and electron microscopic assessments were carried out in Dr. 
Jason Unrine’s laboratory (Department of Plant and Soil Sciences, University of 
Kentucky). 
3.5. Silver NP administration  
Silver NP were first suspended in DI water and then mixed with Yeager sandy loam 
artificial soil to which young adult earthworms were exposed (Shoults-Wilson et al. 
2011). All the preparatory work was carried out in Dr. Jason Unrine’s laboratory. 
3.6. Biological sample preparation  
For ceria ENM projects, three brain regions, namely, hippocampus, cortex and 
cerebellum, were used from each ceria ENM or saline treated rat brain. Frozen brain 
samples obtained from our collaborator, Dr. Robert Yokel, were separately homogenized 
using a manual Wheaton glass homogenizer in Media 1 (300-500 µL) buffer containing: 
0.32 M sucrose, 0.10 mM Tris-HCl- pH 8.0, 0.10 mM MgCl2, 0.08 mM EDTA, 10 µg/ml 
leupeptin, 0.5 µg/ml pepstatin, 11.5 µg/ml aprotinin and PMSF 40 µg/ml; pH 8.0. After 
sample homogenization, protein concentration in brain homogenates was determined by 
the Pierce Bicinchoninic acid (BCA) assay. However, a small portion of un-homogenized 
frozen brain tissue from each region of each rat was saved for GSH assay. 
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For silver NP treated earthworm samples, control and silver NP treated whole 
earthworms were frozen in liquid nitrogen and then ground using a porcelain mortar and 
pestle. The frozen powder formed tissue was obtained from our collaborator (Dr. J. 
Unrine). The powdered samples were thawed, mixed with 300- 400 µL Media 1 buffer 
and sonicated with a Fischer Scientific 550 Sonic Dismembrator (Fischer Scientific, 
Pittsburgh, PA) for 10 s at 20 % power. After sample homogenization, samples were 
centrifuged at 5000 x g for 10 min in a Hettich Mikro 22R Microcentrifuge (Hettich, 
Beverly, MA) to remove debris. Protein concentration in the supernatant was determined 
by the BCA assay.  
3.7. Bicinchoninic acid (BCA) protein estimation assay 
All the protein concentrations in this dissertation were determined using the Pierce BCA 
Protein Estimation Assay (Pierce, Rockford, IL). The Pierce method combines the biuret 
reaction, chemical reaction used for detection of peptide bonds, by subsequent chelation 
of Cu1+ with BCA molecules results in a violet-colored complex (Smith et al. 1985). In 
this reaction Cu2+ ions are reduced by peptide bonds under basic condition and the 
presence of cysteine, tryptophan, and tyrosine residues aide the reaction. The resultant 
Cu1+- bicinchoninic acid complex has absorbance maximum at 562 nm (Figure 3.7). This 
assay follows Beer- Lambert law (A = ξ l c); therefore, protein concentration is directly 
proportional to the intensity or absorbance of the sample. The bovine serum albumin 
(BSA) was used as a standard and loaded with 3 µL sample on 96-well plate (Evergreen 
Scientific, Los Angeles, CA). The mixture of solution A and B from Pierce BCA assay 
kit in the ratio (49:1) was added to standards and protein samples to make an equal final 
volume 100 µL in each well. The plate was then incubated in oven at 37 ºC for 10 min 
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and shacked gently before reading the absorbance in a µ-Quant UV plate reader (Bio-
Tek, Winooski, VT) at 562 nm.  
 
Figure 3.7: Formation of Cu+-BCA complex upon BCA interaction with Cu+ as a result 
of protein interaction. 
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3.8. Detection of Oxidatively Modified Proteins 
3.8.1. Protein Carbonyls (PC) 
Protein carbonyls are a global index of protein oxidation. The oxidized proteins contain 
an abundance of carbonyl groups in the form of conjugated aldehydes or ketones. 
Addition of carbonyl groups on protein back-bone could be result of either cleavage of 
protein back-bone or covalent attachment with HNE or acrolein or lipid or sugar 
oxidation products. As a result the oxidative modification changes the three-dimensional 
conformation of the protein, subsequently affecting its catalytic activity (Subramaniam et 
al. 1997). In this dissertation research a sensitivetest used for identification of protein 
carbonyls is derivatization of carbonyl groups by 2, 4,-dinitrophenylhydrazine (DNPH) to 
form a hydrazone (Figure 3.8.1), where under acidic conditions carbonyl groups of 
aldehyde or ketone, react with DNPH to form a Schiff base. The protein bound 2, 4-
dinitrophenyhydrazone can be detected using an antibody directed at the hydrazone 
adduct, which is then detected by immunochemical or fluorescent techniques.  
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Figure 3.8.1: Derivatization of protein carbonyls by DNPH 
 
In brief, each brain sample (5 µL) is derivatized at room temperature by incubation with 
5 µL of 12% SDS and 10 µL of 10 mM DNPH solution in 2N HCl for 20 min. After 20 
min the sample is neutralized by adding 7.5 µL of neutralization buffer supplied with the 
OxyBlot Protein Oxidation Detection Kit (Chemicon International Millipore, Temecula, 
CA). Further, a derivatized sample is diluted with phosphate saline buffer (10 mM, pH 8 
with 0.88% NaCl) to obtain a final concentration of 1 µg/ml. A 250 µL aliquot from the 
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diluted sample is loaded in duplicate onto a nitrocellulose membrane under vacuum 
pressure using a BioRad slot blot apparatus (BioRad, Hercules, CA). 
3.8.2. Protein resident 3NT and protein-bound HNE 
Protein-resident 3NT is a global index for nitrated proteins, whereas protein-bound HNE 
is a global index for lipid peroxidation. The biological samples are denatured in sodium 
dodecyl sulfate (SDS) containing buffer and then 3NT and HNE modifications are 
detected using separate antibodies directed at the respective 3NT and HNE modification 
epitopes.  
In brief, each brain sample (5 µL) is incubated at RT with 5 µL of 12% SDS and 10 µL 
of Laemmli buffer (0.125 M Tris pH 6.8, 4% v/v SDS, 20% v/v glycerol) for 20 min. The 
sample mixture is further diluted with phosphate saline buffer (10 mM, pH 8 with 0.88% 
NaCl) to obtain a final concentration of 1 µg/ml. A 250 µL aliquot from diluted sample is 
loaded in duplicate onto a nitrocellulose membrane under vacuum pressure using a 
BioRad slot blot apparatus (BioRad, Hercules, CA). 
3.8.3. Slot Blot Technique 
Slot blot technique or in some cases known as Dot blot technique, get its name from the 
shape of the loading wells on the sample template part of the apparatus (Figure 3.8.3). 
This technique is very useful tool for detection of global levels of a protein modification 
such as PC or 3NT or HNE. Protein sample is solubalized in SDS containing buffer (in 
case of PC, later incubated with DNPH) and loaded in equal concentration on the 
nitrocellulose membrane under vacuum. Nitrocellulose membrane binds to negatively 
charged protein, owing to sulfate groups on SDS, and any uncharged material is passed 
though the sub-micron sized pores of nitrocellulose membrane. The protocol is further 
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standardized so that equal amount of protein is loaded for control as well as treated 
groups and resulting color intensities after development of membrane by 
immunochemical technique will be reflective of the global levels of specific protein 
modification. The advantage of this technique is that very small amount of sample is 
required (< 1 µg) and multiple samples can be analyzed simultaneously.  
 
 
Figure 3.8.3: Slot blot apparatus, adapted from Bio-Rad product instruction manual 
3.9. Enzyme assays 
To determine the activity of various antioxidant enzymes, enzyme assays were performed 
using ready-to-use specific enzyme assay kits from Cayman Chemical Company (Ann 
Arbor, MI). Briefly, 10-20 µg of homogenized sample was loaded along with standards 
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provided on a 96-well plate and mixed with the assay buffer provided in the kit. Along 
with other particular assay related specific reagents, reaction initiator is added to the 
mixture, such as cumene hydroperoxide used for glutathione peroxidase (GPx) assay, 
NADPH used for glutathione reductase (GR) assay, hydrogen peroxide used for catalase 
assay,  and xanthine oxidase used for superoxide dismutase (SOD) assay. Typically an 
initiator is a substrate used during enzymatic reaction. The change in absorbance of the 
substrate is correlated with the change in concentration of the substrate and the enzyme 
activity. The change in absorbance can be measured directly or indirectly (using some 
other chromophore dye) using spectrophometrically in a µ-Quant UV 96-Well plate 
reader (Bio-Tek, Winooski, VT).  
3.10. Reduced and oxidized glutathione assay 
The ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG) is measure of 
cellular redox status. GSH and GSSG levels can be measured simultaneously in a fresh 
tissue using the Hissin-Hiff (Hissin et al. 1976) fluorescence spectroscopic method. In 
brief, freshly thawed brain tissue is weight rapidly on a weighing balance and 
homogenized in 25% metaphosphoric acid (HPO3) and 0.1 M sodium phosphate-0.005 
EDTA buffer (pH 8.0). The homogenized mixture is centrifuged at 14,000 rpm (10 min, 4 
ºC) and supernatant is kept for the assay. For GSH levels, 50 µL of supernatant is diluted 
with 450 µL of phosphate-EDTA buffer. A 10 µL aliquot of this diluted mixture is loaded 
along with the 10 µL GSH standard solutions on a 96-well plate. An additional 180 µL of 
phosphate-EDTA buffer is added followed by 10 µL of o-phthalaldehyde (OPT) solution 
in methanol. The plate is incubated for 15 min and fluorescence is measure at 420 nm 
(excited 350 nm). For GSSG levels, 50 µL of supernatant is incubated with 20 µL of 0.04 
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M N-ethylmaleimide solution in phosphate-EDTA buffer (30 min, RT). After 30 min, 
mixture is diluted by adding 430 µL of 0.1 N NaOH. A 10 µL of this diluted mixture and 
10 µL of GSSG standards are loaded on a 96-well plate and after these same steps are 
followed as described above for determination of GSH level, except 0.1 N NaOH added 
instead of phosphate-EDTA buffer. 
The GSH to GSSG ratio was determined using GSH and GSSG calibration curve. 
Student’s t-test was used to determined significant difference between normalized GSH: 
GSSG ratios from treated and control samples with p < 0.05. 
3.11. One-dimensional SDS-PAGE  
One-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) separate proteins based on their relative migration rates (Abdelmoez et al.). The 
sample (75 µg) is solubilized in 4X SDS-containing buffer composed of 0.5 M Tris (pH 
6.8), glycerol (40% v/v), SDS (8% wt/v), β-mercaptoethanol (20% v/v), and 
bromophenol blue (0.01% wt/v). The samples are then denatured by boiling ~100 ºC in 
water bath for 5 min and cooled immediately on ice before loading on polyacrylamide gel 
(12% Bis-Tris). Precision Plus Protein TM All Blue Standards (~4 µL) are loaded in a 
separate lane along with actual samples on polyacrylamide gel. SDS imparts a net 
negative charge on the samples, so that samples can migrate from negatively charged 
anode to positively charged cathode, under the influence of applied electric field (90 V 
for first 30 min and 120 V till the end). The migration rate Mr is depend on size, 
molecular weight and shape of the protein, generally proteins with low Mr migrate further 
in the gel towards the cathode than proteins with higher Mr (Figure 3.11). 
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Figure 3.11: Separation of protein mixture by SDS-PAGE technique 
3.12. Isoelectric focusing and two-dimensional gel electrophoresis 
 Isoelectric focusing (IEF) is a technique in which proteins loaded on an immobilized pH 
gradient strip (IPG) migrates under the influence of an electric field to a pH in the strip at 
which they reach their respective isoelectric point (pI) (Figure 3.12). The isoelectric point 
is the pH where the net charge on a protein is zero.  
IEF is also the first dimension of separation of proteins in a 2-D-seperation process, in 
which 200 µg homogenized protein samples are precipitated by addition of 
trichloroacetic acid (TCA). Samples are then centrifuged at 14,000 rpm (23,700 x g) for 5 
min at 4 ºC in a microcentrifuge (Hettich, Beverly, MA). The pellets are re-suspended in 
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ethanol-ethyl acetate solution (1:1 v/v) and vortexed to equilibrate. Suspended pellets are 
re-centrifuged at 14,000 rpm for 1 min at 4 ºC. The cycle of suspension and 
centrifugation is repeated for 3 more times to ensure removal of any additional salts that 
may interfere with IEF. After the final cycle, the supernatant is discarded, and pellets are 
dried at RT for ~7-10 min. After drying, pellets are rehydrated in 200 µL of rehydration 
buffer composed of 1:1 (v/v) ratio of the Zwittergent solubilization buffer solution  (7 M 
urea, 2 M thiourea, 2% CHAPS, 65 mM DTT, 1% zwittergent, 0.8% 3-10 ampholytes or 
biolytes, bromophenol blue) and ABS-14 solubilization buffer (7 M urea, 2 M thiourea, 5 
mM TCEP, 1% ABS-14, 1% Triton X 100, 0.5% CHAPS, 0.5% 3-10 ampholytes or 
biolytes) for 2 h, while continuously vortexing at RT (Opii et al. 2007).  
The IEF process is begun by actively rehydrating IEF ready strip (pH 3-10) for 17-18 hr 
at 50 V and 20 ºC. After rehydration IEF is begun at constant temperature 20 ºC and a 
linearly increasing voltage starting from 300 V going up to 8000 V over the next 24 h. 
After completion of IEF, the resolved IPG strip can stored at -80 ºC or can be used 
immediately. For the present work, IPG strops were used immediately without ever 
freezing them.  
To begin 2-D gel or second dimension process, the IPG strip is equilibrated in two 
different buffer solutions for 15 min each. The first buffer was composed of: 50 mM Tris-
HCl (pH 6.8), 6 M urea, 1% SDS w/v, 30% glycerol v/v, and 0.5% dithiothreitol, and the 
second buffer was composed of everything in the first buffer except 4.5% iodacetamide 
was used instead of dithiothreitol. Criterion precast linear gradient 8-16% Tris-HCl gels 
from BioRad are used to perform second dimension electrophoresis, in which proteins are 
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further resolved based upon their relative Mr (Figure 3.12). Precision Protein Standards 
(BioRad, CA) are run along with the samples at 200 V for 65 min. 
 
 
Figure 3.12: First-dimension of protein separation using IEF technique is followed by 
second-dimension SDS-PAGE based separation. 
3.13. Gel fixation and Sypro-Ruby© in-gel protein staining 
After 2D SDS-PAGE, gels are incubated in a fixing solution containing acetic acid (7% 
v/v) and methanol (10% v/v) in DI water for 45 min- 1 h. Later the gels are transferred 
into ~50 ml Sypro Ruby Protein Gel Stain (BioRad, Hercules, CA) for overnight 
incubation on gentle rocking platform. Excess stain is removed by rocking gels in DI 
water for overnight. The stained gels are visualized using a STORM860 Phosphoimager 
(GE Healthcare, Piscataway, NJ) (excitation 470 nm and emission 618 nm), and the 
scanned image is imported and converted into tiff format using Adobe Photoshope 6.0 to 
be used in either PD-Quest image analysis software (Bio-Rad, Hercules, CA) or 
ImageQuant image analysis software (GE, Healthcare, Piscataway, NJ). 
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In-Gel fixation prevents proteins from diffusing out of the gel and sharpens protein band 
or spots on the gel as well it removes unwanted leftover components from SDS-PAGE. 
Sypro Ruby is a fluorescent protein stain composed of a proprietary ruthenium-based 
organometallic compound, which is highly sensitive and does not interfere with mass 
spectrometry analysis of proteins. 
3.14. Western blotting 
In-gel fixation steps are avoided before Western blotting; instead, after 1D- or 2D-SDS-
PAGE gels are directly transferred onto nitrocellulose membrane (0.45 µm). Using a 
Semi-dry Transfer Cell System (BioRad, Hercule, CA) proteins are transferred from a gel 
to nitrocellulose membrane in the presence of electric field (20 V). The resultant 
nitrocellulose membrane blot with protein bound to it can be probed with antibodies 
raised against specific proteins and can be quantified. To achieve this result, the blot is 
incubated with a primary antibody for the specific protein and subsequently in with a 
secondary antibody raised against IgG antibodies (Figure 3.14a). The secondary antibody 
is conjugated to an enzyme that produces a chemiluminescent or colorimetric product, 
which can be quantified using ImageQuant image analysis software (GE Healthcare, 
Piscataway, NJ). 
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Figure 3.14a: Western blotting 
Two types of secondary antibodies were used in this dissertation research, one conjugated 
with alkaline phosphatase (ALP), which reacts with two substrates, 5-bromo-4-chloro-3-
indolyl phosphate dipotassium (BCIP) and nitroazolithium blue chloride (NBT) to 
produce a colorimetric product (Figure 3.14b). The secondary antibody with horseradish 
peroxidase (HRP) reacts with a substrate luminal PS-3 to form a chemifluorescent 
product (Figure 3.14c) 
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Figure 3.14b: Colorimetric method of detection  
 
 
Figure 3.14c: Chemifluorescent method of detection 
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3.15. PD-Quest Image analysis software 
PD-Quest software is used to compare spot intensities densitometrically from Sypro 
Ruby stained control and silver NP treated gels. Briefly, a master gel is selected followed 
by normalization of all the control and treated gels according to the total spot density. 
Differential expression analysis of protein was then initiated by manually matching 
common spots that could be visualized in the gels. After obtaining a significant number 
of matched spots automated matching of all spots is initiated. Automated matching is 
based on user-defined parameters of the “master” gel, the faintest spot, the largest spot 
and the largest spot cluster. Based on these parameters the software defines spot centers 
for the gel. If the software “misses” spots that are obvious to the naked eye, the user can 
manually assign a spot center. This process generates a large pool of data, however, only 
spots showing computer-determined significant differential levels between the groups 
being analyzed are considered for identification. The analysis sets of significant 
differential levels of proteins are created by the software, which is then compared 
statistically. A Student’s t-test is used to identify significant difference in differential 
levels of proteins spots from control and treated group with p < 0.05. These spots were 
selected for subsequent mass spectrometric analysis. 
3.16. ImageQuant software analysis 
The densitometric analysis of slot blots and 1D Western blots are performed using 
ImageQuant software (GE Healthcare, Piscataway, NJ). The nitrocellulose membrane 
blots are scanned using Microtech Scanmaker 4900 scanner and converted into tiff file 
format. The ImageQuant software quantified number of pixels present in the desired 
bands from a tiff image of the blot, which corresponds to an increase/ decrease in protein 
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level or extent of post-translational modification as PC, 3NT or HNE level. A Student’s t-
test is used to identify significant difference in intensities of the bands from control and 
treated group with p < 0.05. 
3.17. In-gel trypsin digestion 
Protein spots that are identified as significantly changed from controls were excised from 
selected gels using a clean micro-pipette tip and placed in separate eppendrof tubes. Spots 
then are washed with 0.1 M ammonium bicarbonate (NH4HCO3, 15 min, RT) and 
incubated with acetonitrile (15 min). The solvent mixture is then removed and gel pieces 
dried. The dried spots are incubated with 30 µL of 20 mM DTT in 0.1 M NH4HCO3 (45 
min, 56 ºC). The DTT solution is then removed and gel pieces incubated with 30 µL of 
55 mM iodacetamide in 0.1 M NH4HCO3 (30 min, RT). The iodacetamide is removed 
and replaced with 0.2 ml of 50 mM NH4HCO3 (15 min, RT), which is again replaced by 
acetonitrile (15 min). After 15 min the solvent is removed and gel pieces are dried in a 
flow hood for 30 min. The gel pieces are then hydrated with 10 µL of (20 ng/µL) 
modified trypsin (Promega, Madison, WI) in 50 mM NH4HCO3.  The gel pieces are 
incubated overnight at 37 ºC in a shaking incubator. After overnight incubation, the 
tryptic digest is cleaned with the Zip-Tip (Millipore, Billerica, MA) method to remove 
any traces of salts, which could interfere with mass spectrometric analysis. 
Trypsin is a protease that specifically cleaves proteins at the C-terminal side of lysine and 
arginine amine acid residue.  
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3.18. Mass Spectrometry 
All the mass spectrometric results reported in this dissertation were obtained in the 
University of Louisville Mass Spectrometry Facility in collaboration with the Department 
of Pharmacology.  
A mass spectrometer (MS) is a mass analyzer that can detect masses of peptides by their 
respective movements in an electric field. Any MS has three basic components, 
ionization source, a mass analyzer, and a detector. A Zip-Tip cleaned tryptic digest 
solution is introduced into a fine capillary containing a high voltage tip in nano-spray or 
electron spray ionization (ESI) source. While passing through high voltage the peptides 
become positively charged, eventually the solvent evaporates and subsequently very 
small charged peptides creates aerosol in the shape of a Taylor cone. The positively 
charged peptides get pulled into the evaporation chamber by the negative charge imposed 
on the chamber inlet. 
After ionization, positively charged peptides are introduced to orbitrap mass analyzer 
mass analyzer. An orbitrap type mass analyzer has a spindle shaped central electrode 
surrounded by a concentric outer electrode. The charged species revolve around the 
central electrode in various oscillation frequencies. The attraction toward the central 
electrode is balanced by the centrifugal force of the rotation of the ion. Unlike radial 
frequency, the axial frequency is independent of energy, angle and position, and it creates 
an image the form of current that can be detected in order to determine m/z ratio.  
The tandem mass spectra generated are searched against Caenorhabditis elegans (C. 
elegans) data base using SEQUEST. This is because there is no existing database for the 
earthworm proteome. Exact peptide masses (known from the mass spectrum) of the 
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digested protein are compared with theoretical peptide masses in the database, producing 
a list of peptide that may possibly match the peptide of interest. The database contains a 
theoretical MS/MS spectrum of the peptides that have similar masses to the unidentified 
peptides. The unidentified peptide is then subjected to MS/MS fragmentation and 
resultant spectrum is then compared with the database. The overlap in fragmentation 
pattern between the unidentified peptide and database spectra of possible matches is 
compared using cross correlation analysis, where proteins receive scores based on the 
quality of overlap. Finally from this data, a protein is identified based on uniqueness of 
identity and probability of theoretical spectral match from selected organism database.  
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CHAPTER 4 
 
IN VIVO OXIDATIVE STRESS EFFECTS OF A SYSTEMICALLY-INTRODUCED 
COMMERCIAL CERIA ENGINEERED NANOMATERIAL  
 
4.1. Overview of Study 
An engineered nanomaterial (ENM) that solves an important problem in the engineering 
or environmental fields (i.e., ENMs for bioremediation) may have serious consequences 
after unintended uptake by humans. Inadequate identification of ENM hazards and 
management of risks from exposure could lead to serious human health problems (Nel et 
al. 2006). The primary anticipated routes of human exposure to ENMs intended for 
industrial or environmental applications include inhalation exposure, dermal uptake, and 
oral ingestion with possible subsequent absorption of ENMs into systemic circulation. 
Although some data exist on the absorption properties and associated toxicities of ENMs 
after exposure via the pulmonary, oral, and topical routes, little is known about their 
distribution into the brain once they reach systemic circulation. There is a need to 
determine the influence of the physico-chemical properties of ENMs on their distribution 
into and across the blood-brain barrier (BBB) and into brain cells and their beneficial 
and/or hazardous effects. Indeed the US Environmental Protection Agency (Shvedova et 
al.) has nominated ceria ENM as on priority for future study to determine its safety and 
awarded a STAR Grant RD-833772 to UK to conduct the research.  
The objective of this study was to evaluate the effects of nanoscale ceria on oxidative 
stress endpoints. The intravenous route of exposure was used to assess the potential for 
the model ENM, after being absorbed by any route and entering systemic circulation, to 
distribute into organs and produce toxicity. A commercial 5% crystalline ceria dispersion 
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in water (average particle size~31 ± 4 nm) was infused intravenously into rats (0, 50, 250 
and 750 mg/kg), which were terminated 1 or 20 h later. Biodistribution in rat tissues was 
assessed by microscopy and ICP-AES/MS. Oxidative stress effects were assessed by 
protein-bound 4-hydroxy 2-trans-nonenal (HNE), 3-nitrotyrosine (3-NT), and protein 
carbonyls.  
4.2 Materials and methods 
4.2.1. Nanomaterial: 
A 5% ceria dispersion in water at pH 4.2 (Aldrich #639648; USA) was used. The 
specifications for this product were:  <150 nm and 4.5- 5.5% dispersion. The physical 
properties of nanoparticles reported by the manufacturer are not always the actual 
properties of a particular lot. The characterization methods used for research in this 
chapter HR-SEM, TEM, FTIR XRDICP-MS, Zeta potentiometer, and DLS techniques 
were performed by our collaborators (Dissertation Section 3.2). 
4.2.2. Animals:  
Nineteen rats were infused with 0 (n=4; 1 infused 0.5 h, 2 infused 2.5 h and 1 infused 7.5 
h), 50 (n=5), 250 (n=5) or 750 (n=5) mg ceria/kg and terminated 1h  after completion of 
the infusion and 32 rats were infused with 0 (n=10; two infused 0.5 h, 4 infused 2.5 h and 
4 infused 7.5 h), 50 (n=7), 250 (n=7) or 750 (n=8) mg ceria/kg and terminated 20 h after 
completion of the infusion (Dr. Yokel’s lab).  
Blood brain barrier integrity assessment (Section 3.3, Dr. Yokel’s lab), light and electron 
microscopic assessment (Section 3.4, Dr. Tseng’s lab), tissue homogenization (Section 
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3.6), BCA protein estimation (Section 3.7), PC, 3NT, protein-bound HNE assays (Section 
3.8) were carried out. 
4.3. Results 
Light scattering particle size determinations suggested the mean ceria ENM size was ~30 
nm, which correlated with HR-STEM imaging of the dosing material (Figure 4.1). FTIR 
results showed several peaks between 1300 and 1700 cm-1 indicating the ceria ENM was 
modified with organic molecules, probably either an intentionally added stabilizer or an 
unintentional contaminant. The exact nature of this organic matter was not determined.  
The XRD results showed the presence of pure ceria in a cubic shape.  
Tissue Ce concentration was ceria dose-dependent. The Ce concentration was highest in 
the spleen, which was higher than the liver, which was higher than the brain (Table 4.1).  
In contrast to the significant accumulation of ceria agglomerations in reticuloendothelial 
organs, much less ceria was seen in the brain (Figure 4.2), consistent with the much lower 
Ce concentration in this organ compared to the spleen, liver and kidney (Table I). No 
microscopic evidence of disruption of the BBB was observed. 
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Figure 4.1: HRTEM results for the ultra-sonicated 5% ceria ENM dispersion used in this 
study. Panel A: Lower magnification showing particle size distribution. The upper limit 
of the particle size range was ~100 nm. Panel B: Higher magnification illustrating that 
the lower limit of the particle size ranges was ~5 nm. All size fractions of the ceria ENM 
were highly crystalline. Panel C: The volume-based particle size distribution was 
bimodal. Panel D: FTIR scan of the powder surface showed the presence of carboxylate 
groups. 
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Figure 4.2: Left image: Electron micrograph of hippocampus of a rat that received 750 
mg ceria/kg and was terminated 20 h after the infusion. Ceria was seen in the vascular 
lumen (red arrows) and an astrocyte (a). The BBB appeared intact (yellow circles). Scale 
bar =1 mm. Right image: Electron micrograph of hippocampus of a rat that received 250 
mg ceria/kg and was terminated 20 h after the infusion. There is an apparent absence of 
ceria. Scale bar =1 mm. 
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Table 4.1: Blood and tissue [Ce] concentrations were measured1 and 20 h after 
completion of intravenous ceria infusion. *All the values were below detection. 
 
Cerium [mg/L or mg/kg wt weight]a 
Ceria dose 
(mg/kg) Blood  Brain  Liver  
1 h Termination    
0 0.032 ± 0.045 0.12 ± 0.09 0.25 ± 0.31 
50 0.56 ± 0.50 0.087 ± 0.067 390 ± 137 
250 1.3 ± 1.4 0.15 ± 0.10 1632 ± 941 
750 41 ± 11 1.1 ± 0.3 6327 ± 725 
20 h 
termination    
0 * * * 
50 1.2 ± 0.1 1.0 ± 0.3 610 ± 131 
250 13 ± 0 3.4 ± 1.0 3139 ± 1451 
750 354 ± 45 7.4 ± 1.2 9335 ± X 
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There were no significant changes in the oxidative stress markers (protein-bound HNE, 
protein-bound 3-NT and protein carbonyls) in brains from rats terminated 1 h after 
completion of the ceria infusion (Figure 4.3., upper panel). Rats terminated 20 h after the 
ceria infusion showed a significant increase of protein-bound HNE in the hippocampus 
and a decrease of protein carbonyls in the cerebellum (Figure 4.3., lower panel). 
 
 
Figure 4.3: Protein-bound HNE, protein-bound 3-NTand protein carbonyls were 
measured in the hippocampus, cortex and cerebellum 1 h (upper panels) and 20 h (lower 
panels) after completion of intravenous ceria ENM infusion. Results are mean ± SD of 4, 
5, 5, and 5 rats that received 0, 50, 250 and 750 mg ceria/kg and were terminated 1 h after 
the infusion and 8, 5, 5 and 7 rats that received 0, 50, 250 and 750 mg ceria/kg and were 
terminated 20 h after the infusion. *=Significantly different from control, p<0.05. 
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4.4. Discussion 
Material characterization results obtained were not fully consistent with the properties of 
this commercial ENM provided by its supplier. FTIR results suggested it had an 
unknown, and not revealed (for proprietary purposes), surface stabilizer(s). Surface 
stabilizers are commonly added to ENM to provide ease of dispersion. However, in an 
adverse effects assessment, as in this study, the presence of unknown components of the 
study material is not desired. To avoid this confound in future studies, we are preparing 
materials to have precise control over surface coating effects in our future studies.  
The commercial ceria ENM used in this study was quite pure in regards to other metals. 
Sonication added little metal to the ceria. The ratio of non-cerium metals to ceria suggests 
that oxidative stress effects seen in this work are due to the ceria ENM (data not shown).  
The lack of profound effects on the oxidative stress endpoints in the brain may relate to 
the limited ceria distribution into the brain. No great BBB disruption was seen 1 and 20 h 
after completion of the infusion. Much less ceria ENM entered the brain than peripheral 
organs, suggesting an intact BBB during the infusion and that the BBB is an effective 
barrier for this crystalline ceria ENM. As it is unknown whether the ceria ENM that did 
enter the brain did so as administered, or after associating with proteins or other 
circulating factors in blood, we cannot glean from this study the properties that did enable 
its limited brain distribution. 
Oxidative injury is a common, primary endpoint of ENM toxicity (Unfried et al. 2007). 
Ceria has been reported to produce toxicity attributed to increased oxidative damage 
(Brunner et al. 2006; Lin et al. 2006; Thill et al. 2006; Park et al. 2008). On the other 
hand, ceria ENM were reported to be protective against oxidative-induced injury in cells 
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from many origins, including the nervous system (Tarnuzzer et al. 2005; Chen et al. 
2006; Schubert et al. 2006; Das et al. 2007; Niu et al. 2007; Singh et al. 2007; Xia et al. 
2008). This may be a direct anti-oxidant effect of ceria owing to its ability to reversibly 
change from Ce (Owens Iii et al.) to Ce (IV). However, that effect was only pronounced 
in acidic environments (Asati et al. 2009). The interest in ceria as a potential therapeutic 
agent with anti-oxidant properties increases the probability that it will be further studied 
for medical applications, making the understanding of its distribution from the central 
compartment (blood) and resultant effects important. The current study is the first report 
of the distribution and effects of ceria from the central compartment, after introduction 
into blood. However, the form of ceria employed in the present study would not be 
effective as a vehicle for drug delivery to the brain.  
In this study, indices of protein oxidation (protein carbonyls and protein-bound 3-NT) 
and lipid peroxidation (protein-bound HNE) were determined. We observed no 
alterations in any of these oxidative stress markers in brain isolated from rats 1 h after 
exposure to ceria ENM. Twenty h after exposure to ceria by intravenous infusion, a dose-
dependent increase of protein-bound HNE in the hippocampus was observed. The 
hippocampus is one of the most vulnerable brain regions, and in the most common 
neurodegenerative disorder, Alzheimer’s disease, the hippocampus, the brains area 
through which initial aspects of memory are formed, is severely damaged by free radicals 
early in the disease (Butterfield et al. 2007). The highly reactive alkenal HNE can bind to 
proteins, thereby inducing conformational and functional changes (Aksenov et al. 1997; 
Subramaniam et al. 1997; Aksenov et al. 2000; Reed et al. 2008). Hence, ceria induced 
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hippocampal lipid peroxidation could lead to deficits in learning and memory, and 
consequently dementia (Butterfield 1997; Butterfield et al. 1997; Lauderback et al. 2001). 
In the cerebellum, protein carbonylation was decreased compared to controls. Cerebellum 
is devoid of oxidative damage and other pathology in Alzheimer’s disease, and though no  
explanation for this observation is yet known, speculation suggests that elevated levels of 
heme oxygenase-1 (which leads to low levels of bilirubin that are highly 
neuroprotective), coupled to both a different neuronal type than in hippocampus and less 
amyloid β-peptide (that leads to free radical oxidative stress) accounts for this protection 
against oxidative stress and  neurodegeneration (Poon et al. 2004). Elevated levels of 
heme oxygenase conceivably might be induced by ceria that lead to neuroprotection 
against oxidative stress as assessed by protein carbonyl levels. The commercial ceria used 
in this study was not obviously accumulated in brain, perhaps because of its size as well 
as its propensity for agglomeration. That, nevertheless, elevated lipid peroxidation was 
observed in vulnerable hippocampus may reflect two possibilities: (a) Brain-resident 
ceria ENM induced lipid peroxidation directly, which involves a chain reaction and 
requires only a modest initiation step to greatly amplify its effect; or (b) ceria-induced 
pro-inflammatory cytokines, e.g., TNF-a, in the periphery that are well-known to cross 
the BBB and induce oxidative stress in brain, including lipid peroxidation (Tangpong et 
al. 2006; Joshi et al. 2007). Further studies will be necessary to distinguish between these 
or other alternatives. It is  interesting to speculate that ceria ENM <10 nm in size, and of 
defined shape and surface properties, in marked contrast to what was used in the current 
study, might have accumulated more in brain and led to either more oxidative or more 
neuroprotective effects. Studies to test this notion are in progress. 
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In summary, much less ceria entered the BBB cells or the brain. The commercial ceria 
studied induced oxidative stress and a stress response in the brain. Ceria provides an inert 
core ENM enabling the study of the effects of size, shape and surface chemistry on the 
biodistribution, and neurotoxic or neuroprotective potential of metal oxide ENMs. These 
results provide a foundation to study the impact of physico-chemical properties of ENMs 
on their brain entry and neurotoxicity or neuroprotection activity.  
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CHAPTER 5 
 
IN VIVO OXIDATIVE STRESS EFFECTS OF A SYSTEMICALLY-INTRODUCED 
IN-HOUSE ENGINEERED 5 NM CERIA NANOMATERIAL  
5.1. Overview of Study 
Ceria ENM (a.k.a. cerium oxide; CeO2), which is one of the most used ENM employed in 
different industrial applications (Yokel et al. 2009; Hardas et al. 2010), has been shown 
to have both anti-inflammatory properties as well as potent toxicity. However, there is no 
clear understanding of what exactly controls ceria’s pro-or anti-oxidant effects. A 
recently published report summarizes findings of in vitro and in vivo studies conducted 
with ceria ENM under basal and induced oxidative stress conditions (Celardo et al. 
2011). Ceria exhibited antioxidant properties by scavenging free radicals, by reducing 
levels of peroxides, iNOS, TNF-α, NF-ĸβ, and interleukin, promoted cell viability or 
protected organelles from diesel exhaust and cigarette smoke-induced oxidative stress, 
ROS generating chemical agents, or side effects of radiation treatment. Ceria is reported 
to have potential use in the treatment of diabetic cardiomyopathy, cancer, stroke, retinal 
degradation and Alzheimer’s disease as well as to prolong  life span (Chen et al. 2006; 
Rzigalinski et al. 2006; Das et al. 2007; Xia et al. 2008; D'Angelo et al. 2009; Hirst et al. 
2009; Babu et al. 2010; Colon et al. 2010; Younce et al. 2010; Estevez et al. 2011; Niu et 
al. 2011). Antioxidant properties of ceria may be related to its SOD- and catalase-
mimetic activity (Korsvik et al. 2007; Pirmohamed et al. 2010) attributed to Ce3+/ Ce4+ 
redox coupling (Celardo et al. 2011) . In contrast, there are reports of ceria induced pro-
oxidant effects under basal conditions. Ceria ENM mediated ROS injury, elevation of the 
lipid peroxidation marker MDA, as well as the membrane damage marker LDH, 
 81 
cytokines, IL-8 mRNA levels, GSH depletion, and reduced cell viability (Brunner et al. 
2006; Lin et al. 2006; Park et al. 2008; Auffan et al. 2009).  
To utilize ceria for therapeutic and non-therapeutic applications, it is important to know 
the long term effects of intended and un-intended ceria exposure on mammals. Most 
reports on effects of ceria ENM were on non-mammalian organisms or in cell culture, 
and they do not address long-term effects or the fate of ceria. In addition to our own 
previous studies (Yokel et al. 2009) (Yokel et al. 2009; Hardas et al. 2010), a few ceria 
ENM studies were conducted in intact animals (Chen et al. 2006; Niu et al. 2007; Hirst et 
al. 2009; Amin et al. 2011; Choi et al. 2011; Hirst et al. 2011; Srinivas et al. 2011; Zhou 
et al. 2011).  
We have shown that iv administration of a commercial ceria ENM induced oxidative 
stress in rat brain (Yokel et al. 2009). However, this ENM was of larger size than 
advertised, tended to agglomerate, and had an unknown surface coating. The objectives 
of the present research were (1) to test the hypothesis that the size of metal oxide ENMs 
inversely relates to their ability to; cross the BBB and produce immediate (1 h) and later 
(20 h) pro- and/or antioxidant effects in the brain using ceria as a model metal oxide 
ENM; and (2) evaluate residual effects of long-term ENM exposure (30 days) on 
oxidative stress parameters in brain. Toward these goals, the iv route was used to assess 
the potential for this ENM, after being absorbed by any route and entering systemic 
circulation, to distribute into the brain and produce effects. Quite large doses were 
initially studied to likely produce significant effects.  
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In the current study, 5-nm ceria ENM was synthesized and characterized, and its toxic 
effects were determined in the cerebellum, cortex, and hippocampus. The levels and 
activities of the antioxidant enzymes catalase, manganese superoxide dismutase (Mn-
SOD), glutathione peroxidase (GPx), and glutathione reductase (GR) were measured 
along with the ratio of reduced glutathione (GSH) to its oxidized form (GSSG). To 
understand the extent of changes in cellular redox status, the levels of oxidative stress 
endpoints, protein carbonyl (PC), 3-nitrotyrosine (3NT), and protein-bound 4- hydroxyl-
2-trans-nonenal (HNE), were measured along with heat shock protein (Hsp70) levels.   
5.2 Materials and Methods 
5.2.1. Nanomaterial: 
Ceria ENM was obtained from our collaborator, which was synthesized in in-house 
facility (Section 3.1). Nanomaterial characterization was carried out by our collaborators, 
prior to ceria ENM treatment to the animals (as described in Section 3.2).  
5.2.2. Animals:  
Seven rats were infused with 0 and 11 rats with 100 mg ceria/kg and terminated 1 h after 
completion of infusion. Eight rats were infused with 0 and 12 rats with 100 mg ceria/kg 
and terminated 20 h after completion of infusion. Seven rats received 0 and nine rats 
received 85 mg ceria/kg and terminated 30 days after completion of infusion. After ceria 
ENM treatments, the BBB integrity assessment (Section 3.3), light and electron 
microscopic assessment (Section 3.4) and EELS analysis (Section 3.2) were carried out 
by our collaborators. The brain homogenates were prepared from control and ceria 
treated rat brain samples (Section 3.6). Total protein content was determined using BCA 
 83 
assay (Section 3.7) and various biochemical assays were carried out on all the samples 
(Section 3.8, 3.9, 3.10, 3.11, and 3.14) in our lab. 
5.3. Results 
Ceria composition 
HR-TEM/HR-STEM showed the ceria ENM was polyhedral shape (Figure 5.1). The 
XRD patterns demonstrated the ceria were highly crystalline. Evaluation of a number of 
TEM images showed that the ceria had a number-average primary particle size of ~ 5 nm. 
Analysis of the ceria dispersion by ICP-MS showed that the ceria content of the as-
synthesized dispersion was 4.35 ± 0.20%. 
 
Figure 5.1: Ceria ENM imaged using HRTEM and HRSTEM. The ceria were dispersed 
on a carbon film. Visually they have a narrow size distribution ranging from 4 to 6 nm, 
the majority 5 nm. The magnified TEM insert at the lower left illustrates that the ceria 
ENMs are highly crystalline. The insert at the top right is a STEM image showing the 
morphology of the ceria ENM (taken by Dr. Peng Wu). 
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Ceria concentration in brain and electron microscope 
ICP-MS analysis suggested that a very small amount of ceria was present in the brain 
parenchyma compared to the peripheral organ liver (Table 5.1). Electron microscopy 
studies suggested that ceria ENM was not found in the brain, but located on the luminal 
side of the BBB endothelium. The hippocampus and cerebellum tissues did not show 
obvious ceria induced injury as no necrotic neurons or elevated gliosis were observed and 
the BBB was visibly intact (data not shown). 
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Table 5.1: Ceria concentration in blood, brain, and liver expressed as concentration and 
as a percentage of the 5 nm ceria ENM dose 1h, 20 h and 30 d after the treatment. % dose 
was based on blood volume of the rat of 7% body weight and brain, and liver ceria 
concentration x organ weights. *All values were below minimum detection limit. 
 
 
 
 
 
 
Cerium (mg/l or mg/kg) wet weight and [% of dose]a 
% dose Blood  Brain  Liver  
1 h termination    
0 (n=7) 0.02 ± 0.03 0.09 ± 0.10 0.30 ± 0.54 
100 (n=11) 27 ± 8 0.020 ± 0.007 22 ± 14 
20 h termonation 
   
0 (n=8) * * * 
100 (n=12) 1 ± 1 0.0046 ± 0.0011 51 ± 11 
30 d termination    
100 (n=9) 0.01 ± 0.02 0.008 ± 0.009 44 ± 27 
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EELS results 
Electron energy loss spectroscopic measurements on liver tissue were performed as a 
representative organ. The ratio of Ce(Owens Iii et al.) to Ce(IV) in the aged ceria was 
evaluated using EELS measurements after locating agglomerates of the 5 nm ceria in 
tissue 20 h and 30 days after infusion into rat and comparing with  synthesized ceria. The 
high Ce3+/ Ce4+ ratio that was obtained in the as-synthesized, fresh 5 nm ceria particles 
seems to have only been altered slightly in individual ceria measured in liver after 30 
days in vivo. However, this difference was not significant after 20 h as well as 30 d (data 
not shown). 
Oxidative Stress Indices 
Ceria treatment affected catalase levels and activities  
Previously ceria ENM was reported  to have H2O2-producing ability (Korsvik et al. 
2007); therefore, the effect of 5 nm ceria ENM on levels and activity of a primary H2O2 
reducing enzyme (catalase) was determined. Catalase activity was significantly increased 
20 h later in the hippocampus (~28%, p<0.05, Table 5.2a) but, decreased after 1 h in 
cerebellum (~16%, p<0.05, Table 5.2b) and 30 d later in the hippocampus (~18%, 
*p<0.05, Figure 5.2b). Catalase levels were significantly increased 1 h after ceria infusion 
in the hippocampus (~ 41%, *p<0.05, Table 5.2) and decreased 30 d after in the 
cerebellum (~16%, *p<0.05, Figure 5.4a). To determine the influence of ceria treatment 
on the SOD enzyme or contribution to H2O2 levels produced from SODs, if any, the level 
of MnSOD and SOD activity were measured after 1 h, 20 h and 30 d. There were no 
significant changes observed in the levels and activity of Mn-SOD (data not shown).  
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Table 5.2a: Oxidative stress indices measured in hippocampus after 1 and 20 h of 5 nm 
ceria treatment. All values are expressed as mean of percentage of controls ± SEM, which 
were concurrently assayed. The control mean was normalized to 100%. *Statistically 
significant difference with (p < 0.05).  
 1 h after treatment 20 h after treatment 
 Control Ceria 
treated 
Control Ceria 
treated 
(a) Hippocampus     
Oxidative stress markers 
PC 100 ± 2 93 ± 3 100 ± 8 103 ± 3 
3NT 100 ± 3 101 ± 3 100 ± 5 103 ± 3 
Protein-bound HNE 100 ± 7 103 ± 6 100 ± 3 101 ± 3 
The GSH antioxidant defense system 
GR levels 100 ± 4 99 ± 13 100 ± 3 109 ± 7 
GR activity 100 ± 7 93 ± 5 100 ± 6 106 ± 5 
GPx levels 100 ± 3 97 ± 4 100 ± 2 102 ± 3 
GPx activity 100 ± 21 97 ± 18 100 ± 13 77 ± 10 
Antioxidant enzymes 
MnSOD levels 100 ± 8 93 ± 8 100 ± 6 98 ± 9 
SOD activity 100 ± 10 93 ± 8 100 ± 8 76 ± 5 
Catalase levels 100 ± 11 141 ± 10* 100 ± 4 91 ± 5 
Catalase activity 100 ± 3 101 ± 5 100 ± 7 128 ± 7* 
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Table 5.2b: Oxidative stress indices measured in cortex and cerebellum after 1 and 20 h 
of 5 nm ceria treatment. All values are expressed as mean of percentage of controls ± 
SEM, which were concurrently assayed. The control mean was normalized to 100%. 
*Statistically significant difference with (p < 0.05).  
 1 h after treatment 20 h after treatment 
 Control Ceria treated Control Ceria treated 
(a) Cortex     
Oxidative stress markers 
PC 100 ± 3 102 ± 3 100 ± 6 102 ± 3 
3NT 100 ± 3 104 ± 4 100 ± 6 97 ± 4 
Protein-bound HNE 100 ± 16 110 ± 9 100 ± 4 106 ± 5 
Antioxidant enzymes 
Catalase levels 100 ± 4 104 ± 2 100 ± 7 109 ± 6 
Catalase activity 100 ± 7 93 ± 4 100 ± 6 105 ± 2 
(b) Cerebellum     
Oxidative stress markers 
PC 100 ± 3 102 ± 3 100 ± 5 85 ± 3 
3NT 100 ± 4 104 ± 2 100 ± 1 98 ± 2 
Protein-bound HNE 100 ± 7 103 ± 6 100 ± 4 104 ± 2 
Antioxidant enzymes 
Catalase levels 100 ± 6 105 ± 6 100 ± 10 91 ± 9 
Catalase activity 100 ± 6 84 ± 3* 100 ± 8 104 ± 5 
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Ceria treatment decreases GPx levels, activity and the GSH-GSSG ratio after 30 d 
GPx reduces H2O2 along with other peroxides using glutathione (GSH) as a source of 
reducing equivalents. The activity of GPx was significantly decreased in the 
hippocampus (~69%, **p<0.001, Figure 5.2b, 30 d) and in cerebellum (~23 %, *p<0.05, 
Figure 5.4b, 30 d). GPx levels showed a decreasing trend in all brain regions but was 
significantly decreased only in cerebellum (~27 %, *p<0.05, Figure 5.4a, 30 d). GR 
levels were significantly decreased (~24%, *p<0.05, Figure 5.3a, 30 d) in the cortex. GR 
activity did not show any significant change in any of the three brain regions of 30 d 
samples. A marker of overall cellular redox status was evaluated by comparing the GSH: 
GSSG ratio of ceria-treated samples. The GSH: GSSG ratio was significantly decreased 
in the hippocampus (~13%, *p<0.05, Figure 5.2b, 30 d) and cerebellum (~15%, 
**p<0.01, Figure 5.4b, 30 d) consistent with an increase in oxidative stress seen in brain 
from ceria ENM-treated animals after 30 d.  
GPx and GR activities and levels remained unchanged in 1 h and 20 h samples, whereas 
GSH and GSSG levels were not measured for these early time points. 
Hsp-70 levels increased 30 d after ceria treatment  
Hsp-70 is a member of the heat shock protein family and inducible by oxidative stress. 
Hsp-70 levels were significantly increased in the hippocampus (~49%, *p<0.05, Figure 
5.2a) and in the cerebellum (~40% *p<0.05, Figure 5.4a), which are consistent with 
depletion of GSH levels indicated by the decreased GSH: GSSG ratio in those regions. 
The levels of Hsp70 were not measured in 1 h and 20 h early time-points. 
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Figure 5.2: Antioxidant levels and activities in hippocampus 30 d after 5 nm ceria ENM 
administration. a) The histograms showing GR, GPx, catalase, antioxidant enzymes and 
HO-1, Hsp70 heat shock proteins levels and corresponding Western blots showing 
protein levels in control [C] and treated [T] samples. The intensity of each band was 
normalized with intensity of corresponding band of β-actin-loading control, and b) GR, 
GPx catalase antioxidant activities, and GSH: GSSG ratio measured in control and ceria 
treated samples. The values are calculated as % control for each measurement expressed 
as mean ± SEM, control n = 7, treated n = 9, *p <0.05, **p < 0.01, compared to control. 
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Figure 5.3: Antioxidant levels and activities in cortex 30 d after 5 nm ceria ENM 
administration. a) histograms showing GR, GPx, catalase, antioxidant enzymes and HO-
1, Hsp70 heat shock proteins levels and corresponding Western blots showing protein 
levels in control [C] and treated [T] samples. The intensity of each band was normalized 
with intensity of corresponding band of β-actin-loading control, and b) GR, GPx catalase 
antioxidant activities, and GSH: GSSG ratio measured in control and ceria treated 
samples. The values are calculated as % control for each measurement expressed as mean 
± SEM, control n = 7, treated n = 9, *p <0.05, **p < 0.01, compared to control. 
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Figure 5.4: Antioxidant levels and activities in cerebellum 30 d after 5 nm ceria ENM 
administration. a) histograms showing GR, GPx, catalase, antioxidant enzymes and HO-
1, Hsp70 heat shock proteins levels and corresponding Western blots showing protein 
levels in control [C] and treated [T] samples. The intensity of each band was normalized 
with intensity of corresponding band of β-actin-loading control, and b) GR, GPx catalase 
antioxidant activities, and GSH: GSSG ratio measured in control and ceria treated 
samples. The values are calculated as % control for each measurement expressed as mean 
± SEM, control n = 7, treated n = 9, *p <0.05, **p < 0.01, compared to control. 
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Ceria treatment induced protein oxidation after 30 d 
Thirty days after ceria ENM treatment, the levels of PC showed a significant increase in 
the hippocampus (~ 19%, *p<0.05, Figure 5.5a) and cerebellum (~12 %, *p<0.05, Figure 
5.5b) in treated vs. control samples.  3NT levels were significantly increased in the cortex 
(~20%, *p<0.05, Figure 5.5c). There was no significant change in protein-bound HNE 
levels in any of the three brain regions. Consistent with increased 3NT levels in cortical 
region, iNOS levels were increased significantly (~27%, *p<0.05, Figure 5.5d), and there 
was a positive correlation between 3NT and iNOS levels (r= 0.67, p < 0.05, Figure 5.5d). 
Measurement of oxidative stress parameters (PC, 3NT, and protein-bound HNE) in the 
hippocampus, cortex, and cerebellum of adult rat brain 1 and 20 h after administration of 
100 mg/kg ceria ENM did not reveal any significant difference in control versus treated 
samples (Table 5.3). 
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Figure 5.5a and b: Protein oxidation and lipid peroxidation markers in hippocampus and 
cerebellum 30 d after 5 nm ceria administration. a) Oxidative stress markers PC, 3NT and 
HNE levels in hippocampus, and b) oxidative stress markers PC, 3NT and HNE levels in 
cerebellum. The values are calculated as % control for each measurement expressed as 
mean ± SEM, control n = 7, treated n = 9, *p <0.05, **p < 0.01, compared to control.  
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Figure 5.5c and d: Protein oxidation and lipid peroxidation markers in cortex 30 d after 
5 nm ceria administration. c) Oxidative stress markers PC, 3NT and HNE levels, and d) 
iNOS levels and correlation between 3NT levels and iNOS levels in ceria treated 
samples, n=9, r=0.67, p < 0.05. The values are calculated as % control for each 
measurement expressed as mean ± SEM, control n = 7, treated n = 9, *p <0.05, **p < 
0.01, compared to control. 
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5.4. Discussion 
A decline in the GSH: GSSG ratio (in hippocampus and cerebellum) after 30 d indicates 
oxidative status of the cellular environment. A similar observation was reported in Park et 
al. in which 30 nm ceria depleted GSH levels in human lung epithelial cells in a dose-
dependent manner (Park et al. 2008). Hydroxylated derivatives of fullerenes decreased 
the GSH: GSSG ratio and induced MDA-lipid peroxidation marker levels (Nakagawa et 
al. 2011). At the cellular level the GSH: GSSG ratio is dependent on GPx and GR 
enzymes, and we observed decreased GPx activity (in hippocampus and cerebellum), 
decreased GPx levels (in cerebellum) and decreased GR levels (cortex) after 30 d. 
Similarly, 15 nm silver and 90 nm copper ENM down-regulated GPx gene expression 
(Wang et al. 2009), 25 nm silver ENM (Rahman et al. 2009) and SWCNT (Wang et al. 
2011) inhibited GPx activity, and silica ENM reduced GR activity (Akhtar et al. 2010). 
Thus it may be that after 30 days post exposure, ENM have deleterious effects on brain-
rendant enzymes needed for maintenance of the reduced thiol status of the cells. Further 
inhibition of catalase activity ( after 30 d) along with GPx activity, may lead to 
accumulation of H2O2 and ultimately increased production of hydroxyl radicals (OH•). 
Activity of  catalase  can be inhibited by hydroxyl radicals (OH•) and that of GPx by 
H2O2 and hydroperoxides (Pigeolet et al. 1990). Ceria ENM can produce H2O2 under 
abiotic conditions (Korsvik et al. 2007; Xia et al. 2008), and H2O2 has high membrane 
permeability (Halliwell 1992).  Further H2O2 can undergo a Fenton-type reaction to 
produce highly potent OH• radicals as noted above. A lack of change in SOD activity and 
level in the current study may imply that endogenous SOD does not account for elevated 
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oxidative stress in brain in this study. Therefore, ceria ENM treatment may have caused 
induction in ROS that lead to oxidative inhibition of antioxidant enzyme activities, 
decreased GSH: GSSG ratio and increased in PC and 3NT levels observed after 30 d. 
Similar augmentation of oxidative stress was seen after exposure to various other ENM 
such as TiO2 (Hao et al. 2009; Liang et al. 2009; Xiong et al. 2011), SWCNT (Wang et 
al. 2011), MWCNT (Guo et al. 2011), hematite (Radu et al. 2010), ZnO (Xia et al. 2008).  
On the other hand increased levels (1 h) and activity (20 h) of catalase in hippocampus 
indicates initial oxidative stress defense response to ceria ENM treatment observed at 
early exposure time-points, which was reinforced by lack of increase in PC, 3NT or HNE 
levels at 1 and 20 h. 
After 30 d, elevated 3NT levels, a marker for increased nitrosive stress, are consistent 
with elevated levels of inducible nitric oxide synthase (iNOS). iNOS exists at extremely 
low levels under normal physiological conditions, but is inducible by endotoxin, and 
inflammatory cytokines among other stresses (Calabrese et al. 2000; Calabrese 2007). 
We found a correlation between 3NT levels and iNOS levels in the cortical region of rats 
examined 30 d after ceria ENM treatment. It may indicate that increased 3NT levels are 
due to increased NO production in the cortex and iNOS levels concurrently may be 
induced following ceria treatment via increased cytokine production.  Electron 
microscopic analysis showed an intact BBB and an absence of any significant amount of 
ceria in the brain. However, cobalt-chromium ENMs have damaged DNAs without 
crossing cellular membranes (Bhabra et al. 2009), and the chemotherapeutic drug 
doxorubicin lead to  neurotoxic effects without ever crossing the BBB (Tangpong et al. 
2006). Similarly, it is conceivable that the observed oxidative stress response in brain 
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regions could be due to the accumulation of 5 nm ceria in peripheral organs and 
subsequent inflammatory cytokines. Studies to test this notion will be carried out in the 
future in our laboratory.  
Induction of heat shock protein Hsp-70 levels as seen after 30 d is in agreement with 
other literature reports. Similar to effects of  silver ENM (Ahamed et al. 2010) and 
fullerene C60 (Usenko et al. 2008) treatments, Hsp-70 levels and other oxidative stress 
markers were induced with concomitant decrease in the GSH: GSSG ratio. In a 
transgenic mouse model for cardiomyopathy, Hsp-70 levels were increased as an 
oxidative stress marker of ER stress. Ceria ENM treatment rescued these cells from ER 
stress and as a result  Hsp-70 expression was down regulated (Niu et al. 2007).  
These pro-oxidant effects in the brain after 30 days exposure in vivo to ceria ENM 
indicate some sort of effect of time after long-term retention of ceria ENM in peripheral 
organs compared to its short term (1 and 20 h) retention, where moderate antioxidant 
effects were observed. The EELS data suggests that mechanisms other than the switching 
between Ce4+ and Ce3+ oxidation states and the possibility to absorb and release oxygen 
by inducing oxygen vacancies may play a critically important role in pro-oxidant effects 
of ceria ENM. Therefore, under the conditions of the present study we propose that 5 nm 
ceria ENM induces in brain initial oxidative stress defense response and upon longer 
exposure, pro-oxidant effects without crossing the BBB. Ceria ENM indirectly induced 
ROS production in brain caused depletion of GSH, which initially induced antioxidant 
levels (1 and 20 h) but over 30 days eventually inhibits H2O2-scavenging catalase and 
GPx enzyme activities. This may increase H2O2 levels and therefore OH• production via 
Fenton reaction, which may cause protein oxidation and induction of Hsp 70, levels 
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(Figure 5.6). We speculate that ceria ENM may cause increased iNOS levels in a similar 
fashion, which leads to increased 3NT levels.  
 
Figure 5.6: In this proposed pathway 5 nm ceria ENM induces pro-oxidant effects after 
30 d in rat brain without crossing the BBB. Ceria ENM indirectly induces ROS 
production as indicated by thick downward arrow leading to GSH depletion and 
inhibition of catalase and GPx enzymes. This inhibition of H2O2 reducing enzyme 
activity can induce H2O2 levels and therefore hydroxyl radicals (OH•) production 
mediated by Fenton reaction. Increased OH• can further oxidize the proteins and may 
hamper their regular function. Hydroxyl radicals may also inhibit H2O2 reducing catalase 
and GPx activity by way of oxidative modification. These bio-chemical reactions could 
make cellular environment more oxidizing, triggering a cellular stress response to induce 
Hsp-70 levels. Hsp-70 is a chaperone protein that can shepherd oxidized protein to 
proteosomes for degradation for further cellular clearance (shown as dotted arrow). If 
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timely clearance of oxidized protein takes place then there may not be any change in 
cellular PC levels. As there was no evidence of the presence of ceria ENM inside the 
brain, it is further proposed that ceria ENM exert its pro-oxidant effect in the brain 
secondary to its peripheral effects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Sarita S. Hardas 2012 
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CHAPTER 6 
 
SYSTEMIC ADMINISTRATION OF 15 NM CERIA ENM INDUCES PHASE II 
ANTIOXIDANTRESPONSE IN RAT BRAIN 
 
6.1. Overview of the Study 
According to the U.S. National Nanotechnology Initiative (NNI) nanoscale material is  
one which has at least one dimension in the range of 1 to 100 nanometers, with properties 
that are often unique due to their dimensions (Yokel et al. 2011). As size of particle 
decreases, its surface area to mass ratio increases concomitantly, the fraction of atoms 
present on the surface also increases. Due to these factors, nanoparticles behave 
significantly different than bulk materials of microparticles. The size of nanoparticles not 
only influences the physico-chemical properties of nanomaterial but also, it’s the 
biological behavior. Upon exposure to biological materials or biological systems, 
nanomaterials can reach to various small cellular compartments, which are otherwise 
inaccessible to microparticles. In addition to this, the large surface area of nanaoparticles 
can be used as a platform or anchor by bio-molecules for different biological processes 
(Nel et al. 2009; Fubini et al. 2010). As well as due to the high fraction of atoms present 
on the surface, nanoparticles can take active part and catalyze biological reactions 
efficiently (Das et al. 2007; Karakoti et al. 2009). Therefore, size becomes an important 
factor to be considered in determining the nanotoxicity of nanomaterials.  
The toxicological studies conducted over past decade have demonstrated that small 
ENMs (< 100nm), cause adverse respiratory effects, by mainly inducing inflammation 
than larger particles with same material composition (Donaldson et al. 2003; Oberdörster 
et al. 2005; Buzea et al. 2007; Kang et al. 2009; Thomassen et al. 2009). Based on 
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literature findings, ~ 15 to 30 nm is a critical width or diameter for ENMs to have 
properties different from the solution and bulk chemistry of their components (Jiang et al. 
2008; Yokel et al. 2011). The significant change in the physico-chemical properties of 
ENM is strongly related to the exponential increase in the number of atoms localized on 
the surface of ENM, making ~ 15 to 30 nm ENM to stand out from microparticles and 
bulk materials (Auffan et al. 2009; Yokel et al. 2011).  Pulmonary toxicity studies with 
TiO2 ENMs compared two sizes 20 nm and 250 nm (Oberdörster et al. 1994; Oberdörster 
et al. 2005). A comparison of ultrafine- and fine-TiO2 particle induced revealed increased 
cytotoxic effects upon untrafine-TiO2 treatment (Kang et al. 2009) as well silica ENM 
showed size-dependent cytotoxicity (Thomassen et al. 2009). In spite of having same 
crystal structure, smaller size ENM induced high inflammatory response, showed 
significantly prolonged retension (up to 1 year), and increased translocation to pulmonary 
intestitium and persistence. In addition to it, small ENM had adverse effect on cell 
proliferation, and it impaired alveolar microphage functions (Oberdӧrster 1988; Buzea et 
al. 2007).   
As explained earlier, oxidative stress effects of ceria ENM are topic of discrepancy. In 
order to understand the influence of size on the oxidative stress effects of ceria ENM, 
ceria ENM with different sizes were synthesized. Each of the proceeding chapters 
focused on one size of ceria ENM and its oxidative stress effects on rat brain evaluated at 
different time points. In this chapter we discuss oxidative stress effects of 15 nm ceria 
ENM on rat brain upon systemic administration. Five% dispersion of the material was 
administered to male rats intravenously (250 mg/kg and 100 mg/kg). The rats that 
received 250 mg/kg dose were terminated after 1 h and the rat that received 100 mg/kg 
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dose were terminated after 30d. Three brain regions, hippocampus, cortex and cerebellum 
from each treatment were harvested from each ceria and saline-control treated rats and 
frozen rapidly in liquid nitrogen. The levels and activities of the antioxidant enzymes 
catalase, manganese superoxide dismutase (Mn-SOD), glutathione peroxidase (GPx), and 
glutathione reductase (GR), were measured along with the ratio of reduced glutathione 
(GSH) to its oxidized form (GSSG). To understand the extent of changes in cellular 
redox status, the levels of oxidative stress endpoints, protein carbonyl (PC), 3-
nitrotyrosine (3NT), and protein bound 4- hydroxyl-2-trans nonenal (HNE), were 
measured along with heat shock protein (Hsp70) levels.   
6.2. Materials and methods 
6.2.1. Nanomaterial: 
Ceria ENM was obtained from our collaborator, which was synthesized in in-house 
facility (Section 3.1). Nanomaterial characterization was carried out by our collaborators, 
prior to ceria ENM treatment to the animals (Section 3.2).  
6.2.2. Animals:  
The male Sprague-Dawley rats received either saline or 5% ceria dispersion 
intravenously. Five rats were infused with 0 and three rats with 250 mg ceria/kg and 
terminated 1 h after completion of infusion. Five rats were infused with 0 and 5 rats with 
100 mg ceria/kg and terminated 30 d after completion of infusion. After ceria ENM 
treatments, the BBB integrity assessment (Section 3.3), light and electron microscopic 
assessment (Section 3.4) and EELS analysis (Section 3.2) was carried out by our 
collaborators. The brain homogenates were prepared from control and ceria treated rat 
brain samples (Section 3.6). Total protein content was determined using BCA assay 
 104 
(Section 3.7) and various biochemical assays were carried out on all the samples 
(Sections 3.8, 3.9, 3.10, 3.11, and 3.14) in our lab. 
6.3. Results 
Ceria composition 
HR-TEM/HR-STEM showed the ceria ENM was polyhedral shape (Figure 1). The XRD 
patterns demonstrated the ceria are highly crystalline. Evaluation of a number of TEM 
images showed that the ceria had a number-average primary particle size of 15 nm.  
 
Figure 6.1: Ceria ENM imaged using HRTEM and HRSTEM. The ceria were dispersed 
on a carbon film. Visually they have a size distribution ranging from X to X nm and the 
majority diameter around 15 nm. The magnified TEM insert at the lower left illustrates 
that the ceria ENMs are highly crystalline (taken by Dr. Peng Wu). 
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Ceria concentration in brain and electron microscopy 
ICP-MS analysis suggested that a very small amount of ceria was present in the brain 
parenchyma compare to peripheral organ liver (Table 1). Electron micrographic studies 
suggested that ceria ENM was not found in the brain, but located on the luminal side of 
the BBB endothelium. The hippocampus and cerebellum tissues did not show obvious 
ceria induced injury as no necrotic neurons or elevated gliosis were observed and the 
BBB was visibly intact (data not shown). 
Table 6.1: Cerium concentrations in blood, brain, liver, and spleen, expressed as a 
percent change of 15 nm ceria ENM dose. a) Based on reference volume of blood in the 
rat (7% of body weight) or weight of the brain, liver x ceria concentration. 
 
Cerium [% of dose]a 
 Blood  Brain  Liver  
% dose (1 h) 0.59 ± 0.15 0.006 ± 0.004 32 ± 14 
% dose (30 d) 0.0048 ± 0.0011 0.0013 ± 0.001 22.6 ± 12 
 
EELS results 
Electron energy loss spectroscopic measurements on liver tissue were performed as a 
representative organ. The ratio of Ce(Owens Iii et al.) to Ce(IV) in the aged ceria was 
evaluated using EELS measurements after locating agglomerates of the ceria nanorods in 
tissue 1 h and 30 days after infusion into rat and comparing with  synthesized ceria. The 
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high Ce3+/ Ce4+ ratio that was obtained in the as-synthesized, fresh 15 nm ceria seems to 
have only been altered slightly in individual ceria measured in liver after 30 days in vivo 
(data not shown). 
Oxidative Stress Indices 
GSH: GSSG ratio increases in a time dependant manner 
One hour after 250 mg/kg dose of 15 nm ceria, brain redox status was affected as 
indicated by declined in GSH: GSSG ratios in hippocampus (~ 16%, ξp < 0.01, Figure 
6.2), and cortex as well as in cerebellum, although the latter was not significant. Thirty 
days after administration of 100 mg/kg dose of 15 nm ceria ENM, GSH: GSSG ratio was 
not significantly changed; however, an increasing trend was observed when compared 
with the respective controls. The declined trend in GSH: GSSG ratio suggests more 
oxidized cellular status after 1 h, while the ascending trend of GSH: GSSG ratio may 
suggest the more reduced redox status of brain after 30 d.  
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Figure 6.2: GSH: GSSG ratios in 3-brain regions 1 h after 250 mg/kg dose and 30 d after 
100 mg/kg dose of 15 nm ceria ENM. The histograms represent % control for saline 
treated controls and ceria treated samples. The values are expressed as mean ± SEM, 
control n = 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of 
respective control samples. 
SOD level and activity spiked up after ceria treatment 
SOD, superoxide dismutase antioxidant enzyme, which converts superoxide radical into 
H2O2 and O2, was significantly affected after 15 nm ceria treatment. MnSOD levels were 
increased significantly in hippocampus (~ 40%, *p < 0.05), cortex (~ 53%, ξp < 0.01), 
and cerebellum (~ 28%, *p < 0.05) 1 h after receiving 250 mg/kg dose of 15 nm ceria 
ENM (Figure 6.3a). However, MnSOD levels remained unaffected 30 days after 
receiving 100 mg/kg dose of 15 nm ceria. The levels of catalase, H2O2 reducing 
antioxidant enzyme,  showed slight increase (H and CB) 1 h after administration of 
higher dose of ceria, and slight decrease (H and CB), 30 d after lower dose of ceria; but 
neither of the changes were significant (Figure 6.3b). Among two glutathione dependant 
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enzymes, only GPx levels were significantly elevated in cortex (~ 33%, *p < 0.05, Figure 
6.3c) 1 h after ceria ENM treatment. GPx levels were decreased in hippocampus, almost 
unchanged in cortex and slightly increased in cerebellum, 30 d after 100 mg/kg ceria 
treatment, but none of the changes were significant. GR levels were slightly increased in 
cortex and decreased in cerebellum after 1 h, and showed no change after 30 d (Figure 
6.3d). 
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Figure 6.3a, b, c and d: The antioxidant enzyme levels in 3-brain regions 1 h after 250 
mg/kg dose and 30 d after 100 mg/kg dose of 15 nm ceria ENM. a) The histograms 
represent % control MnSOD levels measured in saline treated controls and ceria treated 
samples, b) the histograms represent % control catalase levels measured in saline treated 
controls and ceria treated samples, c) the histograms represent % control GPx levels 
measured in saline treated controls and ceria treated samples, d) the histograms represent 
% control GR levels measured in saline treated controls and ceria treated samples. All the 
values are expressed as mean ± SEM, control n = 5, treated n = 5, *p <0.05, ξp < 0.01, 
and Θp < 0.001, compared to mean of respective control samples.  
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Figure 6.3e: Separate Western blots were used to estimate antioxidant protein levels in 
hippocampus, cortex and cerebellum. However, only representative examples from 
hippocampus are shown. Protein levels in control [C] n=5, and treated [T] n=3 (1 h, left, 
consider only labeled bands) and [T] n=5 (30 d, right) 15 nm ceria ENM treatment. The 
intensity of each antioxidant protein band was normalized with intensity of corresponding 
band of β-actin-loading control. Similar blots were obtained for cortex and cerebellum 
regions. 
Similar to the antioxidant levels, antioxidant enzyme activities were heavily affected 1 h 
after 250 mg/kg dose treatment of 15 nm ceria ENM. SOD activity was significantly 
increased after 1 h in hippocampus (~ 30%, *p < 0.05), cortex (~ 26%,*p < 0.05), and 
cerebellum (~ 24%,*p < 0.05) but remained unaffected after 30 d (Figure 6.4a).  Catalase 
activities were significantly elevated in hippocampus (~ 24%, ξp < 0.01) and in 
cerebellum (~ 16%, *p < 0.05) after 1 h, cortex region catalase activity was slightly 
increased (Figure 6.4b). 30 d after 100 mg/kg ceria treatment, catalase activity was 
slightly declined in cortex, while elevated in cerebellum, but remained unaffected in 
hippocampus (Figure 6.4b). GPx activity was increased after 1 h in hippocampus (~ 28%, 
ξp < 0.01) and cortex (~ 33%, *p < 0.05), and remained unchanged in cerebellum, while 
after 30 d GPx activity did not change in any of the brain region (Figure 6.4c). While GR 
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activity showed some decreasing trend after 1 h (C and CB) and somewhat increasing 
trend after 30 d (C and CB), the changes were not statistically significant (Figure 6.4d).  
 
Figure 6.4: The antioxidant enzyme activities in 3-brain regions 1 h after 250 mg/kg 
dose and 30 d after 100 mg/kg dose of 15 nm ceria ENM.  a) the histograms represent % 
control SOD activities measured in saline treated controls and ceria treated samples, b) 
the histograms represent % control catalase activities measured in saline treated controls 
and ceria treated samples,c) The histograms represent % control GPx activities measured 
in saline treated controls and ceria treated samples, d) the histograms represent % control 
GR activities measured in saline treated controls and ceria treated samples. All the values 
are expressed as mean ± SEM, control n = 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 
0.001, compared to mean of respective control samples.  
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PC, 3NT and HNE levels decreased after 1h however, HSP levels increased 
PC, 3NT and HNE levels were affected only after 1 h. PC levels were decreased in 
hippocampus (~ 30%, *p < 0.05) and cerebellum (~ 29%, *p < 0.05) (Figure 6.5a). 3NT 
levels were decreased significantly in hippocampus (~ 69%, ξp < 0.01) and showed 
decreasing trend in cortex (Figure 6.5b). HNE levels were decreased significantly in 
hippocampus (~ 38%, ξp < 0.01) and in cerebellum (~ 28%, ξp < 0.01) (Figure 6.5c). 
There was no effect on the PC, 3NT or HNE levels after 30 d in 3-brain regions (Figure 
4a, b and c). The reduction in protein oxidation and lipid peroxidation markers (1 h) is 
consistent with elevated antioxidant protein levels and activities after 1 h.   
The heat shock proteins function as intra-cellular chaperones for other proteins. As a 
chaperon, they assist in the establishment of proper protein conformation and prevent 
unwanted protein aggregation. HSPs also help in stabilizing partially folded proteins and 
transporting proteins across membranes within the cell. The upregulation of heat shock 
protein is an important cellular stress response and can be induced by oxidative stress. 
Unlike observed in our other studies, heat shock protein HO-1 and Hsp70 levels were 
induced after 1 h, even though protein oxidation and lipid peroxidation markers were 
significantly decreased. Induction in Hsp70 levels was observed in all 3-brain regions; 
hippocampus (~ 36%, *p < 0.05), cortex (~ 33%, *p < 0.05) and cerebellum (~ 38%, *p < 
0.05) after 1 h (Figure 6.6a). Induction of HO-1 levels was seen after 1 h in hippocampus 
(~ 25%, *p < 0.05) and in cerebellum (~ 27%, *p < 0.05), whereas decreased in cortex 
but this change was not significant (Figure 6.6b).  
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Figure 6.5: The oxidative stress marker levels in 3-brain regions 1 h after 250 mg/kg 
dose and 30 d after 100 mg/kg dose of 15 nm ceria ENM.  a) The histograms represent % 
control PC levels measured in saline treated controls and ceria treated samples, b) the 
histograms represent % control 3NT levels measured in saline treated controls and ceria 
treated samples, c) the histograms represent % control HNE levels measured in saline 
treated controls and ceria treated samples. All the values are expressed as mean ± SEM, 
control n = 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of 
respective control samples 
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Figure 6.6a and b: The heat shock protein levels in 3-brain regions 1 h after 250 mg/kg 
dose and 30 d after 100 mg/kg dose of 15 nm ceria ENM.  a) The histograms represent 
%control HO-1 levels measured in saline treated controls and ceria treated samples, b) 
the histograms represent %control Hsp70 levels measured in saline treated controls and 
ceria treated samples. All the values are expressed as mean ± SEM, control n = 5, treated 
n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control 
samples.  
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Figure 6.6c: Separate Western blots were used to estimate HSPs levels in hippocampus, 
cortex and cerebellum. However, only representative examples from hippocampus are 
shown. Protein levels in control [C] n=5, and treated [T] n=3 (1 h, left, consider only 
labeled bands) and [T] n=5 (30 d, right) 15 nm ceria ENM treatment. The intensity of 
each antioxidant protein band was normalized with intensity of corresponding band of β-
actin-loading control. Similar blots were obtained for cortex and cerebellum regions. 
6.4. Discussion 
The toxicity of nanomaterials is governed by various factors including chemical 
composition, size, morphology, and surface modifications. According to the ENM 
toxicity studies from past decade, the smaller the size of ENM, the higher is the toxicity 
(Lippmann 1990; Buzea et al. 2007). Additionally, based on correlation between surface 
area and fraction of atoms present on the surface of a particle, ENM with one or more 
dimensions in the range of ~ 15 to 30 nm exhibits distinctly different physico-chemical 
behavior (Jiang et al. 2008; Yokel et al. 2011). Therefore, to evaluate the influence of 
size on the oxidative stress effects of ceria ENM, we synthesized 5 nm, 15 nm 30 nm and 
55 nm size ceria ENM. 5% dispersion of each ceria ENM was administered intravenously 
to the separate groups of male rats. The tissues were harvested at different time intervals 
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after ceria administration from each saline and ceria ENM treated rats. The oxidative 
stress effects of ceria ENM on three rat brain regions were evaluated separately. 
In the current study the three rats that received higher dose (250 mg/kg) of 15 nm ceria 
ENM were terminated after 1 h along with five saline-treated rats. Antioxidant enzyme 
SOD levels were dramatically induced in all the brain regions of ceria treated rats, along 
with SOD enzyme activity. GPx levels (C) with its activity (H and C) were increased, 
catalase levels were elevated and activity was increased (H and CB).  Such coordinated 
upregulation of phase II enzymes can be induced by minor increase in oxidative stress 
caused by external or internal stimuli (Li et al. 2004; Kim et al. 2009). Induction of phase 
II antioxidant enzymesalso can be seen as a response to GSH depletion or decreased 
GSH: GSSG ratio (Limón-Pacheco et al. 2007; Lee et al. 2008; Speciale et al. 2011), as 
observed in the current study after 1 h ceria ENM treatment. Similar cellular response 
was observed where ceria ENM  rescued rat liver from monocrotaline mediated ROS 
injury (Amin et al. 2011), protected H9c2 cardiomyocytes exposed to cigarette smoke 
(Niu et al. 2011), human colon cells exposed to radiation (Colon et al. 2010) from 
induced ROS injury by restoring phase II enzyme activities and / or levels.  
The phase II antioxidant enzyme induction is a cellular defense mechanism against 
increased oxidative stress and to protect protein, lipids and DNA from any further 
oxidative damage (Li et al. 2004; Limón-Pacheco et al. 2007; Lee et al. 2008; Speciale et 
al. 2011). Although increased levels and activity of SOD can effectively degenerate super 
oxide radicals (O2
-•), it can also increase levels of H2O2 (Poon et al. 2004), which can 
generate OH• radical if not reduced in time by catalase or GPx enzymes. The OH• radical 
is highly reactive and notorious for causing oxidative damage to proteins and lipids. 
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However, decreased levels of PC, 3NT and HNE levels suggest additional cellular 
defense responses that may have protected proteins and lipids from any further ROS 
injury. HSPs, also known as chaperon proteins; assist the establishment of proper protein 
conformation and prevents unwanted protein aggregation. HSPs also helps in stabilizing 
partially folded proteins and transporting proteins across membranes within the cell. The 
upregulation of heat shock protein is an important cellular stress response and can be 
induced by heat, chemical toxins or oxidative stress. Inductions of HSPs have shown 
protection against oxidative stress as well as it prevented protein and lipid peroxidation 
(Broome et al. 2006; Wang et al. 2006; Shrivastava et al. 2008). In current study, HO-1 
(H and CB) and Hsp70 (H, C and CB) levels were significantly induced after 1 h 
concurrent with increased levels of phase II enzymes and decreased levels of PC (H and 
CB), 3NT (H) and HNE (H and CB).  
Thirty days retention of 15 nm ceria ENM (100 mg/kg dose) in the body did not have any 
adverse effect on rat brain redox status. The slightly elevated GSH: GSSG suggests 
favorable reduced status of cellular environment, which was not significantly different 
than that of saline treated controls. Unlike our pervious study with 5 nm ceria ENM, lack 
of significant change in levels or activities of phase II enzymes, HSPs and protein or lipid 
oxidative stress markers (PC, 3NT, HNE) delineate absence of any profound anti- or pro-
oxidant effects of 15 nm ceria ENM on rat brain after 30 d. Considering the antioxidant 
cellular response induced by milder levels of oxidative stress mediated by high dose of 15 
nm ceria ENM after 1 h, presumably same 15 nm ceria ENM would have induced similar 
antioxidant cellular responses after 1 h also at lower dose (100 mg/kg). Thus, absence of 
any profound anti- or pro-oxidant effect after 30 d, may be due to decreased oxidative 
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stress or compensation of ceria induced oxidative stress by initial antioxidant defense 
response at 1 h. 
Considering the ENM size-effect on its oxidative stress related effects, smaller sized (5 
nm) ceria likely to have more adverse effects on rat brain compared to larger ENMs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Sarita S. Hardas 2012 
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CHAPTER 7 
 
MODULATION OF PHASE-II ANTIOXIDANT RESPONSE BY 30 NM CERIA ENM 
IN RAT BRAIN IN TIME-DEPENDENT MANNER  
 
(30 nm-Size and exposure period – prolong persistence of ceria ENM) 
 
7.1. Overview of the study 
Engineered nanomaterials (ENMs) have potential to contribute to applications that could 
produce intended (e.g., drug and gene delivery) or unintended (e.g. occupational and 
environmental) exposure. Understanding potential ENM toxicity lags behind application 
development, as is usually the case for new technologies. Insufficient understanding of 
ENM hazards could lead to human health problems and decreased public acceptance.  
Ceria (cerium [Ce] oxide) ENMs have many current and potential commercial 
applications. Ceria is highly insoluble, including in phagolysosomal fluid at pH 4.5 (He et 
al. 2010) and abrasive, enabling its use in chemical-mechanical planarization (integrated 
circuit manufacture) (Feng et al. 2006). Most ceria applications capitalize on its redox 
activity, including as an oxygen sensor (Molin et al. 2008), diesel fuel catalyst (increases 
combustion and converts carbon monoxide to carbon dioxide) ((HEI) ; Park et al. 2007), 
2001 #659;Cassee, 2011 #177), in fuel cells (Yuan et al. 2009), and for potential medical 
applications. 
Therapeutic ceria ENM applications are generally based on its ability to reduce reactive 
oxygen species (Dalle-Donne et al. 2006). Using many different cells in culture ceria 
ENMs have been shown to reduce levels of H2O2, the superoxide radical, i-NOS, NF-κB, 
TNF-α, interleukins, and other ROS endpoints. It has been suggested that ceria ENMs 
have utility in the prevention and/or treatment of cancer, diabetic cardiomyopathy, diesel 
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exhaust- and cigarette smoke-induced oxidative stress, radiation therapy side effects, 
retinal degeneration, stroke, and neurodegenerative disorders (Chen et al. 2006; Das et al. 
2007; Xia et al. 2008; D'Angelo et al. 2009; Hirst et al. 2009; Babu et al. 2010; Colon et 
al. 2010; Younce et al. 2010; Estevez et al. 2011; Niu et al. 2011). Ceria mediated ROS 
reduction may relate to its properties as a SOD mimetic and possessing catalase-like 
activity (Kagan et al. 1992; Korsvik et al. 2007; Pirmohamed et al. 2010) and is perhaps 
attributed to Ce (Owens Iii et al.) rather than Ce(IV) (Celardo et al. 2011). Most of these 
studies were conducted in models of induced oxidative stress. 
On the other hand, there are reports of ceria-induced toxicity, indicated by decreased cell 
viability, lutathione, and DNA content; and increased LDH release, malondialdehyde, 
and apoptosis (Brunner et al. 2006; Lin et al. 2006; Park et al. 2008; Auffan et al. 2009). 
Most of these studies were conducted in non-ROS stimulated cells. The reported effects 
of ceria ENM on non-mammalian organisms have generally been detrimental, including 
decreased growth, fertility, and survival; and increased lipofuscin accumulation and 
susceptibility to oxidative stress, shown in Pseudokirchneriella subcapitata (green algae), 
Synechocystis PCC6803 and Anabaena CPB4337 (cyanobactreria), E. coli, Daphnia 
magna, and C. elegans (Roh et al. ; Thill et al. 2006; VanHoecke et al. 2009; Zeyons et 
al. 2009; Zhang et al. 2010; Rodea-Palomares et al. 2011). All of these studies do not 
inform about the long-term effects and fate of ceria ENM in the intact mammal, the target 
of medical applications and a concern about unintended exposures. Nanoscale ceria was 
identified as an important material for toxicity evaluation by the NIEHS (ILS), 2006 
#668) and OECD Environment Directorate ((OECD)), 2010 #669). The need for in vivo 
studies that examine its biokinetics and toxicity w as recently identified (Cassee et al. 
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2011). A few studies with ceria ENM have been conducted in the intact mammal. 
Reduced myocardial oxidative stress was seen in transgenic mice that display ischemic 
cardiomyopathy (Niu et al. 2011). Granulomatous inflammation was seen after 
pulmonary instillation and inhalation (Cho et al. 2010; Srinivas et al. 2011). Intravitreal 
injection reduced retinal vascular lesions (Zhou et al. 2011).  
Most therapeutic applications of ceria ENM will require systemic or pulmonary 
administration as its oral absorption is poor (~0.001%) and better from the lung (~0.1 to 
1%) (He et al. 2010; Yokel et al. 2012). Translocation can occur from the lung (and 
potentially other sites of uptake) to blood and ultimately all organs (He et al. 2010). 
Therefore the fate of ceria that is introduced into, or reaches, blood needs to be better 
understood. 
Our previous research described in this dissertation has shown that, although ceria ENM 
does not cross BBB and enter brain parenchyma, accumulation and retention of ceria 
ENM in peripheral organs exerts oxidative stress effects on brain even after 30 d of 
administration of ENM.  The present study was conducted to evaluate the oxidative stress 
effects on rat brain induced by retention of ceria ENM in peripheral organs for 90 d.  In 
addition we set up our experimental design to test the model for oxidative stress hierarchy 
model for nanomaterial toxicity proposed by Nel (Nel et al. 2006).  
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7.2. Materials and methods 
7.2.1. Nanomaterial: 
Ceria ENM was obtained from our collaborator, which was synthesized in in-house 
facility (Section 3.1). Nanomaterial characterization was carried out by our collaborators, 
prior to ceria ENM treatment to the animals (Section 3.2).  
7.2.2. Animals:  
The male Sprague-Dawley rats received either saline or 5% ceria dispersion 
intravenously. Five rats were infused with 0 and 5 rats with 100 mg ceria/kg and 
terminated 1 h after completion of infusion. Five rats were infused with 0 and 5 rats with 
100 mg ceria/kg and terminated 20 h after completion of infusion. Three rats with 0 and 3 
rats were infused with 100 mg ceria/kg and terminated 1 d after, 3 rats with 0 and 3 rats 
were infused with 100 mg ceria/kg and terminated 7 d after, 10 rats with 0 and 11 rats 
were infused with 100 mg ceria/kg and terminated 30 d after, and 6 rats with 0 and 7 rats 
were infused with 100 mg ceria/kg and terminated 90 d after completion of infusion. 
After ceria ENM treatments, the BBB integrity assessment (Section 3.3), light and 
electron microscopic assessment (Section 3.4) and EELS analysis (Section 3.2) was 
carried out by our collaborators. The brain homogenates were prepared from control and 
ceria treated rat brain samples (Section 3.6). Total protein content was determined using 
BCA assay (Section 3.7) and various biochemical assays were carried out on all the 
samples (Sections 3.8, 3.9, 3.10, 3.11, and 3.14) in our laboratory. 
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7.3. Results 
Ceria composition 
HR-TEM/HR-STEM showed the ceria ENM was cubic shape (Figure 7.1). The XRD 
patterns demonstrated the ceria are highly crystalline. Evaluation of a number of TEM 
images showed that the ceria had a number-average primary particle size of ~31.2 ± 17.1 
nm.  
Ceria concentration in brain and Electron micrograph 
ICP-MS analysis suggested that very small amount of ceria was present in the brain 
parenchyma compare to peripheral organ liver (Table 7.1). Electron micrograph studies 
suggested that ceria ENM was not found in the brain, but located on the luminal side of 
the BBB endothelium. The hippocampus and cerebellum tissues did not show obvious 
ceria induced injury as no necrotic neurons or elevated gliosis were observed and the 
BBB was visibly intact (data not shown). 
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Figure 7.1: Ceria ENM imaged using HRTEM and HRSTEM. The ceria were dispersed 
on a carbon film. Visually they have average size distribution 31.2 ± 17.1 nm (taken by 
Dr. Peng Wu). 
 
Table 7.1: Cerium concentrations in blood, brain, liver, and spleen, expressed as a 
percent change of the ceria ENM dose. a) Based on reference volume of blood in the rat 
(7% of body weight) or weight of the brain, liver x ceria concentration. 
 
Cerium [% of dose]a 
 Blood  Brain  Liver  
% dose (1 h) 0.01 ± 0.009 0.0003 ± 0.001 40 ± 10 
% dose (30 d) 0.0056 ± 0.003 0.0056 ± 0.004 20.29 ± 6 
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EELS results 
Electron energy loss spectroscopic measurements on liver tissue were performed as a 
representative organ. The ratio of Ce(Owens Iii et al.) to Ce(IV) in the aged ceria was 
evaluated using EELS measurements after locating agglomerates of the ceria nanorods in 
tissue 1 h and 30 days after infusion into rat and comparing with  synthesized ceria. The 
high Ce3+/ Ce4+ ratio that was obtained in the as-synthesized, fresh ceria nanorods seems 
to have only been altered slightly in individual ceria measured in liver after 30 days in 
vivo (data not shown). 
Oxidative Stress Indices 
GSH: GSSG ratio was decreased at all time points- marker of increased oxidative stress 
Glutathione (GSH) is an abundant antioxidant is a part of primary cellular defense against 
ROS or RNS stress. GSH provides H or electrons for detoxification of free radicals 
carried out by GPx and in the process get oxidized to form disulfide bond with another 
GSH molecule. Oxidized glutathione (GSSG) is recycled back to reduced GSH by action 
of GR enzyme. GSH: GSSG ratio reflects the status of cellular redox state and a decline 
in GSH: GSSG ratio indicates an oxidative state of the cellular environment, which may 
activate various downstream signaling pathways. The GSH: GSSG ratio was significantly 
decreased in hippocampus after 1 h (*p < 0.05), 20 h (*p < 0.05), 1 d (*p < 0.05), 7 d (ξp 
< 0.01), and 30 d (*p < 0.05), in cortex after 1 h (*p < 0.05), and in cerebellum after 1 d 
(*p < 0.05), 7 d  (*p < 0.05), and 30 d (*p < 0.05) after 30 nm ceria administration 
(Figure 7.2). However, there was sudden a spike was observed in GSH: GSSG ratio in 90 
d brain samples indicating restoration of cellular redox status. 
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Figure 7.2: GSH: GSSG ratios measured in 3-brain regions after 1 h, 20 h, 1 d, 7 d, 30 d 
and 90 d- 30 nm ceria ENM treatment. The histograms represent %control GSH: GSSG 
ratio for ceria treated samples normalized with mean of their respective controls. The 
values are expressed as mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h 
(n=5), 1 d (n=3), 7 d (n=3), 30 (n=11), 90 d (n=7). Statistical difference was estimated as 
*p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples. 
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Induction of Tier 1 oxidative stress response: Phase II antioxidant activities were 
increased after 1h, 20 h and after 90 d chronic exposure 
An oxidative insult, generation of free radicals, or decline in cellular redox state can 
activate cellular antioxidant defense response and induction of phase II enzymes. Decline 
in GSH: GSSG ratio can activate Nrf-2 pathway, which regulates transcription of phase II 
enzymes like GPx, GR, GST catalase, and SOD (Xiao et al. 2003; Li et al. 2004; Lee et 
al. 2008; Chia et al. 2010; Speciale et al. 2011). At earlier time points GPx levels were 
induced in hippocampus (*p < 0.05, 1 & 20 h) and cerebellum (*p < 0.05, 1 h); Figure 
7.3a, and catalase levels in hippocampus (*p < 0.05, 1 & 20 h), in cortex (*p < 0.05, 1 & 
20 h), and in cerebellum (ξp < 0.01, 1 h & Θp < 0.001, 20 h); Figure 7.4a. However, GR 
levels were decreased significantly in hippocampus (Θp < 0.001, 1 h & *p < 0.05) Figure 
7.5a. Concomitantly activities of phase II enzymes were also increased; GPx activities in 
hippocampus (*p < 0.05, 1 & 20 h), in cortex (*p < 0.05, 1 h) and in cerebellum (*p < 
0.05, 1 h & ξp < 0.01, 20 h); Figure 7.3b, GR activities in cerebellum (*p < 0.05); Figure 
7.5b, and catalase activities in hippocampus (*p < 0.05, 1 & 20 h), in cortex (ξp < 0.01, 
20 h), and in cerebellum (*p < 0.05, 1 h & ξp < 0.01, 20 h); Figure 7.5b. Glutathione S-
transferase (GST) activities remained unaffected at these earlier time points Figure 7.6. 
 While after 1 d and 7 d although phase II enzyme levels were increased (not all 
significantly), their activities were reduced. GPx and GR levels showed a increasing trend 
in hippocampus, cortex and cerebellum after 7 d (Figure 7.3a and 7.5a, respectively) and 
catalase levels were significantly increased in hippocampus (*p < 0.05, 1 d, Figure 7.5a) 
alone. Exhibiting a inverse trend compare to earlier time points a significant decrease was 
observed in GPx activities in hippocampus (*p < 0.05, 1 & 7 d), in cortex (*p < 0.05, 1 d) 
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and in cerebellum (*p < 0.05, 1 d); Figure 7.3b, GR activities in cerebellum (*p < 0.05, 1 
and 7 d) alone; Figure 7.5b, and catalase activities in hippocampus (ξp < 0.01, 1 d & *p < 
0.05, 7 d), in cortex (ξp < 0.01, 1 d & *p < 0.05, 7 d), and in cerebellum (*p < 0.05, 1 & 7 
d); Figure 7.5b. 
After 30 d, the levels and activities of some phase II enzymes were selectively inhibited. 
GPx and GR levels were significantly increased in hippocampus (ξp < 0.01 & *p < 0.05; 
respectively) while decreased in cortex (*p < 0.05); Figure 7.3a and 7.5a, respectively. 
Catalase levels were increased in all the brain regions (*p < 0.05), Figure 7.5a. Along the 
line of 1 and 7 days, phase II enzyme activities were significantly decreased; GPx 
activities in all brain regions (*p < 0.05); Figure 7.3b, catalase activities in all brain 
regions (*p < 0.05, H and C, Θp < 0.001, CB); Figure 7.5b, as well as GST activities were 
inhibited in all brain regions (ξp < 0.01, H and *p < 0.05, C and CB); Figure 7.6. 
Conversely, GR activities were not inhibited but increased in all brain regions (*p < 
0.05), Figure 7.5b.  
After 90 d, all three phase II enzymes levels were restored to that of control levels and no 
significant changes were observed in either of brain region, Figure 7.3a, 7.5a, & 7.5a, 
while activities of phase II enzymes were selectively elevated. GR activities were 
selectively increased in cerebellum (*p < 0.05); Figure 7.3b, catalase activities were 
increased in all brain regions (*p < 0.05, H and CB, Θp < 0.001, C); Figure 7.5b, while 
GST activities were selectively increased in hippocampus (*p < 0.05) and in cortex (*p < 
0.05); Figure 7.6. Conversely, GPx activities alone were significantly reduced in 
hippocampus (*p < 0.05), Figure 7.3b. 
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Figure 7.3a and b: The GPx antioxidant enzyme levels and activities in 3-brain regions 
1 h, 20 h, 1 d, 7 d, 30 d and 90 d after 30 nm ceria ENM treatment. a) The histograms 
represent %control GPx levels for ceria treated samples normalized with mean of their 
respective controls, b) The histograms represent %control GPx activities for ceria treated 
samples normalized with mean of their respective controls. The values are expressed as 
mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h (n=5), 1 d (n=3), 7 d (n=3), 
30 (n=11), 90 d (n=7). Statistical difference was estimated as *p <0.05, ξp < 0.01, and Θp 
< 0.001, compared to mean of respective control samples. 
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Figure 7.4a and b: The GR antioxidant enzyme levels and activities in 3-brain regions 1 
h, 20 h, 1 d, 7 d, 30 d and 90 d after 30 nm ceria ENM treatment.  a) The histograms 
represent %control GR levels for ceria treated samples normalized with mean of their 
respective controls, b) The histograms represent %control GR activities for ceria treated 
samples normalized with mean of their respective controls. The values are expressed as 
mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h (n=5), 1 d (n=3), 7 d (n=3), 
30 (n=11), 90 d (n=7). Statistical difference was estimated as *p <0.05, ξp < 0.01, and Θp 
< 0.001, compared to mean of respective control samples. 
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Figure 7.5a and b: The catalase antioxidant enzyme levels and activities in 3-brain 
regions 1 h, 20 h, 1 d, 7 d, 30 d and 90 d after 30 nm ceria ENM treatment.  a) The 
histograms represent %control catalase levels for ceria treated samples normalized with 
mean of their respective controls, b) The histograms represent %control catalase activities 
for ceria treated samples normalized with mean of their respective controls. The values 
are expressed as mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h (n=5), 1 d 
(n=3), 7 d (n=3), 30 (n=11), 90 d (n=7). Statistical difference was estimated as *p <0.05, 
ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples. 
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Figure 7.6: The GST antioxidant enzyme activities in 3-brain regions 1 h, 20 h, 1 d, 7 d, 
30 d and 90 d after 30 nm ceria ENM treatment.  The histograms represent %control GST 
activities for ceria treated samples normalized with mean of their respective controls. The 
values are expressed as mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h 
(n=5), 1 d (n=3), 7 d (n=3), 30 (n=11), 90 d (n=7). Statistical difference was estimated as 
*p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples. 
Failure to Tier 1 response: Inhibition of phase II enzyme activities, increased PC, 3NT, 
HNE levels and HSP levels  
Following the administration of ceria ENM, markers of protein oxidation and lipid 
peroxidation were decreased at earlier time points were increased later (up to 30 d), 
suggesting protection against oxidative stress at earlier time points (1 h and 20 h) and 
failure to antioxidant defense against oxidative stress at later time points (1 d -30 d). Heat 
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shock proteins are induced under increased oxidative stress conditions, increase in their 
levels at later time points (1 d to up to 30 d) supports the PC, 3NT and HNE data. 
After 1 and 20 h, PC levels were significantly decreased in all brain regions (*p < 0.05, 1 
& 20 h); Figure 7.7a, 3NT levels decreased in hippocampus (*p < 0.05, 1 & 20 h); Figure 
7.7b and HNE levels showed a decreasing trend, Figure 7.7c. Along the same line, HO-1 
levels were significantly decreased in hippocampus (*p < 0.05, 1 h and ξp < 0.01, 20 h), 
and in cortex (ξp < 0.01, 1 h); Figure 7.9a. Similarly Hsp70 levels were decreased in 
hippocampus (*p < 0.05, 20 h), in cortex (*p < 0.05, 1 & 20 h), and in cerebellum (*p < 
0.05, 1 h); Figure 7.9b. 
After 1 and 7 d, PC levels were induced in all brain regions (*p < 0.05. 1 d) and (*p < 
0.05, H & C, ξp < 0.01, CB, 7 d) respectively; Figure 7.7a. 3NT levels were significantly 
elevated in hippocampus (*p < 0.05, 1 d); Figure 7.7b and HNE levels showed some 
increasing trend, Figure 7.7c. Following the same trend, HO-1 levels were significantly 
increased in hippocampus (*p < 0.05, 1 & 7 d), in cortex (*p < 0.05, 1 & 7 d) and in 
cerebellum (*p < 0.05, 1 d); Figure 7.9a. Similarly Hsp70 levels were significantly 
elevated in cerebellum (*p < 0.05, 7 d), Figure 7.9b. 
After 30 d, PC levels were induced in all brain regions (*p < 0.05. 1 d) and (*p < 0.05, H 
& C, ξp < 0.01, CB, 7 d) respectively; Figure 7.8a. 3NT levels were significantly elevated 
in hippocampus (*p < 0.05, 1 d); Figure 7.8b and HNE levels showed some increasing 
trend, Figure 7.8c. Following the same trend, HO-1 levels were significantly increased in 
hippocampus (*p < 0.05, 1 & 7 d), in cortex (*p < 0.05, 1 & 7 d) and in cerebellum (*p < 
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0.05, 1 d); Figure 7.8a. Similarly Hsp70 levels were significantly elevated in cerebellum 
(*p < 0.05, 7 d), Figure 7.8b. 
After 90 d, however, PC levels not only restored by significantly decreased all brain 
regions (*p < 0.05); Figure 7.8a. 3NT levels decreased in hippocampus (*p < 0.05) and 
restored in cortex and cerebellum along with HNE levels; Figure 7.8b & 7.8c. Along the 
same line, HO-1 levels were restored in hippocampus and significantly decreased in 
cortex and cerebellum (*p < 0.05), Figure 7.8a. Similarly Hsp70 levels were restored in 
all brain regions, Figure 7.8b. 
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Figure 7.7: The oxidative stress marker levels in 3-brain regions 1 h, 20 h, 1 d, 7 d, 30 d 
and 90 d after 30 nm ceria ENM treatment.  a) The histograms represent %control PC 
levels; b) the histograms represent %control 3NT levels, and c) the histograms represents 
%control protein-bound HNE levels for ceria treated samples normalized with mean of 
their respective controls. The values are expressed as mean ± SEM of ceria treated 
samples from, 1 h (n = 5), 20 h (n=5), 1 d (n=3), 7 d (n=3), 30 (n=11), 90 d (n=7). 
Statistical difference was estimated as *p <0.05, ξp < 0.01, and Θp < 0.001, compared to 
mean of respective control samples. 
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Figure 7.8: The heat shock protein levels in 3-brain regions 1 h, 20 h, 1 d, 7 d, 30 d and 
90 d after 30 nm ceria ENM treatment.  a) The histograms represent %control HO-1 
levels, and b) the histograms represent %control Hsp70 levels, for ceria treated samples 
normalized with mean of their respective controls. The values are expressed as mean ± 
SEM of ceria treated samples from, 1 h (n = 5), 20 h (n=5), 1 d (n=3), 7 d (n=3), 30 
(n=11), 90 d (n=7). Statistical difference was estimated as *p <0.05, ξp < 0.01, and Θp < 
0.001, compared to mean of respective control samples. 
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Induction of Tier 2 oxidative stress response: Activation of pro-inflammatory response 
after 1 d exposure 
In case of failure to phase II antioxidant defense to restore the cellular redox status, 
elevated oxidative stress further activates cascade of pro-inflammatory response via NF-
ĸB signaling pathway (Hiura et al. 1999; Li et al. 2003; Xiao et al. 2003; Chia et al. 
2010). Due to observed inhibition of phase II antioxidant activities concomitant with 
increased PC, 3NT  and HSPs levels at 1 d, 7 d and 30 d time points, hippocampus 
samples were selected to explore the downstream effects of escaladed oxidative stress. 
Levels of inflammatory cytokines IL-1β and TNF-α were measured in hippocampus 
sample for all the time points employing Western blot technique. IL-1β levels did not 
show any change at earlier time point (1 h and 20 h), but increased after 1 d (*p < 0.05, 
H) and 30 d (ξp < 0.01, H); Figure 7.9a. TNF-α were not significantly increased at either 
of the time point, but decreased levels of TNF-α after 1 h (ξp < 0.01, H), Figure 7.9b.  
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Figure 7.9: The inflammatory cytokine levels in hippocampus regions 1 h, 20 h, 1 d, 7 d, 
30 d and 90 d after 30 nm ceria ENM treatment.  a) The histograms represent %control 
IL-1β levels, and b) the histograms represent %control TNF-α levels, for ceria treated 
samples normalized with mean of their respective controls. The values are expressed as 
mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h (n=5), 1 d (n=3), 7 d (n=3), 
30 (n=11), 90 d (n=7). Statistical difference was estimated as *p <0.05, ξp < 0.01, and Θp 
< 0.001, compared to mean of respective control samples. 
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Induction of Tier 3 oxidative stress response: Activation of pro-apoptotic response at 30d 
Downstream consequences of activated pro-inflammatory cytokines, activates caspase-3 
pro-apoptotic proteins, which can lead cell towards apoptotic pathway (Nesic et al. 2004; 
Shakibaei et al. 2007). Pro-caspase-3 protein is precursor for caspase-3 and its levels 
were measured in hippocampus to estimate possibility of activation of caspase-3. Levels 
of pro-caspase-3 were increased only after 30 d (*p < 0.05), suggesting possible increase 
in caspase-3 levels, Figure 7.10. 
 
Figure 7.10: The apoptosis marker levels in hippocampus regions 1 h, 20 h, 1 d, 7 d, 30 d 
and 90 d after 30 nm ceria ENM treatment.  The histograms represent %control pro-
caspase-3 levels, for ceria treated samples normalized with mean of their respective 
controls. The values are expressed as mean ± SEM of ceria treated samples from, 1 h (n = 
5), 20 h (n=5), 1 d (n=3), 7 d (n=3), 30 (n=11), 90 d (n=7). Statistical difference was 
estimated as *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control 
samples. 
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Autophagy marker appears at 7 d, 30 d and at 90 d 
Escaladed oxidative stress can activate autophagy (Gottlieb et al. 2010; Marambio et al. 
2010; Hariharan et al. 2011) to recycle or restored defected macromolecules and 
organelles. Autophagy marker LC-3AB levels were increased after 7 d (*p < 0.05), 30 d 
(ξp < 0.0), and 90 d (*p < 0.05) in hippocampus, Figure 7.11. 
 
Figure 7.11: The autophagy marker levels in hippocampus regions 1 h, 20 h, 1 d, 7 d, 30 
d and 90 d after 30 nm ceria ENM treatment.  The histograms represent %control LC-
3AB levels, for ceria treated samples normalized with mean of their respective controls. 
The values are expressed as mean ± SEM of ceria treated samples from, 1 h (n = 5), 20 h 
(n=5), 1 d (n=3), 7 d (n=3), 30 (n=11), 90 d (n=7). Statistical difference was estimated as 
*p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples. 
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7.4. Discussion 
There are some in vivo and in vitro studies are available on oxidative stress effects of 
ceria ENM, however they are far from uniform on whether ceria is pro-oxidant or 
antioxidant (Yokel et al. 2009). This dissertation research is among the first 
comprehensive in vivo study that addresses mechanisms of oxidative stress effects 
induced by ceria ENM. This study demonstrates that 30 nm ceria ENM administration 
induces oxidative stress response and secondary oxidative stimulus in time dependant 
manner in the brain, without ever crossing BBB.  
A review summarizes the evidence available on free radical scavenging ability of ceria 
ENM under pre-induced oxidative stress condition (Karakoti et al. 2009). However, 30 
nm ceria was shown to induce ROS in BEAS-2B cell culture after 24 h incubation in 
dose-dependent manner  in absence of any other external source of ROS. In the same 
experiment ceria ENM also decreased cell viability in size-independent manner (Park et 
al. 2008). GSH an important cellular thiol and antioxidant, is known to buffer free 
radicals and ROS; thus GSH maintains cellular redox balance (Meister et al. 1983; 
Forman et al. 2003; Rahman et al. 2005). However, in the process GSH gets oxidized to 
GSSG and decreased levels of this ratio can activate various downstream signaling 
pathways. We also evaluated cellular redox status by measuring GSH: GSSG ratio in 
three brain regions. The GSH: GSSG ratio measurements showed continuous decrease in 
GSH: GSSG ratio at all the time points except after 90 d.   
According to the hierarchy of oxidative stress model proposed by Nel’s research group 
(as explained in section 2.6), a mild decrease in GSH: GSSG ratio activates phase II 
antioxidant response (Tier-1) via Nrf-2 and ARE pathway (Li et al. 2004; Nel et al. 2006; 
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Lee et al. 2008). In the current study, 30 nm ceria also launched similar Tier-1 response 
at earlier time points and phase II antioxidant enzymes GPx, GR and catalase levels as 
well as activities were increased significantly after 1 h and 20 h to protect cell from 
possible oxidative insult. Concomitantly, the protein oxidation marker-PC, protein 
nitration marker-3NT, and the lipid peroxidation marker-protein-bound HNE levels, were 
decreased. As well as heat shock protein HO-1 and Hsp70 levels were decreased after 1 h 
and 20 h. PC, 3NT and HNE are product of oxidative degradation of biomolecules and 
both HSPs are induced by elevated oxidative stress (Calabrese et al. 2000; Calabrese et 
al. 2000), therefore concomitant declined in these parameters indicates cytoprotective 
environment and success to phase II antioxidant (Tier-1) defense response.  
However, unlike earlier time points, phase II antioxidant activities were decreased after 1 
d and 7 d, although some of the antioxidant levels were up. As well as after 1 d and 7 d, 
PC, 3NT and HNE levels were concurrently elevated with HO-1 and Hsp70 levels. 
Increased levels of oxidative stress suggested by decreased GSH: GSSG ratio after 1 d 
and 7 d, which may further oxidatively modify phase II antioxidant enzymes (Butterfield 
1997; Butterfield 2006). Oxidative modification can disrupt protein- spatial structure and 
consequently protein function or enzyme activities often get altered either partially or 
completely (Stadtman et al. 2003; Stadtman 2006). Failure of phase II antioxidant (Tier-
1) defense and escaladed oxidative stress, activates NF-ĸB cascade further inducing pro-
inflammatory cytokine levels (Tier-2) (Nel et al. 2006; Meng et al. 2009; Xia et al. 2009). 
We measured cytokine levels in the current study for all the exposure time periods after 
ceria ENM treatment. Observed decrease in TNF-α level after 1 h suggested inactivated 
pro-inflammatory response. Along the same line, decline in cytokine IL-1β levels at 
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earlier time points and then induction after 1 d, and 30 d suggests activation of pro-
inflammatory signaling pathways (Tier-2) at later time points of ceria ENM exposure.  
According to Nel, downstream consequences of deactivation or failure of Tier-1 response 
induces pro-inflammatory Tier-2 response through activation of NF-ĸB signaling 
pathway and Tier-3 response by activation of pro-apoptotic signaling cascade (Xiao et al. 
2003; Nel et al. 2006). In current study oxidative stress remained elevated up to 30 d as 
GSH: GSSG ratio remained decreased and phase II antioxidant enzyme activities were 
inhibited after 1 d; further causing oxidative damage to proteins and lipids. Induction of 
HSPs did not seem to protect against this elevated oxidative stress at 1 d- 30 d. Therefore 
to evaluate the possible occurrence of pro-apoptotic / cytotoxic Tier-3 response, levels of 
pro-caspase-3 were measured. Pro-caspase-3 is the precursor protein for caspase-3 and 
induction of pro-caspase-3 is definitive marker of activated apoptotic cellular death 
pathway (Walters et al. 2009). Increased levels of cytokine IL-1β caused transcription of 
caspase-3 in pig’s heart, which further induced pro-caspase-3 levels (Zitta et al. 2010). In 
addition IL-1β antagonist inhibited activation of caspase-3 and consequent apoptotic 
pathway in rat spinal cord injury model (Nesic et al. 2004). In current study pro-caspase-
3 levels were induced after 30 d alone, concomitant with induction of IL-1β, fostering 
activation of Tier-3 response. So up to this point all the oxidative stress related 
observations made in the current study very well fits the oxidative stress hierarchy model 
of ENM toxicity, proposed by Nel’s research group (Li et al. 2003; Xiao et al. 2003; Nel 
et al. 2006) and ours is the first comprehensive study that has mapped the oxidative stress 
mechanism of ENM toxicity in animal model for sub-chronic exposure period (30 d).  
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As we continued pursuing measurement of oxidative stress indices for chronic-exposure 
period of 90 d, very interesting observations were revealed. Along the line of hierarchy 
oxidative stress model, we were expecting profound deleterious effects on cellular redox 
status after 90 d. But quite contrary GSH: GSSG ratio was restored back, phase II 
antioxidant levels and activities increased again after 90 d, and PC, 3NT and HNE levels 
were suppressed along with HSP levels; as shown in Figure 7.12. In brief, after 90 d, 
there was no sign of oxidative stress, let alone damage caused by it. To understand such 
dramatic change we looked for autophagy marker. Autophagy is a cellular process for 
bulk degradation of cytosolic proteins and organelles carried out by lysosome (Hariharan 
et al. 2011). Measurement of autophagy marker LC-3AB levels by Western blot 
technique revealed increased levels of LC-3AB after 7 d and 30 d, whereas LC-3AB 
levels were decreased after 90 d; Figure 7.12. Seven days and 30 d are the time points at 
which possibly ascended oxidative stress induced Tier-2 and Tier-3 response and 
consecutive oxidation of biomolecules; Figure 7.12.  
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Figure 7.12: This demographical presentation summarizes changes in the key oxidative 
stress indices as observed at different exposure periods in hippocampus, after systemic 
injection of 30nm ceria ENM. The variation in oxidative stress indices were in good 
agreement with the hierarchy oxidative stress model proposed by Nel’s research group 
(Nel et al. 2006). 
Similar to HSPs (Calabrese et al. 2000; Calabrese et al. 2002), autophagy response can be 
induced by increased oxidative stress (Marambio et al. 2010; Hariharan et al. 2011). 
HSPs, especially Hsp70 is a well known chaperon for other proteins and which assist the 
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establishment that refolds the aggregated proteins as well as aid in transporting damaged 
proteins across intracellular membranes probably for degradation (Hartl et al. 2002; 
Young et al. 2003; Calabrese et al. 2004; Mayer et al. 2005; Calabrese et al. 2007). 
Therefore, observed changes after 90 d are may be a result of early activation of 
autophagy process (7 d) or induction of HSPs (30 d in H), which might have cleared 
damaged macromolecules and organelles, and helped the cell to restore its redox balance. 
We propose that this current trend of data to be termed as Tier-4 response (Figure 7.13 
and 7.14), which also fits the description of hormesis (defined as total response of an 
organism to external stimulus, which includes initial reaction and later adaption). 
 
Figure 7.14: Modified model for hierarchy oxidative stress mechanism of nanomaterial 
toxicity based on our finding from 30 nm ceria ENM induced oxidative stress in 
hippocampus, at different exposure time points.  
 147 
At this moment we do not have any data in between 30 d to 90 d period, which is a very 
large time gap for any biochemical or bio-molecular event to occur. Filling some gap of 
this 60 d period will able to shade some more light on autophagy process or induction of 
HSPs and their presumable relationship with restoration of redox balance after 90 d in rat 
brain after 30 nm ceria exposure. Nonetheless, the significance of these observations lies 
in the choice of the biological model i.e. multicellular organism (rat), which allows 
expression of adaptation mechanism such as Tier-4 or hormesis unlike cell culture 
models. These results also emphasize importance of use of in vivo models for evaluation 
of toxicity of nanomaterials as oppose completely relying on in vitro models.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Sarita S. Hardas 2012 
 148 
CHAPTER 8 
 
VARIATIONS OF OXIDATIVE STRESS EFFECTS INDUCED BY 55 NM CERIA 
ENM IN RAT BRAIN IN TIME-AND DOSE-DEPENDENT MANNER 
8.1. Overview of the Study 
The material and chemical properties of ENMs are highly dependent upon two main 
factors: surface effects related to the fraction of atoms or molecules present on the 
surface, and quantum effects related to delocalized electrons (Buzea et al. 2007). Both 
these effects are therefore related to size of the ENMs, as size decreases surface and 
quantum effects become more predominant (Oberdörster et al. 1994; Nel et al. 2006; 
Buzea et al. 2007). The size of ENMs also hold key to its biological behavior as due to 
small size ENMs can get distributed rapidly and may get an easy access to various 
cellular compartments which are otherwise inaccessible.  Due to high surface area, ENMs 
can interact with or harbor different biomolecules, as well as facilitate bio-reactions with 
great efficiency (Nel et al. 2009; Fubini et al. 2010).  Thus the very properties that make 
the ENMs popular in various applications may also determine their toxicity. The reports 
available on size-dependent nanotoxicity are in vitro studies with BEAS-2B human lung 
epithelial cells, which have explored ENM sizes up to 45 nm (Park et al. 2008; Eom et al. 
2009) and to our best knowledge, the work presented in this dissertation will be the first 
study to explore size-dependant toxicity of ceria ENM in multicellular organism. The 
current chapter of dissertation study focuses on the oxidative stress effects of ~55 nm 
ceria ENM on rat brain, which will be compared with the findings from Chapters 5 (5 nm 
ceria ENM), Chapter 6 (15 nm ceria ENM) and Chapter 7 (30 nm ceria ENM) to better 
understand the role of ENM size in its toxicity. 
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Apart from size, toxicity of ENM also depends upon composition, aggregation, 
crystallinity, surface functionality, dose of ENM, exposure period, etc. Dose of ENM is 
usually defined as the amount or quantity of ENM that will reach a biological system 
(Buzea et al. 2007). The dose is directly related to exposure or concentration of material 
in the medium like air, water or food, multiply by the duration of contact (Buzea et al. 
2007). Most commonly in a dose-metric study, dose of a substance is determined on the 
basis of its mass or concentration (Yokel et al. 2011). However, in case of nanomaterials, 
the choice is not such simple (Oberdörster et al. 1994; Wittmaack 2006; Jiang et al. 2008; 
Oberdorster et al. 2009; Rushton et al. 2010; Yokel et al. 2011), as nanotoxicity is also 
co-depend upon matrices like size, surface area, and number of particles etc. Most of the 
time toxicity mechanism is taken into consideration while determining the appropriate 
dose matrix and since one is likely to see different mechanism for different materials 
there will not be a unique choice (Fubini 1997). Nonetheless most studies of ENM have 
expressed exposure based on dose or concentration.  
In current study, the role of dose was evaluated by intravenous administration of two 
types of bolus doses 50 mg/kg (10 male rats) and 100 mg/kg (5 male rats) of 55 nm ceria 
ENM. Five rats that received 50 mg/kg ceria ENM were terminated after 1 h with five 
saline treated control rats. The remaining five rats from 50 mg/kg dose group were 
terminated with the five rats that received 100 mg/kg of ceria ENM and five saline 
treated control rats, 20 h after ceria administration. Three brain regions, hippocampus, 
cortex and cerebellum from each treatment were harvested from each ceria- and saline-
control treated rat and frozen rapidly in liquid nitrogen. The levels and activities of the 
antioxidant enzymes catalase, manganese superoxide dismutase (MnSOD), glutathione 
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peroxidase (GPx), and glutathione reductase (GR), were measured. To understand the 
extent of changes in cellular redox status, the levels of oxidative stress endpoints, protein 
carbonyl (PC), 3-nitrotyrosine (3NT), and protein bound 4- hydroxyl-2-trans nonenal 
(HNE), were measured along with heat shock protein (Hsp70) levels.   
8.2. Materials and methods 
8.2.1. Nanomaterial: 
Ceria ENM was obtained from our collaborator, which was synthesized in in-house 
facility (Section 3.1). Nanomaterial characterization was carried out by our collaborators, 
prior to ceria ENM treatment to the animals (Section 3.2).  
8.2.2. Animals:  
The male Sprague-Dawley rats received either saline or 5% ceria dispersion 
intravenously. Five rats were infused with 0 and five rats with 50 mg ceria/kg and 
terminated 1 h after completion of infusion. Five rats were infused with 0 and 5 rats with 
50 mg/kg and 5 more with 100 mg ceria/kg and terminated 20 h after completion of 
infusion. After ceria ENM treatments, the BBB integrity assessment (Section 3.3), light 
and electron microscopic assessment (Section 3.4) and EELS analysis (Section 3.2) was 
carried out by our collaborators. The brain homogenates were prepared from control and 
ceria treated rat brain samples (Section 3.6). Total protein content was determined using 
BCA assay (Section 3.7) and various biochemical assays were carried out on all the 
samples (Sections 3.8, 3.9, 3.10, 3.11, and 3.14) in our laboratory. 
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8.3. Results 
Ceria composition 
High resolution-TEM/HR-STEM showed the ceria ENM was polyhedral shape (Figure 
8.1). The XRD patterns demonstrated the ceria are highly crystalline. Evaluation of a 
number of TEM images showed that the ceria had a number-average primary particle size 
of 55 nm.  
 
 
Figure 8.1: 55 nm ceria ENM imaged using HRTEM and HRSTEM. The ceria were 
dispersed on a carbon film. Visually they have a size distribution ranging from X to X nm 
and the majority diameter around 55 nm. The magnified TEM insert at the lower left 
illustrates that the ceria ENMs are highly crystalline (taken by Dr. Peng Wu and as 
published in Dan et.al. 2012). 
Ceria concentration in brain and Electron micrograph 
ICP-MS analysis suggested that very small amount of ceria was present in the brain 
parenchyma compare to peripheral organ liver (Table 8.1). Electron micrograph studies 
suggested that ceria ENM was not found in the brain, but located on the luminal side of 
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the BBB endothelium. The hippocampus and cerebellum tissues did not show obvious 
ceria induced injury as no necrotic neurons or elevated gliosis were observed and the 
BBB was visibly intact (data not shown). 
 
Table 8.2: Cerium concentrations in blood, brain, liver, and spleen, expressed as a 
percent change of 55 nm ceria ENM dose. a) Based on reference volume of blood in the 
rat (7% of body weight) or weight of the brain, liver x ceria concentration. 
 
Cerium [% of dose]a 
 Blood  Brain  Liver  
% dose (1 h) 0.0053 ± 0.005 0.014 ± 0.01 11.6 ± 9 
 
EELS results 
Electron energy loss spectroscopic measurements on liver tissue were performed as a 
representative organ. The ratio of Ce(Owens Iii et al.) to Ce(IV) in the aged ceria was 
evaluated using EELS measurements after locating agglomerates of the ceria nanorods in 
tissue 1 h and 30 days after infusion into rat and comparing with  synthesized ceria. The 
high Ce3+/ Ce4+ ratio that was obtained in the as-synthesized, fresh 55 nm ceria seems to 
have only been altered slightly in individual ceria measured in liver after 20 h in vivo 
(data not shown). 
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Oxidative Stress Indices 
Phase II antioxidant activities were increased after 1 and 20 h 
 
Similar to our observation with 15 nm and 30 nm ceria ENM, induction of phase II 
antioxidant enzymes was observed in different brain regions 1 and 20 h after 55 nm ceria 
ENM administration. Amongst two glutathione related antioxidant enzymes GPx and 
GR; only GPx  activities and levels were induced after 55 nm ceria ENM treatment at 
both 1 h and 20 h. GPx activities were induced in hippocampus (~ 19%, *p < 0.05, 50 
mg/kg) and in cortex (~ 27%, *p < 0.05, 50 mg/kg,) after 1 h as well as strongly hiked up 
after 20 h in hippocampus (~ 43%, *p < 0.05, 100 mg/kg) and cortex (~ 49%, *p < 0.05, 
50 mg/kg and ~ 41%, *p< 0.05, 100 mg/kg); Figure 8.2a. Catalase activities were 
strongly induced in all 3-brain regions after 1 h; in hippocampus (~ 24%, *p < 0.05, 50 
mg/kg), in cortex (~ 21%, *p < 0.05, 50 mg/kg), and in cerebellum (~ 21%, *p < 0.05, 50 
mg/kg); Figure 8.2c. After 20 h catalase activity followed a trend similar to that as GPx 
activity and increased only in hippocampus (~ 17%, *p < 0.05, 100 mg/kg) and cortex (~ 
21%, *p < 0.05, 50 mg/kg and ~ 15%, *p< 0.05, 100 mg/kg); Figure 8.2c.  
A huge upsurge in GPx and catalase levels was observed only after 20 h in hippocampus 
(~ 56%, Θp < 0.0001) and (~ 50%, ξp < 0.001) respectively, after administration of 100 
mg/kg dose of ceria, Figure 8.3a. GPx and catalase levels in hippocampus measured after 
100 mg/kg dose of ceria were significantly increased compared to corresponding levels 
after 50 mg/kg dose (Θp < 0.001); Figure 8.3a and c respectively. On the other hand GR 
and SOD activities and levels remained fairly unaffected from post-treatment effect of 
ceria administration at smaller and larger doses (Figure 8.2b -8.3b and 8.2d-8.3d, 
respectively). 
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Figure 8.2: The antioxidant enzyme activities in 3-brain regions 1 h and 20 h after i.v 
administration of 50 mg/kg and 100 mg/kg dose 55 nm ceria ENM. a) The histograms 
represent %control GPx activities measured in saline treated controls and ceria treated 
samples, b) the histograms represent %control GR activities measured in saline treated 
controls and ceria treated samples, c) the histograms represent %control catalase 
activities measured in saline treated controls and ceria treated samples, d) the histograms 
represent %control SOD activities measured in saline treated controls and ceria treated 
samples. All the values are expressed as mean ± SEM, control n = 5, treated n = 5, *p 
<0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples.  
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Figure 8.3a, b, c and d: The antioxidant enzyme levels in 3-brain regions 1 h and 20 h 
after i.v administration of 50 mg/kg and 100 mg/kg dose 55 nm ceria ENM. a) The 
histograms represent %control GPx levels measured in saline treated controls and ceria 
treated samples, b) the histograms represent %control GR levels measured in saline 
treated controls and ceria treated samples, c) the histograms represent %control catalase 
levels measured in saline treated controls and ceria treated samples, d) the histograms 
represent %control MnSOD levels measured in saline treated controls and ceria treated 
samples. All the values are expressed as mean ± SEM, control n = 5, treated n = 5, *p 
<0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples.  
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Figure 8.3e: Separate Western blots were used to estimate antioxidant protein levels in 
hippocampus, cortex and cerebellum. However, only representative examples from 
hippocampus are shown. Protein levels in control [C] n=4, and treated [T] n=5 samples 
for 1 h (left, consider only labeled bands) and control [C] n=4, treated [T] n=6- black for 
50 mg/kg dose and treated [T] n=6- blue for 100 mg/kg dose samples for 20 h 55 nm 
ceria treatment. The intensity of each antioxidant protein band was normalized with 
intensity of corresponding band of β-actin-loading control. Similar blots were obtained 
for cortex and cerebellum regions. 
Reduction in protein oxidation after 1 and 20 h 
Protein oxidation marker-PC levels were decreased in all three brain regions after 1 h, in 
hippocampus (~ 25%, *p < 0.05, 50 mg/kg), in cortex (~ 39%, *p < 0.05, 50 mg/kg), and 
in cerebellum (~ 26%, *p < 0.05, 50 mg/kg) Figure 8.4a. PC levels were also decreased 
after 20 h in hippocampus (~ 13%, *p < 0.05, 100 mg/kg) and in cortex (~ 18%, ξp < 
0.001, 50 mg/kg and ~ 17%, *p < 0.05, 100 mg/kg) Figure 8.4a. PC levels in 
hippocampus measured after 100 mg/kg dose of ceria were significantly decreased 
compared to that after 50 mg/kg dose (ξp < 0.01). Protein nitrotyrosine marker-3NT 
levels were decreased after 1 h in hippocampus (~ 21%, *p < 0.05, 50 mg/kg), in cortex 
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(~ 30%, *p < 0.05, 50 mg/kg) and again after 20 h only in cortex (~ 17%, *p < 0.05, 50 
mg/kg and ~ 18%, *p < 0.05, 100 mg/kg) Figure 8.4b. 
Both the doses, 50 mg/kg and 100 mg/kg of 55 nm ceria ENM did not have any effect on 
lipid peroxidation marker-HNE levels in rat brain. HNE levels were unchanged in all 
three brain regions after 1 and 20 h, Figure 8.4c. 
Reduction in HSPs 20 h after high dose 
HO-1 and Hsp70 levels were fairly unchanged in all three brain regions 1 h after 
administration of 50 mg/kg dose of 55 nm ceria ENM peripherally, Figure 8.5a and b. 
Further HO-1 levels were declined after 20 h with significant decrease in hippocampus (~ 
21%, *p < 0.05, 100 mg/kg) and in cortex (~ 17%, *p < 0.05, 50 mg/kg and ~ 26%, ξp < 
0.001, 100 mg/kg), both after high dosage of ceria, Figure 8.5a. Hsp70 levels were also 
declined after 1 h with significant decrease in hippocampus (~ 13%, *p < 0.05, 50 
mg/kg), and after 20 h in cortex (~ 17%, *p < 0.05, 100 mg/kg), and in cerebellum (~ 
23%, *p < 0.05, 100 mg/kg), but decrease in Hsp70 levels was not dose specific, Figure 
8.5b. Hsp70 levels in hippocampus measured after 50 mg/kg dose of ceria were 
significantly decreased compared to that after 100 mg/kg dose (*p < 0.05), Figure 8.5b.   
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Figure 8.4: The oxidative stress marker levels in 3-brain regions 1 h and 20 h after i.v 
administration of 50 mg/kg and 100 mg/kg dose 55 nm ceria ENM. a) The histograms 
represent %control PC levels measured in saline treated controls and ceria treated 
samples, b) the histograms represent %control 3NT levels measured in saline treated 
controls and ceria treated samples, c) the histograms represent %control HNE levels 
measured in saline treated controls and ceria treated samples. All the values are expressed 
as mean ± SEM, control n = 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, 
compared to mean of respective control samples. 
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Figure 8.5a and b: The heat shock protein levels in 3-brain regions 1 h and 20 h after i.v 
administration of 50 mg/kg and 100 mg/kg dose 55 nm ceria ENM. a) The histograms 
represent %control HO-1 levels measured in saline treated controls and ceria treated 
samples, b) the histograms represent %control Hsp70 levels measured in saline treated 
controls and ceria treated samples. All the values are expressed as mean ± SEM, control n 
= 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective 
control samples.  
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Figure 8.5c: Separate Western blots were used to estimate HSPs levels in hippocampus, 
cortex and cerebellum. However, only representative examples from hippocampus are 
shown. Protein levels in control [C] n=4, and treated [T] n=5 samples for 1 h (left, 
consider only labeled bands) and control [C] n=4, treated [T] n=6- black for 50 mg/kg 
dose and treated [T] n=6- blue for 100 mg/kg dose samples for 20 h 55 nm ceria 
treatment. The intensity of each antioxidant protein band was normalized with intensity 
of corresponding band of β-actin-loading control. Similar blots were obtained for cortex 
and cerebellum regions. 
8.4. Discussion 
The fraction of atoms or molecules present on the surface and therefore the size of ENM, 
are key to determine not only the material properties but also chemical and biological 
properties of ENM. In order to understand the role play of size in determining the 
biological effects of ceria ENM, we prepared the ENMs from size ~ 5nm to ~ 55 nm, 
with aspect ratio-1. The current study focuses on the oxidative stress effects of 55 nm 
ceria ENM on rat brain after its systemic administration. The oxidative stress effects were 
evaluated in terms of changes in the levels of phase II antioxidant enzymes, protein and 
lipid oxidation markers, heat shock protein response, and phase II antioxidant enzyme 
activities, when compared with saline treated rats from control groups. In addition to the 
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size effect, we also examined the dose effect with 50 mg/kg and 100 mg/kg dose of 55 
nm ceria ENM.  
The 50 mg/kg dose of 55 nm ceria ENM induced cellular antioxidant defense response in 
time-dependent manner in hippocampus and cerebellum region. The phase II antioxidant 
enzymes, GPx and catalase activities were elevated after 1 h of 50 mg/kg dose and 
reduced back to the normal levels after 20 h (H and CB). The induction of phase II 
enzymes is usually seen at low levels of oxidative stress caused by internal or external 
stimuli (Talalay et al. 2003; Li et al. 2004; Kim et al. 2009; Speciale et al. 2011) as 50 
mg/kg dose of 55 nm ceria ENM administration in current case. The elevated GPx and 
catalase activities may have caused reduction in PC and 3NT levels after 1 h, although 
PC and 3NT levels were resorted back to the control levels (H and CB) after 20 h. 
Various other studies have reported protection against oxidative stress by induction of 
phase II antioxidant response (Cerutti et al. 1994; Hayes et al. 1999; Talalay et al. 2003; 
Kim et al. 2009; Speciale et al. 2011). Increased oxidative stress induces HSP levels, 
therefore lack of change in HO-1 and Hsp70 levels after 1 h and decreasing trend in HO-
1 (H, and CB) levels after 20 h suggest reduction in oxidative stress. Decline in oxidative 
stress can be achieved by either scavenging ROS or by inducing cellular antioxidant 
enzyme levels and activities. In the current case it was achieved by strong induction of 
phase II enzyme response, which reduced oxidative stress and oxidative stress indices at 
initial stage (1 h) and then restored the delicate balance in ROS levels and antioxidant 
molecules and enzymes, reflected in terms of lack of change in oxidative stress indices as 
seen after 20 h of 50 mg/kg dose of 55 nm ceria. Also the cortical region showed similar 
protective antioxidant defense response after 50 mg/kg dose of 55 nm ceria, but levels of 
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oxidative stress indices did not varyied much with time. Thirty nm ceria treatment also 
induced similar antioxidant defense-Tier-1 response at 1 and 20 h, but again the variation 
in the magnitude of oxidative stress indices were not dramatically time dependant 
(Chapter 7). A time-dependent decrease in cell viability mediated by oxidative stress has 
been reported by Park in two independent studies with 30 nm ceria and 21 nm TiO2 
ENMs (Park et al. 2008; Park et al. 2008).  
In addition to time-dependent changes, 55 nm ceria ENM treatment also mediated 
changes in oxidative stress indices in dose-dependent manner.  The dose-dependent 
changes in the levels and activities of GPx and catalase was observed only in 
hippocampus region after 20 h where magnitude of change was higher at higher dose of 
55 nm ceria ENM (100 mg/ kg). Concomitantly, PC (H), HO-1 (H and C), and Hsp70 (C 
and CB) levels were decreased to greater magnitude after 100 mg/kg dose of 55 nm ceria 
ENM compared to 50 mg/kg dose. In slight contrary, Hsp70 levels were decreased to 
greater magnitude after 50 mg/kg dose of 55 nm ceria ENM compared to 100 mg/kg dose 
in hippocampus alone. Similar dose-dependency was reported with after treatment of 30 
nm ceria (Park et al. 2008) and 21 nm ENM (Park et al. 2008) to human lung epithelial 
cells, where cell viability was decreased and ROS generation was increased in a dose-
dependent manner. A dose-dependent correlation was observed in brain-HNE and PC 
levels, where hippocampal HNE levels were increased and cerebral PC levels were 
decreased after 30 nm commercial ceria ENM i.v injections (Yokel et al. 2009). 
Similarly, some positive dose-dependent correlations in oxidative stress effects were 
observed in mice brain after systemic delivery of TiO2 (Ma et al. 2010), in lung after 
inhalation of cobalt containing MWCNTs (Pauluhn 2010). Concentration-dependent 
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inhibition of murine microphage cell proliferation and lipopolysaccharide-induced COX-
2 expression (up to 20 µg/ml), was observed after in vitro SWCNT exposure (Dutta et al. 
2007). A dose-dependent increase in LDH activity and total protein was seen after 
intratracheal instillation of MWCNTs (L ~6µm) and after ground MWCNTs (L ~0.7µm) 
in rat lung bronchoalveolar lavage fluid (Muller et al. 2005). 
In the current study, 55 ceria ENM selectively induced the activity of H2O2 reducing 
catalase and GPx phase II enzymes. The induction of catalase and GPx is an adaptive 
cellular response against various ROS insults, which can facilitate clearance of oxidative 
stress markers (Cerutti et al. 1994; Hayes et al. 1999; Miyamoto et al. 2003; Bagnyukova 
et al. 2005; Margonis et al. 2007) and exposure to H2O2 can selectively induce the 
transcription/ mRNA levels of catalase and GPx gene expression in a feed-back 
mechanism manner (Wang et al. 2011). Studies in the past have reported the SOD 
mimetic activity of ceria ENM where it can reduce superoxide radicals to H2O2 and 
oxygen (Korsvik et al. 2007; Heckert et al. 2008). Thus may be by causing some increase 
in cellular oxidative stress, 55 nm ceria ENM induced a strong antioxidant defense 
response in the brain hippocampal and cortical region. The cellular defense response in 
hippocampus brain region was varied in the time- as well as dose-dependent manner.  
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CHAPTER 9 
 
ROLE OF ASPECT RATIO (SHAPE) OF ENM IN THE MODULATION OF 
TOXICITY OF CERIA ENM IN THE RAT BRAIN 
9.1. Overview of the Study 
At emergent of new technologies, creation of nanometer scale functional devices requires 
the production and handling of component of submicron sizes, which necessitates 
exploration of development of various nanostructure especially nanofilament (carbon or 
inorganic nanotubes or nanowires). Nanofilaments (NFs) are envisioned as building 
blocks of new technologies such as flat panel screens, composite materials, or catalyst 
supports, expected to be applied in medical diagnosis and imaging (Magrez et al. 2009). 
NFs are also foreseen as second generation (active) ENMs used in applications like 
targeted control-release drug delivery systems with some of the popular examples are 
carbon nanotubes (CNT) and gold nanorods (Lewinski et al. 2008; Yokel et al. 2011). In 
spite of the promising nature of these NFs, the knowledge on the health effects related to 
the production, handling and exposure of these materials is essential. 
Depending on the aspect ratio (L-length / D-diameter) of a nanofilament, its toxicity is 
affected, with the higher the aspect ratio, the more toxic the particle (Lippmann 1990). 
Particles with a length ≤ 1 µm has a low aspect ratio material, while a particle with a 
length > 5 µm and aspect ratio ≥ 3:1 are high aspect ratio materials or conventionally 
known as fibers (WHO/EURO et al. 1985; Lippmann 1990). The high aspect ratio 
morphology includes nanotubes and nanowires, with various shapes like helices, zigzags, 
belts, with varying diameters and lengths (Buzea et al. 2007).  The morphology of low 
aspect ratio nanomaterials morphology includes spheres, ovals, cubes, prisms, helices, 
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pillar, wires or rods (Buzea et al. 2007). The long length fibers or high aspect ratio 
materials (> 20 µm) are cleared less effectively compared to the low aspect ratio material 
or broken fibers, by alveolar macrophages, therefore leading to pulmonary toxicity 
ranging from asbestosis, mesothelioma to lung cancer (Lippmann 1990; Buzea et al. 
2007). However, even low aspect ratio material, (D < 100 nm, L < 1 µm) may escape 
phagocyte clearance entering into the vascular system, some of which may end up in 
various organs including brain, liver, kidney etc., causing adverse health effects (Buzea et 
al. 2007; Oberdorster et al. 2009; Yokel et al. 2011).  
There have been some efforts made to answer the questions on the toxicity of NFs either 
during the manufacturing process or after short-or long-term exposure. However, as early 
development was a focus of carbon-based NFs (Iijima 1991) most of the toxicity studies 
have also exclusively focused on carbon based NFs (Shvedova et al. 2003; Lam et al. 
2004; Maynard et al. 2004; Warheit et al. 2004; Monteiro-Riviere et al. 2005; Panessa-
Warren et al. 2006; Helland et al. 2007). The toxicity of inorganic materials (Soenen et 
al. 2011) such as iron oxides, titanium oxides, zinc oxide, gold, silver, has been 
investigated, but is limited to their isotropic forms (aspect ratio 1) with a few exceptions 
as asbestos fibers and gold nanorods (Lewinski et al. 2008; Stern et al. 2008). 
Unfortunately, toxicity of NFs cannot be predicted from their known toxicity in different 
structural forms for example, “benine” silicates renders highly toxic effects in their fiber 
form known as asbestos (Magrez et al. 2009). There is only one study available on metal 
oxide, where TiO2 based nanotubes and nanowires exposed to human lung tumor cells 
strongly affected cell proliferation and caused cell death (Magrez et al. 2009). 
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Considering the increasing applications of ceria ENM in various fields including 
biomedical applications and discrepancy in the oxidative stress related effects (as 
explained in earlier chapters), the current study was designed to evaluate the influence of 
aspect ratio on the neuro-nanotoxicity of ceria ENM.   
To fulfill the objective, 10 nm ceria nanorods with an aspect ratio 5 to 60, were 
synthesized, and 5% dispersion of the material was administered to male rats 
intravenously. The rats were terminated 1 h and 30 d after the ceria treatment. Three 
brain regions, hippocampus, cortex and cerebellum, were harvested from each ceria- and 
saline-treated rats and frozen rapidly in liquid nitrogen. The levels and activities of the 
antioxidant enzymes catalase, manganese superoxide dismutase (Mn-SOD), glutathione 
peroxidase (GPx), and glutathione reductase (GR), were measured along with the ratio of 
reduced glutathione (GSH) to its oxidized form (GSSG). To understand the extent of 
changes in cellular redox status, the levels of oxidative stress endpoints, protein carbonyl 
(PC), 3-nitrotyrosine (3NT), and protein bound 4- hydroxyl-2-trans nonenal (HNE), were 
measured along with heat shock protein (Hsp70) levels.   
9.2. Materials and methods 
9.2.1. Nanomaterial: 
Ceria ENM was obtained from our collaborator, which was synthesized in in-house 
facility (Section 3.1). Nanomaterial characterization was carried out by our collaborators, 
prior to ceria ENM treatment to the animals (Section 3.2).  
 
 
 167 
9.2.2. Animals:  
The male Sprague-Dawley rats received either saline or 5% ceria dispersion 
intravenously. Five rats were infused with 0 and 5 rats with 20-50 mg ceria/kg and 
terminated 1 h after completion of infusion. Five rats were infused with 0 and 5 rats with 
100 mg ceria/kg and terminated 30 d after completion of infusion. After ceria ENM 
treatments, the BBB integrity assessment (Section 3.3), light and electron microscopic 
assessment (Section 3.4) and EELS analysis (Section 3.2) was carried out by our 
collaborators. The brain homogenates were prepared from control and ceria treated rat 
brain samples (Section 3.6). Total protein content was determined using the BCA assay 
(Section 3.7), and various biochemical assays were carried out on all the samples 
(Section 3.8, 3.9, 3.10, 3.11, and 3.14) in our laboratory. 
9.3. Results 
Ceria composition 
HR-TEM/HR-STEM showed the ceria ENM was polyhedral shape (Figure 9.1). The 
XRD patterns demonstrated the ceria are highly crystalline. Evaluation of a number of 
TEM images showed that the ceria had a number-average primary particle size of ~ 10 
nm with aspect ratio (length/ diameter) 5-60.  
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Figure 9.1: Ceria ENM nanorods were imaged using HRTEM and HRSTEM. The ceria 
nanorods were dispersed on a carbon film. Visually they have a size distribution ranging 
from 50 to 600 nm in length and the majority diameter around 10 nm. The magnified 
TEM insert at the lower left illustrates that the ceria ENMs are highly crystalline (taken 
by Dr. Peng Wu). 
Ceria concentration in brain and Electron micrograph 
ICP-MS analysis suggested that very small amount of ceria was present in the brain 
parenchyma compare to peripheral organ liver (Table 9.1). Electron micrograph studies 
suggested that ceria ENM was not found in the brain, but located on the luminal side of 
the BBB endothelium. The hippocampus and cerebellum tissues did not show obvious 
ceria induced injury as no necrotic neurons or elevated gliosis were observed and the 
BBB was visibly intact (data not shown). 
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Table 9.1: Cerium concentrations in blood, brain, liver, and spleen, expressed as a 
percent change of the ceria ENM dose. a) Based on reference volume of blood in the rat 
(7% of body weight) or weight of the brain, liver x ceria concentration. 
 
Cerium [% of dose]a 
 Blood  Brain  Liver  
% dose (1 h) 0.47 ± X 0.013 ± X 42 ± X 
% dose (30 d) 0.018 ± X 0.001 ± X 7.1 ± X 
 
EELS results 
Electron energy loss spectroscopic measurements on liver tissue were performed as a 
representative organ. The ratio of Ce(Owens Iii et al.) to Ce(IV) in the aged ceria was 
evaluated using EELS measurements after locating agglomerates of the ceria nanorods in 
tissue 1 h and 30 days after infusion into rat and comparing with  synthesized ceria. The 
high Ce3+/ Ce4+ ratio that was obtained in the as-synthesized, fresh ceria nanorods seems 
to have only been altered slightly in individual ceria measured in liver after 30 days in 
vivo (data not shown). 
Oxidative Stress Indices 
Decrease in GSH: GSSG ratio in time dependant manner 
One hour after treatment of ceria nanorods, GSH: GSSG ratio showed a decreasing trend 
in cortex. However, decline in the ratio was statistically significant after 30 d in the 
 170 
hippocampus (~ 28%, ξp < 0.01, Figure 9.2), in the cortex (~ 18%, *p < 0.05, Figure 9.2) 
and in the cerebellum (~ 17%, *p < 0.05, Figure 9.2), when compared with the respective 
control samples. GSH: GSSG ratio is a reflector of the cellular redox status, thereby a 
decline in the ratio suggest the oxidative nature of the cellular environment, which can 
affect various signal transduction pathways.   
 
 
Figure 9.2: GSH: GSSG ratios in 3-brain regions measured 1 h and 30 d after ceria ENM 
nanorod treatment. The histograms represent %control for saline treated controls and 
ceria treated samples. The values are expressed as mean ± SEM, control n = 5, treated n = 
5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples. 
After initial increase, antioxidant enzyme activities were decreased at 30 d 
Glutathione (GSH) dependant antioxidant enzymes GPx and GR activities showed a 
trend for increased values after 1 h in the hippocampus, the cortex and the cerebellum as 
an initial response to ceria nanorods treatment. However, after 30 d GPx activity was 
significantly decreased in the hippocampus (~ 22%, *p < 0.05, Figure 9.3a), in the cortex 
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(~ 28%, *p < 0.05, Figure 9.3a), and in the cerebellum (~ 19%, *p < 0.05, Figure 9.3a). 
Similarly, a non-significant  trend was seen in GR activity in three brain regions, Figure 
9.3b. Following the trend of GPx and GR, catalase activity was increased significantly in 
the hippocampus (~ 23%, *p < 0.05, Figure 9.3c), the cortex (~ 17%, ξp < 0.01, Figure 
9.3c), and the cerebellum (~ 20%, *p < 0.05, Figure 9.3c) at 1 h, it was significantly 
decreased after 30 d in the hippocampus (~ 17%, *p < 0.05, Figure 9.3c), and the 
cerebellum (~ 17%, *p < 0.05, Figure 9.3c). In similar way, SOD activity was 
significantly increased after 1 h in the hippocampus (~ 19%, ξp < 0.01, Figure 9.3d) and 
in the cerebellum (~ 21%, *p < 0.05, Figure 9.3d) and significantly decreased after 30 d 
in the hippocampus (~ 11%, *p < 0.05, Figure 9.3d) alone.  
GPx, GR, catalase and SOD levels were affected by ceria nanorods treatment; however, 
the change in the levels was not statistically significant when compared with the 
respective controls for both the time points, Figure 9.4.  
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Figure 9.3: The antioxidant enzyme activities in 3-brain regions 1 h and 30 d after ceria 
nanorod treatment. a) The histograms represent %control GPx activities measured in 
saline treated controls and ceria treated samples, b) the histograms represent %control 
GR activities measured in saline treated controls and ceria treated samples, c) the 
histograms represent %control catalase activities measured in saline treated controls and 
ceria treated samples, d) the histograms represent %control SOD activities measured in 
saline treated controls and ceria treated samples. All the values are expressed as mean ± 
SEM, control n = 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean 
of respective control samples.  
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Figure 9.4a, b, c and d: The antioxidant enzyme levels in 3-brain regions 1 h and 30 d 
after ceria nanorod treatment. a) The histograms represent %control GPx levels measured 
in saline treated controls and ceria treated samples, b) the histograms represent %control 
GR levels measured in saline treated controls and ceria treated samples, c) the histograms 
represent %control catalase levels measured in saline treated controls and ceria treated 
samples, d) the histograms represent %control MnSOD levels measured in saline treated 
controls and ceria treated samples. All the values are expressed as mean ± SEM, control n 
= 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective 
control samples. 
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Figure 9.4e: Separate Western blots were used to estimate antioxidant protein levels in 
hippocampus, cortex and cerebellum. However, only representative examples from 
hippocampus are shown. Protein levels in control [C] n=5, and treated [T] n=5 samples 
for 1 h (left) and control [C] n=5, treated [T] n=5 for 30 d (Bhabra et al.) ceria nanorod 
treatment. The intensity of each antioxidant protein band was normalized with intensity 
of corresponding band of β-actin-loading control. Similar blots were obtained for cortex 
and cerebellum regions. 
Ceria nanorods reduce protein oxidation at early time point but increases later, similar 
effect on HSP’s 
An inverse correlation was seen in between antioxidant activities and that of PC levels at 
1 h and 30 d time points. Concomitant with increased antioxidant activities 1 h after Ceria 
nanorods treatment, PC levels were significantly decreased in the hippocampus (~ 27%, 
*p < 0.05, Figure 9.5a) and in the cortex (~ 22%, *p < 0.05, Figure 9.5a) regions. On the 
other hand, PC levels were significantly increased after 30 d in the hippocampus (~ 36%, 
*p < 0.05, Figure 9.5a) and in the cortex (~ 27%, ξp < 0.01, Figure 9.5a) concomitant 
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with significant decrease in the antioxidant activities. 3NT and HNE levels did not show 
any significant change after 1 h or 30 d. 
 
 
Figure 9.5: The oxidative stress marker levels in 3-brain regions 1 h and 30 d after ceria 
nanorod treatment. a) The histograms represent %control PC levels measured in saline 
treated controls and ceria treated samples, b) the histograms represent %control 3NT 
levels measured in saline treated controls and ceria treated samples, c) the histograms 
represent %control HNE levels measured in saline treated controls and ceria treated 
samples. All the values are expressed as mean ± SEM, control n = 5, treated n = 5, *p 
<0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples 
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Furthermore, induction of HSP levels was directly related with changes in PC levels and 
inversely related with changes in antioxidant enzyme activities. HO-1 levels showed a 
decreasing trend in all 3-brain regions after 1 h, however, HO-1 was significantly induced 
after 30 d in the hippocampus (~ 30%, *p < 0.05, Figure 9.6a), and in the cortex (~ 23%, 
*p < 0.05, Figure 9.6b). Hsp70 followed a decreasing trend after 1 h and an increasing 
one after 30 d; however, the changes were not significant in either of the three brain 
regions.  
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Figure 9.6a and b: The heat shock protein levels in 3-brain regions 1 h and 30 d after 
ceria nanorod treatment. a) The histograms represent %control HO-1 levels measured in 
saline treated controls and ceria treated samples, b) the histograms represent %control 
Hsp70 levels measured in saline treated controls and ceria treated samples. All the values 
are expressed as mean ± SEM, control n = 5, treated n = 5, *p <0.05, ξp < 0.01, and Θp < 
0.001, compared to mean of respective control samples.  
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Figure 9.6c: Separate Western blots were used to estimate HSPs levels in hippocampus, 
cortex and cerebellum. However, only representative examples from hippocampus are 
shown. Protein levels in control [C] n=5, and treated [T] n=5 samples for 1 h (left) and 
control [C] n=5, treated [T] n=5 for 30 d (Bhabra et al.) ceria nanorod treatment. The 
intensity of each antioxidant protein band was normalized with intensity of corresponding 
band of β-actin-loading control. Similar blots were obtained for cortex and cerebellum 
regions. 
9.4. Discussion 
The toxicity of nanomaterials is governed by various factors including chemical 
composition, size, morphology, and surface modifications of nanomaterials. The 
morphology of nanomaterials can be sub-categorized as high aspect ratio nanomaterials 
and low aspect ratio nanomaterials. The classification of aspect ratio (length to diameter) 
is a relative terminology. Typically, nanomaterials with length ≤ 1 µm is consider as low 
aspect ratio material, length >1 µm is considered as high aspect ratio material (Yokel et 
al. 2011). High aspect ratio material with length > 5µm and diameter ≥ 100 nm is 
considered highly toxic, regardless of its chemical composition (Buzea et al. 2007; 
Lewinski et al. 2008). However, studies with long SWCNT’s and MWCNT’s with 
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diameter < 100 nm were reported to produce significant pulmonary toxicity compared to 
short length or spherical nanomaterials (Lam et al. 2004; Warheit et al. 2004; Muller et 
al. 2005; Bottini et al. 2006; Kostarelos 2008; Kim et al. 2010). The ceria nanorods used 
in present work were highly crystalline with average diameter 10 nm and length has wide 
distribution over 50-600 nm range, thus the aspect ratio is 5-60. This aspect ratio is much 
lower compare to most of the SWCNTs and MWCNTs used in various applications. 
SWCNTs and MWCNTs have high aspect ratio owing to their long length (>1 – 5 µm). 
Compared to CNTs, not much work has been done on toxicological evaluation of metal 
oxide-based nanotubes or nanowires. Only one such study has been done, which is on 
pulmonary toxicity of TiO2 nanofilaments to human lung tumor cells (Magrez et al. 
2009). Four days after exposure to TiO2 based nanotubes (D-12 nm) and nanowires (D-75 
nm), the fragments from both the nanofilaments were found around and inside the 
nucleus. Both nanotubes and nanowires affected cell proliferation and cell death in dose-
dependent manner (Magrez et al. 2009). However, in the current study, although a very 
small fraction of ceria nanorods was seen in the vascular compartment of brain, brain 
redox status had profound impact of the ceria treatment. 
After earlier exposure (1 h) to ceria nanorods, a significant increase in catalase (3-
regions) and SOD (hippocampus and cerebellum) activities and an increasing trend in 
GPx and GR activities (3-regions) indicated activation of phase II enzymes. A slight 
decline in GSH: GSSG ratio in 3-regions suggested slight increase in oxidative stress. 
Induction of phase II enzymes was seen as an antioxidant response induced by small 
increment of oxidative stress, such as decline in GSH: GSSG ratio (Li et al. 2008; Xia et 
al. 2008; Xia et al. 2009). Similar augmentation of phase II antioxidant enzymes was 
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reported after exposure to ceria ENM with aspect ratio one. Catalase levels and activities 
were increased in hippocampus 1 h after 5 nm ceria exposure (Chapter 5), GPx, GR and 
catalase activities and levels were increased in hippocampus, and cerebellum concomitant 
with declined GSH: GSSG ratio; 1 -20 h after 30 nm ceria exposure (Chapter 7), GPx, 
SOD, catalase, GR and GST activities were increased with decreased GSH levels; 48 and 
72 h after hematite NP exposure to human lung cell line (Radu et al. 2010) (also 
increased MDA and Lipid perx). Concurrent administration of >25 nm ceria ENM 
(multiple doses before and after) with monocrotaline (MCT, single dose) rescued rat liver 
from MCT induced ROS injury by restoring GSH levels and GR-GPx activities (Amin et 
al. 2011).  
Unlike hematite NP (24 h, 48 h and 72 h) and hydroxylated fullerene (2-3 h, rat liver) 
exposure where lipid peroxidation markers MDA and LDH levels were increased (Radu 
et al. 2010; Nakagawa et al. 2011), PC, 3NT or HNE levels were decreased in 
hippocampus and cortex 1 h after the treatment in the current study. Additionally absence 
of any significant change in oxidative stress induced heat shock proteins HO-1 and 
Hsp70 suggests that there was no oxidative damage to cellular proteins. In a separate 
study with different metal oxide based ENM, 8 nm ceria ENM exhibited antioxidant 
behavior and HO-1 levels were not induced in RAW 264.7 and BEAS-2B cells after ceria 
treatment (Xia et al. 2008).  
Unlike initial oxidative stress response after 1h, dramatic changes in the oxidative stress 
indices 30 d after ceria nanorod exposure were observed. Concurrent decrease in GSH: 
GSSG ratio (H, C, and CB), GPx (H, C and CB), catalase (H, CB) and SOD (H) activities 
with increased PC (H, C) and HO-1 levels (H, C) indicated failure of phase II antioxidant 
 181 
defense response due to increased or persistent oxidative stress. Similar augmentation of 
oxidative stress is reported by toxicity studies on high aspect ratio materials such as 
SWCNTs and MWCNTs as well as time-dependent toxicity studies with ceria ENM, 
aspect ratio-1 (Chapter 5 and 9).  In a comparison study, both short-SWCNTs (D~ 1-2 
nm, L~ 0.5-2 µm) and long-SWCNTs (D~ 1-2 nm, L~ 20 µm) reduced GSH levels, 
induced lipid peroxidation marker levels, inhibited catalase, SOD  and GPx activity, after 
24 and 48 h in PC-12 cells in dose-dependent manner. Although both decreased cell 
viability and cell proliferation, the long-SWCNTs were more toxic (Wang et al. 2011). 
MWCNTs exposure to human umbilical vein endothelial cells decreased cell viability in 
dose- and time-dependant manner (up to 24 h) (Guo et al. 2011). MWCNTs promoted 
ROS levels just after 2 h exposure, inhibited SOD and GPx activity as well as induced 
lipid peroxidation (MDA), thus causing cytotoxicity (Guo et al. 2011). Another report on 
comparative toxicity of MWCNTs (D~ 10-15 nm) with low aspect ratio (L~ 192 nm) and 
high aspect ratio (L~ 0.5- 1 µm), showed that both MWCNTs inhibited cell growth and 
cell proliferation of normal human embryonic cell at 24 h, 48 h and 72 h after exposure, 
as well as increased LDH levels in dose-dependent manner (Kim et al. 2010). 
Comparison of TiO2 based aspect ratio-1, low and high aspect ratio ENM revealed, 
aspect ratio-dependant cytotoxicity and induction of inflammatory cytokines at high 
aspect ratio in alveolar microphages (Hamilton et al. 2009). 
As with ceria ENM with aspect ratio-1, changes in oxidative stress indices 30 d after 
exposure to ceria nanorods are analogous with that observed 30 d after exposure to 5 nm 
as well 30 nm ceria ENM (Chapter 5 and 9). In a separate study, 24 h after exposure to 15 
and 100 nm silver ENM depleted GSH levels, decreased mitochondrial membrane 
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potential and increased lipid peroxidation levels (LDH) in a dose-dependent manner 
(Hussain et al. 2005). In a similar fashion, ceria ENM with different sizes and with aspect 
ratio-1 decreased cell viability in time- and dose-dependent manner (Park et al. 2008). 
Further ceria and TiO2 ENM with aspect ratio-1 ceria induced ROS under in vitro 
condition, reduced GSH levels, and induced pro-apoptosis marker (Park et al. 2008; Park 
et al. 2008).   
Thus ceria nanorods, a low aspect ratio metal based material, behave as aspect ratio-1 
material at the initial exposure period; however at longer exposure it has oxidative stress 
effects similar to high aspect ratio CNTs. In addition, ceria nanorods have similar 
oxidative stress impact as that of 5 nm and 30 nm ceria ENM, than do 15 nm ceria ENM. 
Thus, based on findings from our lab it may propose that aspect ratio of ENM plays a 
major role in modulation of ENM toxicity compared to its aspect ratio. However, similar 
experiments should be repeated with a high aspect ratio ceria ENM to solidify this 
hypothesis. 
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CHAPTER 10 
 
CONCLUSIONS AND FUTURE STUDIES 
10.1 Conclusions 
The work presented in this dissertation examined the ceria-ENM induced oxidative stress 
effects in hippocampus, cortex and cerebellum of the rat brain. Specifically the influence 
of size, aspect ratio (shape) and exposure period on ceria ENMs induced oxidative stress 
was determined in vivo. Furthermore, a mechanism of oxidative stress in the brain, 
induced by systemically injected ceria ENMs was elucidated. 
Overall results of oxidative stress analysis of brain revealed a pattern (Figure 10.1) where 
at early exposure time points (1 h and 20 h) after systemic administration of ceria ENM, 
showed either no effect (Chapter 5) on oxidative stress end points or showed anti-oxidant 
effects (Chapter 6-9). At 1 h and 20 h, levels and activities of the phase II antioxidants 
were induced and markers of protein oxidation and lipid peroxidation were suppressed. 
However, at later exposure time points (1 d, 7 d, and 30 d), ceria ENM showed pro-
oxidant effects (Chapter 5, 7, and 9), except after treatment of 15 nm ceria ENM (Chapter 
6). The phase II antioxidant activities were inhibited after 1 d-30 d, although their levels 
were increased; concomitantly markers of protein oxidation, lipid peroxidation and HSP 
levels were induced in almost all three brain regions. Interestingly enough, at very late 
exposure time point (90 d), levels and activities of phase II antioxidant enzymes were 
restored and there was no sign of protein oxidation or lipid peroxidation was left, as well 
as HSPs levels were lowered to below control-levels.  
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 Mean % Control Protein 
carbonyl levels 
  
       
 1 h 20 h 1 d 7 d 30 d 90 d 
       
5 nm 93 103 -- -- 119 -- 
15 nm 70 -- -- -- 104 -- 
30 nm 87 85 125 138 134 85 
55 nm 75 87 -- -- -- -- 
nanorod 73 -- -- -- 136 -- 
 
Figure 10.1: a) Upper left figure represents the demographic depiction of the pattern 
followed by a representative oxidative stress end point, protein carbonyl levels after 
treatment of different size ceria ENM at various exposure time points. Red and green 
color areas represent antioxidant effects, while purple and light blue areas represent pro-
oxidant effects. Dark blue color (50-70) covers the points where no data was collected for 
the specific ceria ENM treatment. b) The table inserted bellow the chart shows the 
corresponding values expressed as mean % control protein carbonyl levels, taken from 
corresponding chapters.  
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Furthermore, the results of oxidative stress end-points measured at earlier time points 
such as 1 h and/or 20 h and after 30 d, revealed the size-effect of ceria ENM treatment. 
As shown (as a representative example) in Figure 10.1, 5 nm ceria ENM did not have any 
significant impact on oxidative stress at 1 h and 20 h (Chapter 5), as opposed  to  15 nm, 
30 nm, and 55 nm which induced significant tier-1 protective effects in the brain 
(Chapters 6, 7, and 9 ). After 30 days, 15 nm ceria did not show any pro-oxidant effects 
suggesting success of tier-1 effects (Chapter 6). Whereas, 5 nm, and 30 nm lead to failure 
of tier-1 defense and induced downstream pro-oxidant effects in the brain (Chapters 5, 7). 
A comparison of ultrafine- and fine-TiO2 particles revealed increased cytotoxic effects 
upon untrafine-TiO2 treatment (Kang et al. 2009) as well as silica ENM showed size-
dependent cytotoxicity (Thomassen et al. 2009). On contrary, literature studies have also 
reported  lack of any size-effect on ceria ENM induced toxicity and  nickel-ferrite ENM 
induced toxicity (in absence of oleic acid coating) (Yin et al. 2005; Park et al. 2008; Eom 
et al. 2009). As for the shape-effect or more precisely the aspect ratio-effect, it is more 
logical to compare nanorod ceria ENM with 5 nm and 15 nm ceria ENM (aspect ratio-1) 
as diameter of nanorod was ~10 nm, although nanorod were of varied length (50 nm- 600 
nm). The oxidative stress results of 5 nm, 15 nm and nanorod ceria ENM treatments, 
followed a trend which was very similar at the initial (1 h) time point. All three ceria 
ENMs induced antioxidant (Tier-1) effects in the brain (Chapter 5, 6, 9). On the other 
hand, both nanorod and 5 nm ceria treatment lead to failure of tier-1 defense response 
after 30 d (Chapter 9 and 5 resp.), however, ceria nanorod induced pro-oxidant effects at 
much smaller dose (20-50 mg/kg) compare to 5 nm or 30 nm ceria ENM. Additionally, 
the oxidative stress effects induced by nanorod were also in complete agreement with the 
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findings of 30 nm (1 h and 30 d) and 55 nm (1 h) ceria ENM treatments (Chapter 7 and 
8).  
In Chapter 7, we examined the dose-effect of 55 nm ceria ENM induced oxidative stress 
at 20 h. The larger dose 100 mg/kg of 55 nm ceria ENM induced more significant tier-1 
antioxidant effects after 20 h compared to the half of dose (50 mg/kg). Similarly, 30 nm 
ceria and 21 nm TiO2 ENM induced antioxidant tier-1 and apoptotic tier-3 effects in 
dose-dependent manner in BEAS-2B (Park et al. 2008; Park et al. 2008). In addition to 
the dose and aspect ratio-effects, we had selected three different brain regions in order to 
deduce any region-effects of ceria treatment. However, no such differential effects were 
observed, although overall the hippocampus showed oxidative stress for most of the time 
points and cerebellum showed for the least, there were no distinct preferences observed.  
The major findings of this dissertation work, includes elucidation of the mechanism of 
oxidative stress based on an oxidative stress hierarchy model of nanomaterial toxicity. 
Additionally, as we could extend and modify the existing model for in vivo toxicity of 
ceria ENM (Figure 10.2). The systemic injection of ceria ENM induced phase II 
antioxidant – tier-1 response in the brain without crossing or disrupting BBB and 
decreased GSH: GSSG ratio at 1 h and 20 h- exposure time points. In all the cases, except 
15 nm ceria ENM, with increasing exposure period (≥ 1 d), the loss of GSH: GSSG ratio 
was not recovered and as  a consequence of escalading oxidative stress activated 
downstream signaling pathways. These signaling pathways induced tier-2 and tier-3 
oxidative stress response in the brain. However, after 90 d, GSH: GSSG ratio improved 
favorably with phase II antioxidant levels and activities. Thus, the brain redox imbalance 
was reversed to normal by 90 d. At present we are not sure about what happened in the 
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last 30 d period where redox balance was restored, but it may be that HSPs or autophagy 
response together or separately might have cleared damaged macromolecules and thus 
helped to restored cellular redox status.  
 
 
Figure 10.2: The modified version of oxidative stress hierarchy model of nanotoxicity. 
Addition of Tier-4 response is a result of our finding from 30 nm ceria treatment after 90 
d exposure period.  
This work was the first attempt where the literature-proposed oxidative stress model was 
tested on multicellular organism. As well as this was the first attempt where the “Tier” 
responses explained in the model were tested and connected with ENM treatment 
exposure period. Thus, this work also helps us to understand and clear the fog of 
discrepancy around oxidative stress effects of ceria ENM treatment. Based on our 
experience it can be hypothesized that, the antioxidant effects of ceria ENM (in absence 
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of pre-existing or external source ROS or oxidative stress) reported in literature are result 
of Tier-1 response induced by initial oxidative stress stimuli generated by ceria ENM. 
Depending upon this initial oxidative stress insult and “strength” of Tier-1 response, the 
secondary oxidative stress represented as Tier-2 and Tier-3 may or may not be seen.  
10.2. Future studies 
Based on the results in this dissertation, the following experiments may warrant future 
investigation: 
1. After examining the oxidative stress effects of ceria ENM at considerably high 
dose, it will be useful to study the pharmacokinetics and corresponding oxidative 
stress effects at lower dosage curve (10 and 100 times) and at different exposure 
period.   
2. The oxidative stress effects of ceria treatment observed in this dissertation work 
were induced by ceria ENM in brain but without crossing or disrupting BBB. 
Therefore, it is important to investigate the mechanism of peripheral effects of 
ceria ENM and measurement of circulatory cytokine levels in blood or plasma 
might shade some light. 
3. After deducting the size and time-effect of ceria ENM treatment, current work can 
be extended to investigate role more surface properties like surface charge, 
surface coating, hydrophobicity etc. 
4.  Based on the finding of results of nanorod ceria ENM treatment, where ceria 
nanorods behaved as aspect ratio-1 ENM at initial exposure period (1 h), and 
similar to high aspect ratio ENM such as CNT’s at longer exposure (30 d) time 
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points. Therefore, it will be interesting to investigate the role of aspect ratio in 
detail with high aspect ratio ceria ENM.  
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APPENDIX A 
 
OXIDATIVE STRESS EFFECTS INDUCED BY SILVER NANOPARTICLES IN 
EARTHWORMS (Eisenia fetida) AND PROTEOMICS ANALYSIS OF 
DIFFERENTIALLY EXPRESSED PROTEINS 
With the rapid growth of nanotechnology, there is a constant demand for research and 
production of new engineered nanomaterials (ENM). However, once used in consumer, 
industrial and medical goods, these ENM will be released into the environment 
intentionally or accidentally. After released into ecosystem ENMs can enter into 
wastewater stream and eventually end up in the terrestrial ecosystem-an ultimate sink. 
Silver metal is known for its antibacterial properties and by virtue it Ag-ENMs are used 
in medical devices, food-storage containers, soap and sanitizers, wound dressings, and 
fabrics (Luoma 2008). Thus increasing use of Ag-ENM will contribute to the 
anthropogenic accumulation of ENM in ecosystem (Blaser et al. 2008). Although some 
studies are available on aquatic toxicity as reviewed by (Shoults-Wilsona et al. 2010; 
Shoults-Wilson et al. 2011) however, very little is known about their environmental fate, 
potential effects especially on terrestrial environment (Klaine et al. 2008; Unrine et al. 
2008). The previous studies conducted primarily in cell culture, have reported that 
smaller Ag-ENMs have greater toxicological effects than larger Ag-ENMs; summarized 
in (Shoults-Wilson et al. 2011). However, there is very little known about Ag-ENM size-
effect toxicity towards fully developed multicellular organisms in terrestrial 
environmentally realistic exposure scenarios (Shoults-Wilson et al. 2011).  
 The objective of present study was to compare 1) oxidative stress effects of Ag-ENMs 
with two different sizes and with toxicity of Ag ions exposed to earthworm Eisenia fetida 
at different exposure period, 2) identify the differential expressed proteins in earthworms 
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after exposure to Ag-ENM and Ag ions, through artificial soil media. This is a very first 
proteomics (described in Chapter 3) study on earthworm Eisenia fetida conducted ever.  
 
a] PC levels 
 
Figure A.1a: The oxidative stress marker levels measured in whole earthworm 1 d, 3 d 
and 7 d after exposure to AgNO3, 10 nm Ag-ENM and 30-50 nm Ag-ENM. a) The 
histograms represent % control PC levels measured in control and treated samples. All 
the values are expressed as mean ± SEM, control n = 4, treated n = 4 for each group and 
each exposure period, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of 
respective control samples. 
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b] 3NT levels 
 
c] HNE levels 
 
Figure A.1b and c: The oxidative stress marker levels measured in whole earthworm 1 
d, 3 d and 7 d after exposure to AgNO3, 10 nm Ag-ENM and 30-50 nm Ag-ENM. b) The 
histograms represent % control 3NT levels measured in control and treated samples, c) 
the histograms represent % control HNE levels measured in control and treated samples. 
All the values are expressed as mean ± SEM, control n = 4, treated n = 4 for each group 
and each exposure period, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of 
respective control samples. 
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Figure A.2: The antioxidant catalase activity measured in whole earthworm 1 d, 3 d and 
7 d after exposure to AgNO3, 10 nm Ag-ENM and 30-50 nm Ag-ENM. a) The 
histograms represent % control catalase activity measured in control and treated samples. 
All the values are expressed as mean ± SEM, control n = 4, treated n = 4 for each group 
and each exposure period, *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of 
respective control samples. 
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Table A.1: Description of proteins identified by MS/MS in four treatment groups, 
continue on next page…….. 
Protein Description 
SwissProt 
No. MWt pI 
Peptid
e 
      kDa   hits 
 
          
P54812 
Transitional endoplasmic 
reticulum ATPase homolog 2 
C41C4.8 89.6 5.39 
3(5) 
Q9XXK
1 
ATP synthase subunit alpha, 
mitochondrial 
H28O16.1c 54.1 9.06 2(3) 
P91427 
pgk-1/ phosphoglycerate 
kinase 
T03F1.3 44.1 7.02 
3(4) 
P91427 
pgk-1/ phosphoglycerate 
kinase 
T03F1.3 44.1 7.02 
3(4) 
P46563 
Fructose-bisphosphate 
aldolase 2 
F01F1.12a 38.8 7.88 
3(11) 
Hsp-70A Heat shock 70 kDa protein A F26D10.3 69.7 5.64 2(4) 
Actin-5 
embryo development ending in 
birth or egg hatching 
T25C8.2 41.8 5.68 
5 (14) 
Actin-4c ATP-binding M03F4.2c 40.4 5.83 7 (15) 
Actin-5 
embryo development ending in 
birth or egg hatching 
T25C8.2 41.8 5.68 
3 (9) 
Actin-4b ATP-binding  M03F4.2b 37.3 5.55 4 (7) 
Actin-2 
cytokinesis after mitosis, 
embryo development 
T04C12.5 41.8 5.48 
13 (76) 
Actin-5 
embryo development ending in 
birth or egg hatching 
T25C8.2 41.8 5.68 
10 (64) 
Actin-4c ATP-binding M03F4.2c 40.4 5.83 6 (14) 
Actin-5 
embryo development ending in 
birth or egg hatching 
T25C8.2 41.8 5.68 
5 (11) 
Hsp-70A Heat shock 70 kDa protein A F26D10.3 69.7 5.64 2 (5) 
Actin-4b ATP-binding  M03F4.2b 37.3 5.55 3 (4) 
Actin-4c ATP-binding M03F4.2c 40.4 5.83 3 (4) 
Actin-4c ATP-binding M03F4.2c 40.4 5.83 3 (5) 
Hsp-70A Heat shock 70 kDa protein A F26D10.3 69.7 5.64 2 (7) 
Actin-4c ATP-binding M03F4.2c 40.4 5.83 5 (9) 
P91427 
pgk-1/ phosphoglycerate 
kinase 
T03F1.3 44.1 7.02 
3 (9) 
Hsp-70A Heat shock 70 kDa protein A F26D10.3 69.7 5.64 2 (4) 
Hsp-70A Heat shock 70 kDa protein A F26D10.3 69.7 5.64 2 (5) 
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Table A.1 continued: Description of proteins identified by MS/MS in four treatment 
groups. 
Protein Description 
SwissProt 
No. MWt pI Peptide 
      kDa   hits 
Actin-4c ATP-binding M03F4.2c 40.4 5.83 3 (3) 
Hsp-70A Heat shock 70 kDa protein A F26D10.3 69.7 5.64 2 (2) 
GAPDH-4 
Glyceraldehyde-3-phosphate 
dehydrogenase 4 
F33H1.2 36.4 7.88 
2 (6) 
GAPDH-4 
Glyceraldehyde-3-phosphate 
dehydrogenase 4 
F33H1.2 36.4 7.88 
2 (5) 
Aldose-isoform 
b 
Aldolase (Fructose 
bisphosphate aldolase) protein 
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FTT-2 14-3-3-like protein 2 F52D10.3a 28.0 4.91 2 (3) 
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a] 
 
b] 
 
Figure A.3a and b: 2-D gel map of proteins identified from control and AgNO3 treated 
groups using proteomics among the four groups at 3 d exposure period. a) Representative 
gel from control group of earthworm samples, and d) Representative gel from AgNO3 
treated group of earthworm samples. Protein spots were identified by MS/MS and labeled 
with their corresponding identification. 
c] 
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d] 
 
Figure A.3c and d: 2-D gel map of proteins identified using proteomics among 10 nm 
AgNP and 30-50 nm AgNP treated groups at 3 d exposure period, c) Representative gel 
from 10 nm Ag-ENM treated groups of earthworm samples, and d) Representative gel 
from 30-50 nm Ag-ENM treated group of earthworm samples. Protein spots were 
identified by MS/MS and labeled with their corresponding identification. 
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APPENDIX B 
 
OXIDATIVE MODIFICATION OF LIPOIC ACID IN ALZHEIMER DISEASE BRAIN  
Lipoic acid is an important cofactor for multi-enzyme complexes such as α-ketoglutarate 
dehyede (KGDH), pyruvate dehydrogenase (PDH), branched oxo acid or α-ketoacid 
dehydrogenase complex, and glycine decarboxylase complex or glycine cleavage system 
(Kagan et al. 1992). Lipoic acid is also unique endogenous antioxidant, which can 
scavenge free radicals in aqueous as well as in lipid or membrane phase (Kagan et al. 
1992). Lipoic acid is endogenously present in its native form in the body and remains 
inactive unless reduced to dihydrolipoic acid (DHLA). Lipoamide dehydrogenase is one 
of the main enzyme that catalyzes this reaction in the  presence of a reducing equivalent 
NADPH (Biewenga et al. 1996) Figure B.1. The antioxidant and functional activity of 
lipoic acid as a cofactor is attributed to its reduced form DHLA (Kagan et al. 1992). The 
sulfhydryl groups on DHLA act similar to –SH group from glutathione or cysteine and 
help in reduction of free radicals by providing –H or an electron.  
 
Figure B.1: Reduction of Lipoic acid (LA) to dihydrolipoic acid (DHLA) by enzymatic 
action of lipoamide dehydrogenase in presence of reducing equivalent.  
Apart from acting as an antioxidant itself, lipoic acid can also reinforce other water-or 
lipid-soluble antioxidants such as ascorbate and vitamin E by scavenging their radicals in 
DHLA form (Kagan et al. 1992). Treatment with lipoic acid can reduce lipid peroxide 
marker-HNE and apoptotic markers in patients with Alzheimer disease. This was noted in 
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a study that investigated fibroblast in cell culture. In the same study, co-treatment of cells 
with N-acetyl cysteine showed much better protection from oxidative stress than lipoic 
acid or N-acetyl cysteine alone (Moreira et al. 2007). A study from our lab has shown 
that pretreatment of cortical neurons with acetyl L-carnitine and lipoic acid, plays a 
protective role against HNE-mediated oxidative stress and neurotoxicity by inducing 
GSH levels and reducing protein and lipid oxidation (Hafiz et al. 2007). When rat 
mitochondria were treated with HNE, selective inhibition of KGDH and PDH was 
observed. The same study further reported that loss of enzyme activity of KGDH and 
PDH in mitochondria in presence of a reducing equivalent such as NADPH was closely 
related to the HNE modification of lipoic acid. These findings were also confirmed by 
results from the experiments with purified enzymes (Humphries et al. 1998); Figure B.2. 
Similarly inactivation of KGDH and PDH was observed in human HepG2 cells after 
HNE treatment. However, successive treatment with lipoic acid and other thiol 
supplements protected these complexes from HNE modification. Further the same study 
reported that inhibition of PDH was observed when sulfahydryl groups on lipoic acid 
were in reduced form (Korotchkina et al. 2001). Inhibition was observed at its subunit 
E2E3-BP and the damage was more in presence of subunit E3-dihydrolipoamide 
dehydrogenase and NADPH.  
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Figure B.2: HNE can form Michael adduct with only reduced form of lipoic acid i.e. 
DHLA. 
In this dissertation research, levels of HNE-bound lipoic acid (HNE-LA) were detected 
using specialized antibody against HNE-LA modification (courtesy to Dr. Szweda’s Lab) 
in IPL region of Alzheimer disease (AD). Brain samples from AD-IPL groups were 
compared with group of age matched controls for the purpose of this study. We observed 
significant decrease in HNE-LA levels in AD samples (Figure B.3.).  
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Figure B.3: HNE-LA levels were measured in IPL brain region of control (n=10) and 
AD (n=12) samples by dot blot technique. All the values are expressed as mean ± SEM, 
*p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of respective control samples.  
Alzheimers disease is characterized by increased free radical production and HNE 
modification to proteins (Beal 1995; Markesbery 1997; Markesbery et al. 1998). 
However we found lower levels of HNE bound lipoic acid in AD-IPL samples compared 
to age-matched controls. HNE can only react with a  reduced form of lipoic acid DHLA 
(Humphries et al. 1998). As the enzyme responsible for reduction LA to DHLA is 
lipoamide dehydrogenase, we measured activities and levels of lipoamide dehydrogenase 
(LADH) in AD and control brain-IPL region. Both levels and activities of LADH were 
significantly reduced in AD-IPL as compared to age-matched controls (Figure B.4 a-b). 
Similar reduction in LADH levels and activity was observed in the temporal cortex, 
parietal cortex and in hippocampus of AD patients (Mastrogiacomo et al. 1996). Similar 
to LA, LADH is also shared by four multi-enzyme complexes α-keto- glutaraldehyde 
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dehydrogenase (KGDH), pyruvate dehydrogenase (PDH), the branched oxo acid or α-
ketoacid dehydrogenase complex, and the glycine decarboxylase complex or glycine 
cleavage system (Hunter et al. 1986; Lindsay 1989; Mastrogiacomo et al. 1996) . 
Inhibition of the levels and activity of LADH may reflect on the loss of enzyme activity 
of the multi-enzyme complexes in AD.  
 
 
Figure B.4a] The histograms represent %control Lipoamide dehydrogenase (LADH) 
levels measured in IPL region from AD and age-matched control samples. The 
histograms are accompanying Western blot band of LADH and actin, which was used as 
loading control and intensity of each band was normalized to loading control. All the 
values are expressed as mean ± SEM for control (n=6) and AD (n=10), statistical 
significance was considered at *p <0.05, ξp < 0.01, and Θp < 0.001, compared to mean of 
respective control samples.  
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Figure B.4b] The lipoamide dehydrogenase (LADH) activity in IPL-brain regions. The 
histograms represent % control LADH activity measured in control and AD samples. All 
the values are expressed as mean ± SEM, control n = 10, treated n = 12, *p <0.05, ξp < 
0.01, and Θp < 0.001, compared to mean of respective control samples. 
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APPENDIX C 
DATA TO SUPPLEMENT FIGURES 
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Figure 5.2a hippocampus antioxidant levels 
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Figure 5.2b hippocampus antioxidant activities 
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GPx activity 
Hippo 
Sample 
id Slope Backgd GPx      
   5nm, 
30d     minus activity     
   
 
Backgd 0.004 
       
 
Positive 
C 
0.059 
  
Avg %Control 
   
          c 128 0.006 0.0017 4.457 
 
72 
   c 133 0.007 0.0028 7.004 
 
113 
   c 135 0.0075 0.0033 8.277 
 
133 
   c 138 0.006 0.0018 4.457 
 
72 
   c 141 0.007 0.0028 7.004 
 
113 
   c 191 0.006667 0.0024 6.155 
 
99 
   c 197 0.006667 0.0024 6.155 6.216 99 100 22 8 
          
 
130 0.005 0.0008 1.910 
 
31 
   
 
137 0.005 0.0008 1.910 
 
31 
   
 
142 0.0055 0.0013 3.184 
 
51 
   
 
146 0.0055 0.0013 3.184 
 
51 
   
 
147 0.005 0.0008 1.910 
 
31 
   
 
192 0.0045 0.0003 0.637 
 
10 
   
 
193 0.0045 0.0003 0.637 
 
10 
   
 
195 0.005 0.0008 1.910 
 
31 
   
 
196 
     
31 15 5 
      
TTEST 
8.85284E-
06 
   
 
 
SOD activity 
Hippo 
SOD 
activity 
SOD 
activity               
  
No 
Inhibitor 
LR 
(NInh) 
in 230 
ul in 1ml Avg %Control Avg STDEV SEM 
      (U/ml) (U/ml)     %Cotrol     
          128 0.107 3.70 6.57 28.55 
 
85 
   133 0.105 3.77 6.73 29.28 
 
87 
   135 0.099 3.99 7.28 31.66 
 
94 
   138 0.081 4.88 9.41 40.92 
 
122 
   141 0.107 3.70 6.57 28.55 
 
85 
   191 0.09 4.39 8.24 35.83 
 
107 
   197 0.082 4.82 9.27 40.30 33.58 120 100 16 6 
 
 
        
 
 
        130 0.097 4.08 7.48 32.52 
 
97 
   137 0.09 4.39 8.24 35.83 
 
107 
   142 0.093 4.25 7.90 34.35 
 
102 
   146 0.096 4.12 7.58 32.96 
 
98 
   147 0.087 4.55 8.60 37.41 
 
111 
   192 0.084 4.71 8.99 39.10 
 
116 
   
 211 
193 0.08 4.94 9.56 41.56 
 
124 
   195 0.083 4.77 9.13 39.70 
 
118 
   196 0.086 4.60 8.73 37.96 
 
113 110 9 3 
 
 
Figure 6.5 PC, 3NT and HNE levels at 1h 
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Figure 6.5 PC, 3NT and HNE levels at 30 d 
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70.49614 92.33517 18.53831 8.290586 
 
30d 
   H-HNE 
   % 
Control Avg Stdev SEM 
90.32718 
   116.5991 
   113.3989 
   91.74345 
   87.93135 100 13.80623 6.174332 
    113.4102 
   96.71498 
   104.3548 
   107.3411 
   117.1061 107.7854 7.953531 3.556927 
    
    
    C-HNE 
   % 
Control Avg Stdev SEM 
89.00226 
   98.57678 
   98.25274 
   93.84699 
   120.3212 100 12.00876 5.370479 
    75.34036 
   88.14213 
   81.80681 
   91.84791 
   119.6234 91.35213 17.00961 7.606928 
    
    
    CB-HNE 
   % Avg Stdev SEM 
 215 
Control 
134.7228 
   90.22144 
   82.48256 
   78.26838 
   114.3048 100 23.90107 10.68888 
    72.75657 
   128.8882 
   122.2757 
   76.64967 
   57.20455 91.55495 31.98842 14.30566 
 
Figure 6.3 antioxidant enzyme levels at 30 d 
H1- 
catalase 
H1- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
H1-
catalase H1-actin 
      19670 130863 15 
 
147 
   26923 101779 
      10988 121446 9 
 
88 
   7876 118909 7 
 
65 
   3926 129694 
 
10 
 
100 42 19 
        15404 117794 13 
 
128 
   11628 118020 10 
 
96 
   7911 129505 6 
 
60 
   11075 121904 9 
 
89 
   5970 118711 5 
 
49 84 31 14 
        
     
0.326951 
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H1- 
GPx 
H1- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
H1-
GPx 
H1-
actin 
      6792 130863 5 
 
35 
   14095 101779 14 
 
94 
   27588 121446 23 
 
155 
   20139 118909 17 
 
115 
   40846 129694 
 
15 
 
100 50 22 
        14619 117794 12 
 
85 
   7767 118020 7 
 
45 
   7564 129505 6 
 
40 
   20108 121904 16 
 
112 
   17300 118711 15 
 
99 76 32 15 
        
     
0.436519 
   
 
 
H2- 
MnSOD 
H2- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
H2-
MnSOD 
H2-
actin 
      81463 192625 42 
 
90 
   84606 166926 51 
 
108 
   97480 186581 52 
 
111 
   91883 211039 44 
 
92 
   102766 219221 47 47 99 100 9 4 
        81019 170587 47 
 
101 
   96632 190440 51 
 
108 
   84821 188020 45 
 
96 
   103873 223648 46 
 
99 
   103823 241744 43 
 
91 99 6 3 
        
     
0.765421 
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H3- 
Hsp-32 
H3- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
H3-
Hsp-32 
H3-
actin 
      28022 108615 26 
 
97 
   22931 106205 22 
 
81 
   38787 122781 32 
 
119 
   31097 114136 27 
 
103 
   50144 120262 
 
27 
 
100 16 7 
        40857 111974 36 
 
137 
   27796 125820 22 
 
83 
   36577 133465 27 
 
103 
   37600 120378 31 
 
118 
   38450 112232 34 
 
129 114 22 10 
        
     
0.53582 
   
 
 
H4- 
Hsp-70 
H4- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
H4- 
Hsp-70 
H4-
actin 
      9626 63828 15 
 
98 
   5361 59015 9 
 
59 
   10031 66722 15 
 
98 
   13620 68227 20 
 
130 
   11889 67272 18 15 115 100 26 12 
  
#DIV/0! 
     7358 57312 13 
 
84 
   9499 59346 16 
 
104 
   13092 71472 18 
 
119 
   10346 70949 15 
 
95 
   16362 76815 21 
 
139 108 21 10 
        
     
0.398782 
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Figure 6.4 enzyme activities 
 
Catalase activity at 1h 
 
%Control Avg STDEV SEM 
   %Cotrol     
 
     
 
   
 96    
 104    
 100 100 4 2 
 
 
   
 129 
    118    
 125 124 6 3 0.003198 
     112    
 93    
 87    
 108 100 12 5 
 
 
   
 95 
    125    
 107 109 15 9 0.42176 
     92    
 109    
 96    
 103 100 8 3 
 
 
   
 115 
    125    
 109 116 8 5 0.041831 
 
 
 
 
 
 
 
 
 
 
 
 219 
Catalase activity at 30 d 
 
%Control Avg STDEV SEM 
  %Cotrol     
    
    101 
   101 
   96 
   101 
   101 100 2 1 
100 
   96 
   110 
   104 
   87 99 8 4 
 
0.897349 
  
    81 
   109 
   97 
   104 
   109 100 12 5 
84 
   76 
   78 
   81 
   112 86 15 7 
 
0.1428 
  
    111 
   99 
   99 
   99 
   91 100 7 3 
141 
   120 
   126 
   100 
   94 116 19 9 
 
0.118556 
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GPx activity at 1h 
 
%Control Avg Stdev SEM 
   %Control     
 106 
 
   83 
 
   106 
 
   106 100 11 6 
 
 
    128 
 
   128 
    128 128 0 0 0.008282 
 
    72 
 
   111 
 
   107 
 
   111 100 19 9 
 
 
    150 
 
   130 
    120 133 15 9 0.0536 
 
    
  
   88 
 
   106 
 
   106 100 11 5 
 
 
    106 
 
   125 
    88 106 19 11 0.64333 
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GPx activity at 30 d 
 
%Control Avg Stdev SEM 
   %Control     
 
     106 
 
   106 
 
   96 
 
   86 
 
   106 100 9 4 
 106 
 
   96 
 
   96 
 
   96 
 
   96 98 5 2 0.667 
     100 
 
   111 
 
   89 
 
   100 
 
   100 100 8 3 
 111 
 
   100 
 
   89 
 
   89 
 
   89 96 10 4 0.455 
     108 
 
   98 
 
   87 
 
   98 
 
   108 100 9 4 
 98 
 
   108 
 
   108 
 
   108 
 
   87 102 9 4 0.724 
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SOD activities at 1 h 
 
        
 %Control Avg STDEV SEM 
   %Cotrol     
 
     80 
    114 
    112 
    94 100 16 7 
 
     128 
    128 
    135 130 4 3 0.025484 
     90 
    110 
    108 
    92 100 10 4 
 
     116 
    118 
    143 126 15 9 0.040366 
     88 
    88 
    107 
    116 100 14 6 
 
     133 
    116 
    123 124 9 5 0.049328 
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SOD activities at 30d 
 
        
%Control Avg STDEV SEM 
  %Cotrol     
    99 
   99 
   99 
   107 
   97 100 4 2 
97 
   99 
   93 
   92 
   104 97 5 2 
    
    109 
   90 
   101 
   100 
   100 100 7 3 
104 
   104 
   93 
   100 
   112 102 7 3 
    
    97 
   95 
   97 
   104 
   107 100 5 2 
101 
   106 
   89 
   87 
   97 96 8 3 
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Figure 7.3a, 7.4a, 7.5a  western blot data- antioxidant levels and HSP levels 
 
  
Catalase 
       
          
20hr Codes 
H1-
Catalase  
H1-
Actin Ratio Avg 
% 
Control Avg Stdev SEM 
c 199 14928 38257 39   92       
c 200 19385 38411 50 
 
119 
   c 203 18543 40074 46 
 
109 
   c 206 15584 45407 34 43 81 100 17 8 
c 207 15935 40413 39 
 
100 100 15 7 
          
 
198 19621 38826 51 
 
119 
   
 
201 15792 30586 52 
 
121 
   
 
202 17496 35664 49 
 
115 
   
 
204 18286 37226 49 
 
116 118 3 1 
 
205 23017 45428 51 
 
129 120 5 2 
          
      
TTEST 0.050943 
  1hr 
         c 216 19207 42322 
      c 217 15667 44542 35 
 
108 
   c 220 14967 49775 30 
 
93 
   c 223 14943 46553 32 32 99 100 8 4 
c 224 32362 42359 76 
 
100 100 6 3 
          
 
218 23802 44910 53 
 
163 
   
 
219 26011 42670 61 
 
188 
   
 
221 23594 50964 46 
 
143 
   
 
222 20401 47046 43 
 
134 157 24 12 
 
225 27951 36316 77 
 
101 146 33 15 
          
      
TTEST 0.029872 
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GR 
       
          
20hr Codes 
H3-
GR 
H3-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
c 199 33258 32964 101   94       
c 200 35646 32477 110 
 
103 
   c 203 43340 29045 
      c 206 33658 30558 110 107 103 100 5 2 
c 207 34292 40374 85 
 
100 100 4 2 
          
 
198 24270 33495 72 
 
68 
   
 
201 27094 29127 93 
 
87 
   
 
202 29722 33659 88 
 
83 
   
 
204 25887 25310 102 
 
96 83 12 6 
 
205 31824 40712 78 
 
92 85 11 5 
          
      
TTEST 0.0355 
  
          c 216 27321 18087 151 
 
91 
   c 217 35469 19713 180 
 
109 
   c 220 32238 19469 166 
 
100 
   c 223 21756 13174 165 165 100 100 7 4 
c 224 29376 26663 110 
 
100 100 6 3 
          
 
218 21546 18258 118 
 
71 
   
 
219 23008 19660 117 
 
71 
   
 
221 29361 26895 109 
 
66 
   
 
222 29950 26933 111 
 
67 69 3 1 
 
225 22581 24194 93 
 
85 72 7 3 
          
      
TTEST 0.0002 
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GPx 
        
        
20hr 
H3-
GPx 
H3-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
  11290 32964 34   66       
  20523 32477 63 
 
122 
     23162 39045 59 
 
115 
     15314 30558 50 52 97 100 25 12 
  40374 40374 100 
 
100 100 22 10 
  
          19854 33495 59 
 
115 
     21151 27127 78 
 
151 
     24946 30659 81 
 
157 
     14953 25310 59 
 
114 134 23 12 
  48121 40012 120 
 
120 131 21 9 
  
          
       
0.047 
1hr 
          4296 18087 
        6288 9713 65 
 
102 
     11125 19469 57 
 
90 
     9007 13174 68 63 108 100 9 5 
  26663 26663 100 
 
100 100 7 3 
  
          15570 18258 85 
 
134 
     8163 9660 85 
 
133 
     11960 17895 67 
 
105 
     13861 16933 82 
 
129 126 14 7 
  24194 24194 100 
 
100 120 16 7 
  
       
0.039 
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Hsp-32 
       
         
  
H5-
Hsp-32 
H5-Hsp-32-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
199 10059 28491 35 
 
79 
   200 13441 25957 52 
 
116 
   203 12100 27988 43 
 
97 
   206 13163 27610 48 44 107 100 16 8 
207 14977 34776 43 
 
100 100 14 6 
         198 11886 32728 36 
 
82 
   201 6788 20216 34 
 
75 
   202 8887 29757 30 
 
67 
   204 13402 37733 36 
 
80 76 6 3 
205 11251 37791 30 
 
69 75 6 3 
         
     
TTEST 0.0056 
  216 11167 30369 37 
 
116 
   217 11121 40483 27 
 
86 
   220 11753 41532 28 
 
89 
   223 13356 38477 35 32 109 100 15 7 
224 15059 43345 35 31 100 100 10 5 
         218 9125 43973 21 
 
65 
   219 7388 39392 19 
 
59 
   221 13205 43174 31 
 
96 
   222 11159 38509 29 
 
91 78 18 9 
225 14060 48145 29 
 
84 79 17 8 
         
         
     
TTEST 0.0526 
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H7-
Hsp-70 
H7-
Hsp-
70-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
4669 27940 17 
 
100 
   6472 42600 15 
 
91 
   8831 44079 20 
 
120 
   5792 38394 15 17 90 100 14 7 
10648 19484 55 
 
100 100 12 5 
        4691 44506 11 
 
63 
   5799 40041 14 
 
86 
   6431 42894 15 
 
89 
   7183 45798 16 
 
94 83 14 7 
7131 19892 36 
 
66 80 14 6 
   
TTEST 0.039847 
   
        5456 27872 20 
 
102 
   4623 33931 14 
 
71 
   6917 31024 22 
 
116 
   5555 25852 21 19 112 100 20 10 
7909 22833 35 
 
100 100 18 8 
        6043 37004 16 
 
85 
   4357 35381 12 
 
64 
   5051 23296 22 
 
113 
   5895 25686 23 
 
119 95 26 13 
6405 18300 35 
 
101 96 22 10 
   
TTEST 0.781933 
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30nm- 30d western blot data- antioxidant levels and HSP levels 
H-2-GR 
H-2-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
        33083 26839 123 
     
        27868 20566 136 
 
123 
   27374 32726 84 
 
76 
   27344 26131 105 
 
95 
   41734 37510 111 
 
101 
   41710 39238 106 
 
96 
   34116 28376 120 
 
109 
   44094 21272 
 
110 
 
100 16 6 
        
        29218 19029 154 
 
139 
   31437 23302 135 
 
122 
   33345 26343 127 
 
115 
   25483 22147 115 
 
104 
   34177 28920 118 
 
107 
   39114 36281 108 
 
98 
   33421 23302 143 
 
130 
   34320 21028 163 
 
148 120 18 6 
        
     
0.044321 
   
 
H-2-
GPx 
H-2-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
        10141 26839 38 
             19430 20566 94 
 
107 
   36011 32726 110 
 
124 
   17984 26131 69 
 
78 
   20818 27510 76 
 
86 
   36603 39238 93 
 
105 
   25102 28376 88 
 
100 
   35287 21272 
 
88 
 
100 17 6 
                42960 29029 148 
 
167 
   45420 33302 136 
 
154 
   25621 26343 97 
 
110 
   22843 22147 103 
 
117 
   29781 28920 103 
 
116 
   43039 36281 119 
 
134 
   29266 23302 126 
 
142 
   21751 21028 103 
 
117 132 21 7 
        
     
0.009038 
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H-3-
catalase 
H-3-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
        24964 66890 37 
     
        17247 59313 29 
 
87 
   17917 55328 32 
 
97 
   20332 66801 30 
 
91 
   21747 62742 35 
 
104 
   25387 57725 44 
 
132 
   23842 66560 36 
 
107 
   18691 67562 28 33 83 100 16 6 
        
        20109 59565 34 
 
101 
   23821 72268 33 
 
99 
   30866 66330 47 
 
139 
   21517 64175 34 
 
100 
   31732 59959 53 
 
158 
   24870 47017 53 
 
158 
   21512 34274 63 
 
188 
   25155 39959 63 
 
188 141 38 13 
        
     
0.019249 
   
 
H-3-
Hsp-
32 
H-3-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
        15120 66890 23 
     
        15578 59313 26 
 
90 
   19970 65328 31 
 
105 
   16297 66801 24 
 
84 
   22153 69742 32 
 
109 
   21213 69725 30 
 
105 
   21132 66560 32 
 
109 
   19232 67562 28 29 98 100 10 4 
        
        19598 59565 33 
 
113 
   19506 60268 32 
 
111 
   21996 66330 33 
 
114 
   19632 61175 32 
 
110 
   19078 53959 35 
 
122 
   21059 57017 37 
 
127 
   21606 54274 40 
 
137 
   
 231 
7851 19979 39 
 
135 121 11 4 
        
     
0.001615 
   
 
H-4-
Hsp-
70 
H-4-
actin Ratio Avg 
% 
Control Avg Stdev SEM 
        2969 31558 9 
     
        5562 49740 11 
 
101 
   4563 37606 12 
 
110 
   5778 42027 14 
 
125 
   4108 39522 10 
 
94 
   2067 26267 8 
 
71 
   2234 20518 11 
 
99 
   4152 21532 
 
11 
 
100 18 7 
        
        5689 45097 13 
 
114 
   4631 36545 13 
 
115 
   4226 31020 14 
 
123 
   5126 40319 13 
 
115 
   4655 35785 13 
 
118 
   5198 21886 24 
 
215 
   2677 16348 16 
 
148 
   2968 20506 14 
 
131 135 34 12 
        
        
      
0.042776 
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30nm-90d western blot data- antioxidant levels and HSP levels 
  
H-1-1 
catalase 
H-1-1-
actin 
Normalized 
ratio Avg     Stdev SEM   
          1dc 21762 34858 81 
 
105 
    1dc 25230 40256 81 
 
106 
    1dc 33046 43472 68 77 89 100 10 6 
 1d 22494 33718 86 
 
113 
    1d 20143 31519 83 
 
108 
    1d 43168 53930 72 80 94 105 10 6 0.58808 
          1wc 14852 24141 80 
 
93 
    1wc 21697 23849 118 
 
138 
    1wc 32067 48353 59 86 69 100 35 20 
 1w 21136 27506 99 
 
116 
    1w 32322 37540 111 
 
130 
    1w 36104 43382 75 95 87 111 22 13 0.660974 
          1mc 23773 26841 115 
 
116 
    1mc 10409 15822 85 
 
86 
    1mc 37970 35367 96 99 98 100 15 9 
 1m 26351 26730 128 
 
129 
    1m 19682 19633 130 
 
131 
    1m 41900 45424 119 126 121 127 6 3 0.042585 
          3mc 11061 13984 102 
 
131 
    3mc 17845 25030 92 
 
118 
    3mc 38958 47191 74 
 
95 
    3mc 32964 44334 67 
 
86 
    3mc 25873 33119 70 
 
90 
    3mc 21860 31768 62 78 79 100 20 8 
 3m 17298 18634 120 
 
154 
    3m 13410 21940 79 
 
102 
    3m 46125 37445 110 
 
142 
    3m 37995 42820 80 
 
102 
    3m 21436 30365 63 
 
81 
    3m 18660 33593 50 
 
64 
    3m 21005 30778 61 81 79 103 33 13 0.831894 
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H-1-1-
Hsp-32 
H-1-1-
actin 
Normalized 
ratio Avg     Stdev SEM   
          1dc 29175 34858 63 
 
97 
    1dc 42725 44256 73 
 
112 
    1dc 24701 43472 59 65 90 100 7 4 
 1d 40086 33718 90 
 
138 
    1d 42293 31519 102 
 
156 
    1d 43102 53930 83 92 127 140 9 5 0.018671 
          1wc 34349 24141 108 
 
102 
    1wc 35294 23849 112 
 
107 
    1wc 44695 48353 96 105 91 100 8 5 
 1w 46553 27506 128 
 
122 
    1w 46066 27540 127 
 
120 
    1w 50099 43382 120 125 114 119 5 3 0.023561 
          1mc 28856 26841 81 
 
100 
    1mc 15941 15822 76 
 
94 
    1mc 51173 45367 85 81 105 100 5 3 
 1m 35273 26730 100 
 
123 
    1m 22696 15633 110 
 
136 
    1m 49084 49424 103 104 127 129 5 3 0.004255 
          3mc 19560 13984 106 
 
96 
    3mc 38131 25030 115 
 
104 
    3mc 50783 47191 112 
 
101 
    3mc 47198 44334 110 
 
100 
    3mc 39820 33119 125 
 
112 
    3mc 29707 31768 97 111 87 100 9 4 
 3m 17334 18634 70 
 
64 
    3m 30257 21940 105 
 
94 
    3m 56415 47445 123 
 
111 
    3m 42872 42820 104 
 
94 
    3m 35955 32365 115 
 
104 
    3m 40063 34593 120 
 
108 
    3m 35955 32778 114 107 103 97 18 7 0.671076 
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H-2-1-
Hsp-70 
H-2-1-
actin 
Normalized 
ratio Avg     Stdev SEM   
          1dc 1632 31815 72 
 
92 
    1dc 2287 42450 76 
 
97 
    1dc 1949 28017 88 79 111 100 10 6 
 1d 2446 36724 94 
 
119 
    1d 1927 42621 64 
 
81 
    1d 2279 28575 101 86 128 109 25 14 0.575769 
          1wc 2647 41727 90 
 
103 
    1wc 1138 27580 58 
 
67 
    1wc 2171 24110 114 87 130 100 32 18 
 1w 2783 34777 113 
 
130 
    1w 2539 35534 101 
 
116 
    1w 2558 38915 83 99 95 114 17 10 0.553244 
          1mc 2902 35595 115 
 
131 
    1mc 1723 30856 79 
 
89 
    1mc 2248 40271 70 88 80 100 27 16 
 1m 2412 39939 85 
 
97 
    1m 2387 34456 98 
 
111 
    1m 3428 37923 128 104 145 118 25 14 0.453024 
          3mc 2331 41283 80 
 
101 
    3mc 2676 44052 86 
 
109 
    3mc 2127 44714 60 
 
76 
    3mc 2468 35959 87 
 
110 
    3mc 3000 50045 76 
 
96 
    3mc 2434 36438 84 79 107 100 13 5 
 3m 2134 36381 83 
 
105 
    3m 1918 33652 80 
 
102 
    3m 2291 42142 69 
 
87 
    3m 2284 37399 77 
 
98 
    3m 2950 39611 94 
 
119 
    3m 2102 34382 77 
 
98 
    3m 1334 47213 36 74 45 94 23 9 0.566166 
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H-2-1-
GPx 
H-2-1-
actin 
Normalized 
ratio Avg     Stdev SEM   
          1dc 13844 31815 49 
 
109 
    1dc 9590 42450 25 
 
57 
    1dc 17123 28017 60 45 134 100 18 10 
 1d 15011 36724 46 
 
103 
    1d 15646 42621 41 
 
92 
    1d 20934 28575 72 53 161 118 16 10 0.586023 
          1wc 6650 41727 18 
 
42 
    1wc 9041 27580 37 
 
86 
    1wc 18267 24110 74 43 173 100 29 17 
 1w 25125 34777 81 
 
189 
    1w 15781 35534 50 
 
116 
    1w 11152 38915 28 53 65 123 27 15 0.681157 
          1mc 15665 35595 49 
 
102 
    1mc 16899 30856 61 
 
127 
    1mc 14308 40271 35 48 72 100 13 8 
 1m 20973 39939 59 
 
121 
    1m 12846 34456 42 
 
86 
    1m 19097 37923 49 50 102 103 9 5 0.878345 
          3mc 25987 41283 62 
 
104 
    3mc 16142 44052 36 
 
61 
    3mc 19442 44714 43 
 
72 
    3mc 28768 35959 78 
 
132 
    3mc 29270 50045 57 
 
97 
    3mc 29579 36438 79 59 134 100 18 7 
 3m 25184 36381 68 
 
114 
    3m 24863 33652 72 
 
122 
    3m 33027 42142 77 
 
130 
    3m 25200 37399 66 
 
111 
    3m 32496 39611 80 
 
136 
    3m 23144 34382 66 
 
111 
    3m 23389 41213 56 69 94 117 8 3 0.208601 
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H-3-1-
GR 
H-3-1-
actin 
Normalized 
ratio Avg     Stdev SEM   
          1dc 113799 15566 112 
 
104 
    1dc 109647 16934 99 
 
92 
    1dc 67516 33766 112 108 104 100 7 4 
 1d 108693 15174 110 
 
102 
    1d 92973 13550 105 
 
97 
    1d 82482 37854 122 112 114 104 8 5 0.537041 
          1wc 104577 19243 83 
 
111 
    1wc 86084 19603 67 
 
89 
    1wc 66552 46821 
 
75 
 
100 15 9 
 1w 89815 15324 90 
 
119 
    1w 97441 13183 113 
 
150 
    1w 69514 43100 91 98 121 130 18 10 0.144608 
          1mc 102412 13587 115 
 
121 
    1mc 98470 15744 96 
 
101 
    1mc 54874 41443 74 95 78 100 22 12 
 1m 101519 15961 97 
 
102 
    1m 107597 17761 93 
 
97 
    1m 72377 39430 103 98 108 103 5 3 0.843167 
          3mc 76842 48167 90 
 
86 
    3mc 95886 46047 117 
 
112 
    3mc 77152 42386 102 
 
98 
    3mc 82273 42043 110 
 
105 
    3mc 80615 44295 102 
 
98 
    3mc 75505 39677 107 105 102 100 9 4 
 3m 75847 30867 138 
 
132 
    3m 74341 36240 115 
 
110 
    3m 88186 47780 104 
 
99 
    3m 80396 45155 100 
 
96 
    3m 76353 41196 104 
 
99 
    3m 76366 40511 106 
 
101 
    3m 77710 37647 116 112 111 107 12 5 0.28211 
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Figure 7.3a, 7.4b, 7.5b, 7.6 antioxidant enzyme activities 
 
30nm Catalase Avg %Control Avg STDEV SEM 
 1-20h activity     %Cotrol     
 
        216 14.04 
 
109 
    217 11.60 
 
90 
    220 11.11 
 
87 
    223 13.55 
 
106 
    224 13.88 12.84 108 100 11 5 
 218 22.65 
 
176 
 
 
  219 14.36 
 
112 
    221 13.88 
 
108 
    222 20.86 
 
163 
    225 14.69 
 
114 135 32 14 0.051775 
        199 12.41 
 
120 
    200 9.16 
 
89 
    203 9.33 
 
90 
    206 10.14 
 
98 
    207 10.63 10.33 103 100 13 6 
 198 13.55 
 
131 
 
 
  201 10.46 
 
101 
    202 12.90 
 
125 
    204 12.90 
 
125 
    205 11.76 
 
114 119 12 5 0.038111 
 
 
30nm Catalase Avg %Control Avg STDEV SEM 
30 days activity     %Cotrol     
       209 12.58 
 
88 
   225 15.66 
 
110 
   227 13.39 
 
94 
   228 14.69 
 
103 
   231 13.88 
 
98 
   233 15.34 
 
108 
   235 14.04 14.22 99 100 8 3 
       210 12.90 
 
91 
   211 12.09 
 
85 
   212 13.06 
 
92 
   213 12.90 
 
91 
   214 12.41 
 
87 
   230 11.60 
 
82 
   232 11.93 
 
84 
   234 12.74 
 
90 87 4 2 
       
    
0.001278 
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  30nm Catalase Avg %Control Avg STDEV SEM 
 
  
90 
days activity     %Cotrol     
 
         1dc 260 13.39 
 
102 
    1dc 261 13.06 
 
100 
    1dc 270 12.74 13.06 98 100 2 1 
 1d 259 11.93 
 
91 
    1d 271 11.76 
 
90 
    1d 272 11.60 
 
89 90 1 1 0.003448 
         1wc 268 12.09 
 
98 
    1wc 269 13.39 
 
109 
    1wc 281 11.52 12.33 93 100 8 4 
 1w 278 10.63 
 
86 
    1w 279 10.30 
 
84 
    1w 280 8.03 
 
65 78 11 7 0.053226 
         1mc 263 15.18 
 
101 
    1mc 265 14.20 
 
95 
    1mc 282 15.53 14.97 104 100 5 3 
 1m 264 13.71 
 
92 
    1m 266 13.39 
 
89 
    1m 267 13.55 
 
91 91 1 1 0.025606 
         3mc 246 13.06 
 
89 
    3mc 248 14.85 
 
101 
    3mc 251 14.85 
 
101 
    3mc 254 16.47 
 
112 
    3mc 256 15.01 
 
102 
    3mc 258 14.04 14.71 95 100 8 3 
 3m 247 15.01 
 
102 
    3m 249 18.59 
 
126 
    3m 250 16.80 
 
114 
    3m 252 15.66 
 
106 
    3m 253 15.66 
 
106 
    3m 255 18.42 
 
125 
    3m 257 16.15 
 
110 113 10 4 0.022437 
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Hippo    
   30nm GPx      
   1-20h activity     
   
       
  
Avg %Control Avg Stdev SEM 
  
    %Control     
216 25.47 
 
88 
   217 33.96 
 
118 
   220 25.47 
 
88 
   223 25.47 
 
88 
   224 33.96 28.87 118 100 16 7 
218 36.38 
 
126 
   219 36.38 
 
126 
   221 36.38 
 
126 
   222 33.96 
 
118 
   225 33.96 
 
118 123 5 2 
    
0.016355 
  199 25.47 
 
115 
   200 16.98 
 
77 
   203 25.47 
 
115 
   206 16.98 
 
77 
   207 25.47 22.07 115 100 21 9 
198 8.49 
     201 25.47 
 
115 
   202 25.47 
 
115 
   204 33.96 
 
154 
   205 33.96 
 
154 135 22 10 
    
0.047945 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 240 
Hippo    
   30nm GPx      
   30 days activity     
   
       
  
Avg %Control Avg Stdev SEM 
  
    %Control     
209 25 
 
98 
   
225 17 
 
65 
   
227 28 
 
107 
   
228 25 
 
98 
   
231 25 
 
98 
   
233 36 
 
137 
   
235 25 26 98 100 21 8 
       210 15 
 
59 
   211 15 
 
59 
   212 15 
 
59 
   
213 25 
 
98 
   
214 23 
 
88 
   
230 25 
 
98 
   
232 25 
 
98 
   
234 18 
 
68 78 19 7 
    
0.053098 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 241 
 
 
Hippo    
    
 
30nm GPx      
    
 
90 
days activity     
    
         
   
Avg %Control Avg Stdev SEM 
 
   
    %Control     
 1dc 260 38 
 
93 
    1dc 261 38 
 
93 
    1dc 270 47 41 114 100 12 7 
 1d 259 25 
 
62 
    1d 271 34 
 
83 
    1d 272 30 
 
72 72 10 6 0.039021 
         1wc 268 47 
 
106 
    1wc 269 47 
 
106 
    1wc 281 38 44 87 100 11 6 
 1w 278 21 
 
48 
    1w 279 21 
 
48 
    1w 280 38 
 
87 61 22 13 0.055041 
         1mc 263 38 
 
100 
    1mc 265 38 
 
100 
    1mc 282 38 38 100 100 0 0 
 1m 264 30 
 
78 
    1m 266 25 
 
67 
    1m 267 30 
 
78 74 6 4 0.002192 
         3mc 246 25 
 
66 
    3mc 248 42 
 
113 
    3mc 251 42 
 
113 
    3mc 254 30 
 
81 
    3mc 256 42 
 
113 
    3mc 258 42 37 113 100 21 9 
 3m 247 47 
 
125 
    3m 249 42 
 
113 
    3m 250 30 
 
79 
    3m 252 30 
 
79 
    3m 253 30 
 
79 
    3m 255 30 
 
79 
    3m 257 30 
 
79 91 20 7 0.425164 
 
 
 
 
 242 
30nm GR activity Avg 
% 
Control Avg Stdev SEM 
1-20h nmol/min/ml           
       216 110 
 
123 
   217 84 
 
94 
   220 97 
 
109 
   223 84 
 
94 
   224 71 89 80 100 16 7 
218 97 
 
109 
   219 122 
 
137 
   221 59 
 
66 
   222 84 
 
94 
   225 71 
 
80 97 27 12 
       199 84 
 
86 
   200 84 
 
86 
   203 110 
 
113 
   206 97 
 
99 
   207 112 97 115 100 14 6 
198 102 
 
105 
   201 88 
 
91 
   202 88 
 
91 
   204 97 
 
99 
   205 84 
 
86 94 7 3 
       
    
0.448515
     
 243 
30nm GR activity Avg 
% 
Control Avg Stdev SEM 
30 
days nmol/min/ml           
       209 97 
 
98 
   225 84 
 
85 
   227 110 
 
111 
   228 110 
 
111 
   231 110 
 
111 
   233 
      235 84 99 85 100 13 5 
210 148 
 
149 
   211 122 
 
124 
   212 135 
 
136 
   213 88 
 
89 
   214 102 
 
103 
   230 122 
 
124 
   232 109 
 
110 
   234 122 119 124 120 19 6 
       
    
0.047001 
   
 
  
 244 
 
GR activity 
Avg 
% 
Control Avg Stdev SEM 
 
 
nmol/min/ml           
 
        
        1dc 71 
 
93 
    1dc 71 
 
93 
    1dc 88 77 115 100 13 7 
 1d 84 
 
109 
    1d 97 
 
126 
    1d 71 
 
93 109 17 10 0.488251 
        1wc 84 
 
105 
    1wc 71 
 
89 
    1wc 84 80 105 100 9 5 
 1w 71 
 
89 
    1w 71 
 
89 
    1w 71 
 
89 89 0 0 0.116117 
        1mc 84 
 
111 
    1mc 71 
 
94 
    1mc 71 76 94 100 10 6 
 1m 71 
 
94 
    1m 97 
 
128 
    1m 97 
 
128 117 19 11 0.250815 
        3mc 110 
 
124 
    3mc 84 
 
95 
    3mc 97 
 
110 
    3mc 59 
 
66 
    3mc 71 
 
81 
    3mc 110 88 124 100 24 10 
 3m 84 
 
95 
    3m 84 
 
95 
    3m 110 
 
124 
    3m 97 
 
110 
    3m 97 
 
110 
    3m 71 
 
81 
    3m 97 
 
110 103 14 5 
 
 245 
 
 
Hippo-
PC 1h 
% 
Control Avg  Stdev SEM 
Hippo-
PC-20h 
% 
Control   Avg Avgavg 
          216 103 
   
199 96 
   217 104 
   
200 102 
   220 95 
   
203 103 
   223 98 
   
206 94 
   224 101 100 4 2 207 105 100 5 2 
          218 
    
198 90 
   219 78 
   
201 96 
   221 77 
   
202 96 
   222 94 
   
204 79 
   225 98 87 11 5 205 65 85 13 6 
 
TTEST 0.037 
   
TTEST 0.0501 
  
          Hippo-
3NT 
% 
Control Avg  Stdev SEM 
Hippo-
3NT 
% 
Control Avg  Stdev SEM 
          216 99 
   
199 84 
   217 104 
   
200 88 
   220 95 
   
203 103 
   223 104 
   
206 112 
   224 99 100 4 2 207 113 100 13 6 
          218 92 
   
198 90 
   219 96 
   
201 86 
   221 74 
   
202 87 
   222 94 
   
204 82 
   225 92 90 9 4 205 65 82 10 4 
 
TTEST 0.049 
   
TTEST 0.0435 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 246 
          
Hippo-
HNE 
% 
Contro
l Avg  Stdev SEM 
Hippo-
HNE 
% 
Contro
l Avg  Stdev SEM 
          216 93 
   
199 102 
   217 101 
   
200 117 
   220 112 
   
203 99 
   223 97 
    
206 83 
  224 96 100 7 3 207 99 100 12 5 
          218 105 
   
198 98 
   219 99 
   
201 93 
   221 
 
99 
   
202 91 
  222 
 
67 
   
204 81 
  225 25123 75 89 17 8 205 74 87 10 
  
TTEST 0.212 
  
  TTEST 0.1018 
  
 
Hippo-
PC         
30nm-
30d 
% 
Control Avg Stdev SEM 
     c 126 
   c 113 
   c 117 
   c 125 
   c 80 
   c 61 
   c 78 100 26 10 
     
     
 
143 
   
 
128 
   
 
159 
   
 
114 
   
 
147 
   
 
121 
   
     
 
129 134 16 6 
     
  
0.012216 
    
 
 247 
 
Hippo-3NT  30nm-30d   
% Control Avg Stdev SEM 
    
99 
   82 
   
92 
   90 
   
126 
   
    
110 100 16 6 
    
    126 
   
118 
   99 
   
126 
   124 
   
119 
   151 
   
128 124 14 5 
    
 
0.011772 
  
   
1.702703 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 248 
Hippo-HNE     
% 
Control Avg Stdev SEM 
    115 
   88 
   65 
   
    108 
   117 
   106 100 20 8 
    
    107 
   106 
   119 
   152 
   128 
   127 
   113 
   126 122 15 5 
    
 
0.032935 
   
  
 249 
H-PC 
     
      
        %Control Avg Std SEM TTEST 
1dc 100 
    1dc 92 
    1dc 108 100 8 5 
 1d 126 
    1d 129 
    1d 119 125 5 3 0.010266 
      1wc 89 
    1wc 121 
    1wc 89 100 19 11 
 1w 149 
    1w 137 
    1w 129 138 10 6 0.033998 
      1mc 85 
    1mc 93 
    1mc 122 100 19 11 
 1m 135 
    1m 128 
    1m 142 135 7 4 0.041428 
      3mc 107 
    3mc 98 
    3mc 93 
    3mc 112 
    3mc 87 
    3mc 104 100 9 4 
 3m 82 
    3m 100 
    3m 76 
    3m 62 
    3m 81 
    3m 102 
    3m 90 85 14 5 0.045624 
 
  
 250 
H-3NT %Control Avg Std SEM TTEST 
1dc 104 
    1dc 102 
    1dc 94 100 5 3 
 1d 111 
    1d 116 
    1d 115 114 3 2 0.016201 
      1wc 105 
    1wc 96 
    1wc 98 100 5 3 
 1w 104 
    1w 101 
    1w 92 99 6 4 0.836039 
      1mc 100 
    1mc 97 
    1mc 102 100 3 2 
 1m 108 
    1m 110 
    1m 116 111 4 2 0.017827 
      3mc 105 
    3mc 100 
    3mc 110 
    3mc 107 
    3mc 93 
    3mc 84 100 10 4 
 3m 97 
    3m 89 
    3m 87 
    3m 85 
    3m 89 
    3m 83 
    3m 88 88 5 2 0.015865 
 
  
 251 
H-
HNE %Control Avg Std SEM TTEST 
1dc 94 
    1dc 101 
    1dc 105 100 6 3 
 1d 101 
    1d 96 
    1d 111 103 8 5 0.68127 
      1wc 93 
    1wc 99 
    1wc 109 100 8 5 
 1w 100 
    1w 103 
    1w 108 104 4 2 0.520642 
      1mc 102 
    1mc 100 
    1mc 98 100 2 1 
 1m 108 
    1m 111 
    1m 111 110 2 1 0.003182 
      3mc 89 
    3mc 104 
    3mc 102 
    3mc 102 
    3mc 106 
    3mc 97 100 6 3 
 3m 97 
    3m 85 
    3m 95 
    3m 94 
    3m 97 
    3m 100 
    3m 96 95 5 2 0.132053 
 
 
 
 
 
 
 
 
 252 
 
Caspase, IL-1beta, TNF and LC-3AB data 
 
1h-20h 
       Caspase- 1-
20h  actin Ratio Avg 
% 
Control Avg Stdev SEM 
        1675 38992 0.042958 
 
96 
   2707 50631 0.053462 
 
120 
   2393 52814 0.045302 
 
101 
   1494 40299 0.037073 0.044699 83 100 15 8 
3019 49885 0.060519 
 
135 
   2486 39947 0.062243 
 
139 
   2312 46658 0.049559 
 
111 
   2005 48707 0.041172 
 
92 119 22 11 
     
0.519571 
  
        1895 35058 0.054053 
 
78 
   2786 38189 0.072954 
 
105 
   2959 39491 0.074937 
 
108 
   3140 41075 0.076455 0.0696 110 100 15 8 
3287 38654 0.085036 
 
122 
   3254 34572 0.094108 
 
135 
   3193 38724 0.082462 
 
118 
   2930 41400 0.070783 
 
102 119 14 7 
     
0.10613 
  
        1d- 7d 
       Caspase- 1-
20h  actin Ratio Avg 
% 
Control Avg Stdev SEM 
        26202 5817 4.504453 
 
107 
   30439 7178 4.240372 
 
101 
   25582 6603 3.874365 4.206397 92 100 8 4 
25778 5999 4.296842 
 
102 
   29044 7643 3.800292 
 
90 
   30543 7573 4.033243 
 
96 96 6 3 
        
        22902 19435 1.178403 
 
113 
   20061 21331 0.940461 
 
90 
   25297 24915 1.015334 1.044733 97 100 12 7 
21635 25768 0.83961 
 
80 
   25427 22446 1.132815 
 
108 
   18657 22461 0.83064 
 
80 89 16 10 
     
0.415384 
   
 253 
 
          
  
30d-90d 
       
    
Caspase- 1-
20h  actin Ratio Avg 
% 
Control Avg Stdev SEM 
          30d C 209 29829 9895 3.014359 
 
96 
   30d C 225 33815 9124 3.706342 
 
118 
   30d C 227 31929 9271 3.443959 
 
109 
   30d C 228 32649 11518 2.834577 
 
90 
   30d C 231 28990 10492 2.762978 3.152443 88 100 13 6 
 
210 30130 8218 3.666235 
 
116 
   
 
211 39160 9733 4.023479 
 
128 
   
 
212 38131 10382 3.672753 
 
117 
   
 
213 34130 8441 4.04346 
 
128 
   
 
214 39285 8129 4.832478 
 
153 
   
 
230 27578 10930 2.523133 
  
128 15 6 
       
0.012628 
  
          90d C 246 25438 20253 1.256011 
 
109 
   90d C 248 31759 28010 1.133876 
 
98 
   90d C 251 28357 26831 1.056875 
 
92 
   90d C 254 33308 24282 1.371741 
 
119 
   90d C 256 21132 22189 0.952351 1.154171 83 100 14 6 
 
247 31821 25291 1.258183 
 
109 
   
 
249 32004 23293 1.373964 
 
119 
   
 
250 30173 21843 1.381371 
 
120 
   
 
252 28559 25430 1.123066 
 
97 
   
 
253 28835 31788 0.907103 
 
79 
   
 
255 27630 22583 1.223469 
 
106 105 15 6 
 
  
 254 
IL-1B actin Ratio Avg 
% 
Control Avg Stdev SEM 
        13890 24786 0.560399 
 
117 
   9565 21619 0.442426 
 
93 
   10640 30793 0.345533 
 
72 
   13851 24749 0.559655 0.477003 117 100 22 11 
22147 42987 0.515212 
 
108 
   9535 21191 0.449961 
 
94 
   1324 34651 0.038215 
     8278 28599 0.289452 
 
61 88 24 12 
     
0.446916 
  
        11273 15363 0.733793 
 
103 
   13611 23292 0.584358 
 
82 
   12939 19770 0.654467 
 
92 
   15099 17247 0.875462 0.71202 123 100 18 9 
14726 24415 0.603162 
 
85 
   13626 19484 0.699363 
 
98 
   9948 18939 0.52526 
 
74 
   14917 25926 0.575356 
 
81 84 10 5 
     
0.175264 
  
        
        
IL-1B actin Ratio Avg 
% 
Control Avg Stdev SEM 
        28591 13850 2.064267 
 
90 
   32641 14744 2.213825 
 
97 
   34061 13276 2.565592 2.281228 112 100 11 7 
29969 11468 2.613142 
 
115 
   36302 11109 3.26767 
 
143 
   33245 9473 3.509525 
 
154 137 20 12 
     
0.05022 
  
        22852 11262 2.02913 
 
87 
   23406 10003 2.339798 
 
100 
   28929 10874 2.660318 2.343082 114 100 13 8 
 
 
 
 
 255 
IL-1B actin Ratio Avg 
% 
Control Avg Stdev SEM 
        13890 24786 0.560399 
 
117 
   9565 21619 0.442426 
 
93 
   10640 30793 0.345533 
 
72 
   13851 24749 0.559655 0.477003 117 100 22 11 
22147 42987 0.515212 
 
108 
   9535 21191 0.449961 
 
94 
   1324 34651 0.038215 
     8278 28599 0.289452 
 
61 88 24 12 
     
0.446916 
  
        11273 15363 0.733793 
 
103 
   13611 23292 0.584358 
 
82 
   12939 19770 0.654467 
 
92 
   15099 17247 0.875462 0.71202 123 100 18 9 
14726 24415 0.603162 
 
85 
   13626 19484 0.699363 
 
98 
   9948 18939 0.52526 
 
74 
   14917 25926 0.575356 
 
81 84 10 5 
     
0.175264 
  
        
        
IL-1B actin Ratio Avg 
% 
Control Avg Stdev SEM 
        28591 13850 2.064267 
 
90 
   32641 14744 2.213825 
 
97 
   34061 13276 2.565592 2.281228 112 100 11 7 
29969 11468 2.613142 
 
115 
   36302 11109 3.26767 
 
143 
   33245 9473 3.509525 
 
154 137 20 12 
     
0.05022 
  
        22852 11262 2.02913 
 
87 
   23406 10003 2.339798 
 
100 
   28929 10874 2.660318 2.343082 114 100 13 8 
28955 11046 2.621283 
 
112 
   27860 12405 2.245818 
 
96 
   26749 10060 2.658828 
 
113 107 10 6 
     
0.502512 
  
        
        
 256 
IL-1B actin Ratio Avg 
% 
Control Avg Stdev SEM 
        33151 10060 
      21650 9247 2.341421 
 
96 
   21433 9080 2.360593 
 
97 
   23267 9092 2.559063 
 
105 
   24206 9849 2.457669 2.429686 101 100 4 2 
36416 9466 3.847052 
 
158 
   34382 9650 3.56275 
 
147 
   35201 10518 3.346739 
 
138 
   28778 9822 2.930102 
 
121 
   13928 8919 1.561626 
     23708 8408 2.819819 
 
116 136 18 7 
     
0.005729 
  
        37548 13554 2.770204 
 
97 
   35950 12697 2.831521 
 
99 
   35861 11441 3.134454 
 
110 
   22892 10725 2.134462 
 
75 
   29994 8908 3.367071 2.847542 118 100 16 7 
38924 11429 3.405639 
 
120 
   14328 10396 1.37826 
     23843 10354 2.302882 
 
81 
   37385 10367 3.606143 
 
127 
   17967 7722 2.326693 
 
82 
   26095 7419 3.51754 
 
124 106 23 9 
 
  
 257 
TNF actin Ratio Avg 
% 
Control Avg Stdev SEM 
        7654 26485 0.288994 
 
108 
   5853 24584 0.238067 
 
89 
   5420 21440 0.252777 
 
95 
   5527 19223 0.28752 0.26684 108 100 10 5 
5949 30688 0.193837 
 
73 
   5138 27652 0.185826 
 
70 
   5871 26699 0.219902 
 
82 
   5096 28392 0.179495 
 
67 73 7 3 
     
0.003524 
  
        3789 20072 0.18875 
 
77 
   4497 22027 0.204158 
 
84 
   8425 29047 0.290043 
 
119 
   8803 29905 0.294379 0.244332 120 100 23 11 
4955 19684 0.251714 
 
103 
   3225 21036 0.153296 
 
63 
   3475 22704 0.153035 
 
63 
   4945 25769 0.191913 
 
79 77 19 10 
     
0.168244 
  
        
        
TNF actin Ratio Avg 
% 
Control Avg Stdev SEM 
        5848 24596 0.237751 
 
117 
   5202 26955 0.192982 
 
95 
   4772 26681 0.178844 0.203193 88 100 15 9 
8748 23828 0.367144 
     4435 26012 0.170482 
 
84 
   5836 25349 0.230226 
 
113 99 21 12 
        
        15516 32558 0.476556 
 
113 
   11381 30912 0.36817 
 
87 
   14530 34443 0.421851 0.422192 100 100 13 7 
15394 31554 0.487871 
 
116 
   14024 31131 0.450473 
 
107 
   11744 36604 0.320834 
 
76 99 21 12 
        
        
        
 258 
TNF actin Ratio Avg 
% 
Control Avg Stdev SEM 
        4288 26990 0.158878 
 
71 
   6237 19119 0.326205 
 
146 
   3687 19281 0.19124 
 
86 
   6128 20365 0.300931 
 
135 
   2800 20309 0.137862 0.223023 62 100 38 17 
2180 24605 0.088598 
 
40 
   3924 23698 0.165566 
 
74 
   4191 22641 0.185125 
 
83 
   4266 21735 0.196272 
 
88 
   6378 19618 0.3251 
     3652 17646 0.206947 
 
93 76 21 9 
        
        13973 33749 0.414026 
 
81 
   15636 38006 0.411409 
 
81 
   15454 41479 0.372577 
 
73 
   18424 26611 0.692328 
 
136 
   17222 26437 0.65144 0.508356 128 100 30 13 
14268 37267 0.382866 
 
75 
   8272 43169 0.191626 
 
38 
   24431 44637 0.547324 
 
108 
   15284 33970 0.449915 
 
89 
   14763 29877 0.494126 
 
97 
   15660 21185 0.739184 
 
145 92 36 15 
 
  
 259 
LC-3 actin Ratio Avg 
% 
Control Avg Stdev SEM 
        117260 37652 3.114308 
 
120 
   98561 37922 2.599052 
 
100 
   100158 35767 2.800323 
 
107 
   76871 40317 1.906666 2.605087 73 100 20 10 
110951 34521 3.214027 
 
123 
   104369 33605 3.105736 
 
119 
   78791 36179 2.177778 
 
84 
   72595 37930 1.913951 
 
73 100 25 13 
        
        88113 39901 2.208278 
 
87 
   87676 38778 2.260983 
 
89 
   102008 37645 2.709746 
 
107 
   112218 37734 2.973935 2.538235 117 100 14 7 
88471 40173 2.202253 
 
87 
   112048 36152 3.099363 
 
122 
   87261 39772 2.194047 
 
86 
   99310 37976 2.61509 
 
103 100 17 8 
        
        
        
LC-3 actin Ratio Avg 
% 
Control Avg Stdev SEM 
        55534 25391 2.187138 
 
91 
   66982 26750 2.504016 
 
104 
   70844 27828 2.545786 2.412313 106 100 8 5 
50457 25463 1.98161 
 
82 
   70318 28795 2.442034 
 
101 
   72514 28522 2.542423 
 
105 96 12 7 
        
        89504 22613 3.958158 
 
98 
   85866 24804 3.461765 
 
86 
   130141 27980 4.651209 4.023711 116 100 15 9 
102285 20496 4.990466 
 
124 
   132599 23949 5.536847 
 
138 
   125783 25925 4.851792 
 
121 127 9 5 
     
0.052244 
  
        
        
 260 
LC-3 actin Ratio Avg 
% 
Control Avg Stdev SEM 
        68398 29027 2.356367 
 
98 
   75630 30242 2.500823 
 
104 
   77250 33005 2.34058 
 
97 
   68316 30083 2.270928 
 
94 
   74331 28467 2.611116 2.415963 108 100 6 3 
75226 26989 2.7873 
 
115 
   72948 23789 3.06646 
 
127 
   69009 23461 2.941448 
 
122 
   60497 22330 2.709219 
 
112 
   72226 26868 2.688168 
 
111 
   77475 26288 2.947164 
 
122 118 6 3 
     
0.000729 
  
        142052 21667 6.556126 
 
115 
   132849 23789 5.584601 
 
98 
   116759 23207 5.031186 
 
88 
   94796 17667 5.365719 
 
94 
   92201 15511 5.944285 5.696384 104 100 10 5 
133505 25013 5.337411 
 
94 
   129169 26110 4.947164 
 
87 
   112272 26140 4.295091 
 
75 
   95496 23364 4.087251 
 
72 
   95948 20566 4.665378 
 
82 
   93666 16817 5.569701 
 
98 85 10 4 
     
0.034094 
   
  
 261 
Ceria nanorod PC, 3NT and HNE at 1 h 
H-PC 
% 
Control Avg SEM 
H-3NT 
% 
Control Avg SEM 
H-HNE 
% 
Control Avg SEM 
                  
         104 
  
73 
  
97 
  119 
  
86 
  
105 
  96 
  
120 
  
96 
  81 
  
140 
  
102 
  100 100 6 82 100 13 100 100 2 
50 
  
115 
  
98 
  55 
  
95 
  
88 
  72 
  
131 
  
113 
  95 
  
75 
  
82 
  95 73 9 71 97 11 103 97 5 
 
0.045879 
        
Ceria nanorod PC, 3NT and HNE at 30d 
 
H-PC 
% 
Control Avg SEM 
H-3NT 
% 
Control Avg SEM 
H-HNE 
% 
Control Avg SEM 
                  
         108 
  
78 
  
103 
  115 
  
78 
  
114 
  74 
  
125 
  
98 
  74 
  
119 
  
79 
  130 100 11 
 
100 11 106 100 6 
133 
  
64 
  
117 
  116 
  
105 
  
105 
  120 
  
109 
  
106 
  153 
  
145 
  
83 
  159 136 9 177 120 19 99 102 6 
 
0.034014 
        
 
  
 262 
          
  Codes 
H1- 
catalase 
H1- 
actin             
1 h       Ratio Avg 
% 
Control Avg Stdev SEM 
C 300 25791 104906 25 
 
101 
   C 302 23834 94695 25 
 
103 
   C 304 21704 88502 25 
 
100 
   C 306 27861 111602 25 
 
102 
   C 308 24788 107684 23 24 94 100 3 2 
          
 
301 18529 85905 22 
 
88 
   
 
303 22402 105374 21 
 
87 
   
 
305 26600 86898 31 
 
125 
   
 
307 23498 105424 22 
 
91 
   
 
309 21175 70720 30 
 
122 103 19 9 
       
0.758464 
  
          
          
          
  Codes 
H1- 
catalase 
H1- 
actin             
30 d       Ratio Avg 
% 
Control Avg Stdev SEM 
          C 310 48843 87740 56 
 
106 
   C 312 59617 110974 54 
 
102 
   C 314 55210 104871 53 
 
100 
   C 316 60859 118461 51 
 
98 
   C 318 44771 90269 50 53 94 100 4 2 
          
 
311 60320 105123 57 
 
109 
   
 
313 54661 104248 52 
 
100 
   
 
315 49007 92481 53 
 
101 
   
 
317 49716 94416 53 
 
100 
   
 
319 51164 78146 65 
 
124 107 11 5 
       
0.220555 
   
  
 263 
        
H1- GPx 
H1- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
17960.92 84906.1 21 
 
75 
   25988 94694.85 27 
 
97 
   31226.06 88501.5 35 
 
125 
   34491.29 91602 38 
 
133 
   21399.81 107683.7 20 28 70 100 28 13 
        25703.38 85904.69 30 
 
106 
   31565 105374.3 30 
 
106 
   35250.72 96898 36 
 
129 
   17657 95423.9 19 
 
65 
   34971.33 90720 39 
 
136 108 28 12 
     
0.647705 
  
        
        
        
H1- GPx 
H1- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
        26410 87740 30 
 
92 
   34173 110974 31 
 
94 
   36549 104871 35 
 
107 
   38179 118461 32 
 
99 
   31650 90269 35 33 108 100 7 3 
        27632 105123 26 
 
81 
   33728 104248 32 
 
99 
   39190 102481 38 
 
117 
   35343 104416 34 
 
104 
   37192 78146 48 
 
146 109 24 11 
     
0.43114 
   
  
 264 
H2-GR 
H2- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
94942.24 65455.89 145 
 
146 
   65358.5 71026.85 92 
 
93 
   62995.75 67575.25 93 
 
94 
   76752.22 78393.14 98 
 
99 
   76415.66 111245.6 69 99 69 100 28 13 
        74610.6 53758.05 139 
 
140 
   76930.27 59538 129 
 
130 
   74888.29 93177 80 
 
81 
   75339 124171.9 61 
 
61 
   92995.5 91937.76 101 
 
102 103 33 15 
     
0.893299 
  
        
        
        
H2-GR 
H2- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
        95660 122352 78 
 
109 
   84515 131233 64 
 
90 
   111991 150220 75 
 
104 
   89449 124089 72 
 
101 
   81165 116994 69 72 97 100 7 3 
        121261 132661 91 
 
127 
   105956 122771 86 
 
120 
   70057 105593 66 
 
93 
   75391 112765 67 
 
93 
   80259 113755 71 
 
98 106 16 7 
     
0.44838 
   
  
 265 
H2- 
MnSOD 
H2- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
74571 65455.89 114 
 
101 
   83764 71026.85 118 
 
105 
   87771 67575.25 130 
 
115 
   93895 78393.14 120 
 
107 
   89889 111245.6 81 112 72 100 17 7 
        66235 53758.05 123 
 
110 
   83715.5 59538 141 
 
125 
   100662.3 93177 108 
 
96 
   83528 124171.9 67 
 
60 
   90010 91937.76 98 
 
87 96 25 11 
     
0.743057 
  
        
        
        H2- 
MnSOD 
H2- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
        58047 122352 47 
 
97 
   64360 131233 49 
 
101 
   61548 130220 47 
 
97 
   63006 124089 51 
 
104 
   57538 116994 49 49 101 100 3 1 
        63843 132661 48 
 
99 
   59203 122771 48 
 
99 
   48856 95593 51 
 
105 
   63124 122765 51 
 
105 
   58429 113755 51 
 
105 103 4 2 
     
0.228172 
   
  
 266 
H3- Hsp-
32 
H3- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
34407.75 64501 53 
 
101 
   48206.93 73955.29 65 
 
123 
   30558.02 82060.62 37 
 
70 
   46972.33 68506.54 69 
 
129 
   41121.93 100806.4 41 53 77 100 26 12 
        41208.92 77315.62 53 
 
101 
   38618.59 87758.08 44 
 
83 
   41328.41 80740.6 51 
 
97 
   38309.09 70582.6 54 
 
102 
   40822.7 76962.11 53 
 
100 96 8 4 
     
0.783199 
  
        
        
        H3- Hsp-
32 
H3- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
        21063 108660 19 
 
80 
   31249 100651 
      24146 88341 27 
 
113 
   21237 89665 24 
 
98 
   22303 83911 27 24 110 100 15 7 
        24661 84883 29 
 
120 
   29342 82365 36 
 
147 
   22284 74691 30 
 
123 
   21520 78953 27 
 
112 
   26065 72920 36 
 
147 130 16 7 
     
0.024616 
   
  
 267 
H4- Hsp-
70 
H4- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
22615 28573 79 
 
73 
   17471 20315 86 
 
79 
   18429.35 17590.5 105 
 
97 
   20026 16963 118 
 
109 
   19963 13012 153 108 142 100 27 12 
        17148 24795 69 
 
64 
   19246.5 20642.09 93 
 
86 
   22355.24 18762.39 119 
 
110 
   18095.5 13790.94 131 
 
121 
   16390.65 11212.6 146 
 
135 103 28 13 
     
0.858505 
  
        
        
        H4- Hsp-
70 
H4- 
actin             
    Ratio Avg 
% 
Control Avg Stdev SEM 
        4553 67088 7 
 
123 
   5288 69844 8 
 
137 
   4420 71980 6 
 
111 
   2356 67023 4 
 
64 
   2281 63630 4 6 65 100 34 15 
        4975 67819 7 
 
133 
   4230 72933 6 
 
105 
   2629 40768 6 
 
117 
   2955 47513 6 
 
113 
   2607 44270 6 
 
107 115 11 5 
     
0.378849 
   
  
 268 
Hippo-
1h 
      Low Catalase Avg %Control Avg STDEV SEM 
aspect activity     %Cotrol     
Hippo 
      310 12.25 
 
88    
312 12.74 
 
91    
314 14.20 
 
102    
316 15.01 
 
107    
318 15.66 13.97 112 100 10 5 
311 18.96 
 
136    
313 14.36 
 
103    
315 20.19 
 
144    
317 15.66 
 
112    
319 16.64 
 
119 123 17 8 
 
 
  
0.034 
  
Cortex 
      310 14.36 
 
88    
312 17.29 
 
106    
314 17.94 
 
110    
316 16.15 
 
99    
318 15.50 16.25 95 100 9 4 
311 17.61 
 
108    
313 20.21 
 
124    
315 19.72 
 
121    
317 18.59 
 
114    
319 18.59 
 
114 117 6 3 
 
 
  
0.009 
  
Cereb 
      310 16.64 
 
94    
312 16.80 
 
95    
314 19.24 
 
109    
316 16.80 
 
95    
318 18.91 17.68 107 100 7 3 
311 22.49 
 
127    
313 22.49 
 
127    
315 18.59 
 
105    
317 19.24 
 
109    
319 23.30 
 
132 120 12 5 
 
 
  
0.013 
  
 
  
 269 
Hippo-
30 days 
      Low Catalase Avg %Control Avg STDEV SEM 
aspect activity     %Cotrol     
Hippo 
      300 16.80 
 
104    
302 14.20 
 
88    
304 16.15 
 
100    
306 15.66 
 
97    
308 17.82 16.13 111 100 8 4 
301 13.23 
 
82    
303 11.60 
 
72    
305 13.23 
 
82    
307 12.09 
 
75    
309 16.80 
 
104 83 13 6 
 
 
  
0.036 
  
Cortex  
  
   
300 19.07 
 
100    
302 18.42 
 
97    
304 21.22 
 
112    
306 19.24 
 
101    
308 16.96 18.98 89 100 8 4 
301 18.75 
 
99    
303 16.31 
 
86    
305 18.10 
 
95    
307 13.55 
 
71    
309 16.47 
 
87 88 11 5 
 
 
  
0.072 
  
Cereb  
     300 19.24 
 
99    
302 22.00 
 
113    
304 20.21 
 
104    
306 18.10 
 
93    
308 17.77 19.46 91 100 9 4 
301 11.76 
 
60    
303 18.10 
 
93    
305 18.42 
 
95    
307 15.99 
 
82    
309 16.80 
 
86 83 14 6 
    
0.052 
  
 
  
 270 
1 h GPx %Control Avg Stdev SEM 
Hippo   %Control     
C 89  
  C 103  
  C 103  
  C 89  
  C 116 100 11 5 
 
116 
 
  
 
116 
 
  
 
103 
 
  
 
129 
 
  
 
103 113 11 5 
  
0.095 
  Cortex   
  
C 119  
  
C 92  
  
C 92  
  C 78  
  C 119 100 18 8 
 
78 
 
  
 
119 
 
  
 
119 
 
  
 
105 
 
  
 
132 111 20 9 
  
0.403 
  Cereb   
  
C 133  
  
C 118  
  
C 103  
  C 73  
  C 73 100 27 12 
 
118 
 
  
 
  
  
 
103 
 
  
 
103 
 
  
 
133 114 15 6 
  
0.374 
   
30    
   
 271 
days 
Low GPx      
   aspect activity Avg %Control Avg Stdev SEM 
  
    %Control     
Hippo 
      C 57.73  94  
  C 49.24  
81 
 
  C 66.22  
108 
 
  C 66.22  
108 
 
  C 66.22 61.13 108 100 12 6 
 
32.26 
 
53 
 
  
 
57.73 
 
94 
 
  
 
57.73 
 
94 
 
  
 
40.75 
 
67 
 
  
 
49.24 
 
81 78 18 8 
    
0.053 
  Cortex     
  
C 57.73  
87 
 
  
C 74.71  
113 
 
  
C 74.71  
113 
 
  
C 66.22  
100 
 
  C 57.73 66.22 87 100 13 6 
 
40.75 
 
62 
 
  
 
57.73 
 
87 
 
  
 
49.24 
 
74 
 
  
 
57.73 
 
87 
 
  
 
32.26 
 
49 72 17 7 
    
0.017 
  Cereb     
  
C 49.24  
91 
 
  
C 49.24  
91 
 
  
C 57.73  
106 
 
  
C 57.73  
106 
 
  C 57.73 54.33 106 100 9 4 
 
49.24 
 
91 
 
  
 
40.75 
 
75 
 
  
 
49.24 
 
91 
 
  
 
49.24 
 
91 
 
  
 
32.26 
 
59 81 14 6 
    
0.034 
  Anti-HNE-LA dot blot 
 272 
 
HNE-
LA Avg 
% 
Control Avg STDEV SEM 
 
            
Control 18263 
 
80 
   
 
26981 
 
118 
   
 
29291 
 
128 
   
 
25470 
 
111 
   
 
22476 
 
98 
   
 
24033 
 
105 
   
 
21245 
 
93 
   
 
19137 
 
84 
   
 
21695 
 
95 
   
 
20217 22881 88 100 15 5 
       
       AD-IPL 10621 
 
46 
   
 
18643 
 
81 
   
 
19410 
 
85 
   
 
18847 
 
82 
   
 
18521 
 
81 
   
 
18054 
 
79 
   
 
13733 
 
60 
   
 
21409 
 
94 
   
 
15274 
 
67 
   
 
20215 
 
88 
   
 
14215 
 
62 
   
 
16492 
 
72 75 14 4 
    
0.000615 
    
 273 
LADH activity 
 
Slope Blank minus 
     -0.0022 -0.0014 0.00304 
 
94 
   -0.0028 -0.002 0.00434 
 
134 
   -0.0023 -0.0015 0.00326 
 
101 
   -0.0024 -0.0016 0.00347 
 
107 
   -0.0017 -0.0009 0.00195 
 
60 
   -0.0023 -0.0015 0.00326 
 
101 
   -0.0024 -0.0016 0.00347 
 
107 
   -0.0028 -0.002 0.00434 
 
134 
   -0.0022 -0.0014 0.00304 
 
94 
   -0.0018 -0.001 0.00217 0.00323 67 100 24 8 
-0.0021 -0.0013 0.00282 
 
87 
   -0.0013 -0.0005 0.00109 
 
34 
   -0.0007 0.0001 -0.00022 
     -0.0013 -0.0005 0.00109 
 
34 
   -0.0007 0.0001 -0.00022 
     -0.0023 -0.0015 0.00326 
 
101 
   -0.0017 -0.0009 0.00195 
 
60 
   -0.0016 -0.0008 0.00174 
 
54 
   -0.0017 -0.0009 0.00195 
 
60 
   -0.0019 -0.0011 0.00239 
 
74 
   -0.0017 -0.0009 0.00195 
 
60 
   -0.0017 -0.0009 0.00195 0.00165 60 62 21 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 274 
LADH levels 
 
  
Dihydrolipoamide dehydrogenase (DHLA) enzyme levels by 
Western blot 
  
   
DHLA Actin 
      Controls 1095 1 40788 8319 490 
 
112 
   
 
1132 2 142398 30834 462 
 
106 
   
 
1142 3 140928 29632 476 
 
109 
   
 
1156 4 135418 30786 440 
 
101 
   
 
1163 6 69563 17866 389 
 
89 
   
 
1170 7 123386 33656 367 437 84 100 11 5 
AD 1184 8 122697 49030 250 
 
57 
   
 
1036 11 29476 10410 283 
 
65 
   
 
1053 12 82201 30908 266 
 
61 
   
 
1104 14 83840 29242 287 
 
66 
   
 
1180 17 84308 26852 314 
 
72 
   
 
1185 18 95149 32031 297 
 
68 
   
 
1188 19 74347 22383 332 
 
76 
   
 
1196 20 95777 31417 305 
 
70 
   
 
1202 21 100089 27064 370 
 
85 
   
 
1204 22 69675 21575 323 
 
74 69 8 2 
        
1.53E-05 
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